CRISPRimmunity

Please click to download your results

Overview of predicted results

Overview of the results

Contig_ID	Contig_def	CRISPR array number	Contig Signature genes	Self targeting spacer number	Target MGE spacer number	Prophage number	Anti-CRISPR protein number
NZ_CP012387	Mycoplasma mycoides subsp. capri strain GM12 chromosome clone YCpMmyc1.1-deltaglf, complete genome	7 crisprs	NA	0	1	1	0

Results visualization

Click the left colored region to show detailed information

CRISPR-Cas detection and classification

Crispr_ID: NZ_CP012387_1

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP012387_1

140556-140639

Orphan

Consensus_repeat	Method
AAAAAACACTGGAATTCCATATA	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP012387_1

>merge|NZ_CP012387|1|140556-140639|CRISPRCasFinder
AAAAAACACTGGAATTCCATATATTTTTTTCTAAATTACTAAAAAACAATCTTTTTACGAAAAAAAACACTGGAATTCCATATA

>NZ_CP012387|1|1|140556-140639|CRISPRCasFinder
AAAAAACACTGGAATTCCATATA	TTTTTTTCTAAATTACTAAAAAACAATCTTTTTACGAA
AAAAAACACTGGAATTCCATATA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP012387.1\|WP_020862494.1\|135677_136589_+\|5'-3'-exonuclease	unknown	unknown	gnl\|CDD\|214682
NZ_CP012387.1\|WP_020862503.1\|145929_146328_-\|transcription-antitermination-factor-NusB	unknown	unknown	gnl\|CDD\|273891
NZ_CP012387.1\|WP_020862502.1\|144518_145928_-\|exodeoxyribonuclease-VII-large-subunit	unknown	unknown	gnl\|CDD\|272979
NZ_CP012387.1\|WP_020862491.1\|131271_131988_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020862504.1\|146339_147452_-\|lipoprotein	unknown	unknown	gnl\|CDD\|234767
NZ_CP012387.1\|WP_020862488.1\|125537_127628_-\|lipoprotein	unknown	unknown	gnl\|CDD\|173412
NZ_CP012387.1\|WP_020862490.1\|130517_131288_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020862506.1\|148339_149092_-\|riboflavin-kinase	unknown	unknown	gnl\|CDD\|214901
NZ_CP012387.1\|WP_020862496.1\|137798_138716_+\|DNA-adenine-methylase	unknown	unknown	gnl\|CDD\|223415
NZ_CP012387.1\|WP_020862499.1\|142948_143506_+\|dephospho-CoA-kinase	unknown	unknown	gnl\|CDD\|238980
NZ_CP012387.1\|WP_020862492.1\|132102_134937_-\|preprotein-translocase-subunit-SecA	unknown	unknown	gnl\|CDD\|237258
NZ_CP012387.1\|WP_020862495.1\|136792_137809_+\|DNA-adenine-methylase	unknown	unknown	gnl\|CDD\|225927
NZ_CP012387.1\|WP_020862493.1\|135027_135603_+\|YigZ-family-protein	unknown	unknown	gnl\|CDD\|376491
NZ_CP012387.1\|WP_020862500.1\|143507_144314_-\|TlyA-family-RNA-methyltransferase	unknown	unknown	gnl\|CDD\|224110
NZ_CP012387.1\|WP_020862489.1\|127857_130347_-\|lipoprotein	unknown	unknown	gnl\|CDD\|223496
NZ_CP012387.1\|WP_020862501.1\|144313_144529_-\|exodeoxyribonuclease-VII-small-subunit	unknown	unknown	gnl\|CDD\|273536
NZ_CP012387.1\|WP_020862505.1\|147477_148347_-\|deoxyribonuclease-IV	unknown	unknown	gnl\|CDD\|179214
NZ_CP012387.1\|WP_008362926.1\|142671_142947_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020862498.1\|140716_142012_+\|ATP-binding-protein	unknown	unknown	gnl\|CDD\|224292
NZ_CP012387.1\|WP_020862497.1\|138693_140277_+\|AlwI-family-type-II-restriction-endonuclease	unknown	unknown	gnl\|CDD\|312855

Protein	Function_ID	Function_description	E-value
NZ_CP012387.1\|WP_020862494.1\|135677_136589_+\|5'-3'-exonuclease	gnl\|CDD\|214682	smart00475, 53EXOc, 5'-3' exonuclease.	3.91482e-70
NZ_CP012387.1\|WP_020862503.1\|145929_146328_-\|transcription-antitermination-factor-NusB	gnl\|CDD\|273891	TIGR01951, nusB, transcription antitermination factor NusB. A transcription antitermination complex active in many bacteria was designated N-utilization substance (Nus) in E. coli because of its interaction with phage lambda protein N. This model represents NusB. Other components are NusA and NusG. NusE is, in fact, ribosomal protein S10. [Transcription, Transcription factors].	9.6032e-29
NZ_CP012387.1\|WP_020862502.1\|144518_145928_-\|exodeoxyribonuclease-VII-large-subunit	gnl\|CDD\|272979	TIGR00237, exodeoxyribonuclease_VII_large_subunit, exodeoxyribonuclease VII, large subunit. This family consist of exodeoxyribonuclease VII, large subunit XseA which catalyses exonucleolytic cleavage in either the 5'->3' or 3'->5' direction to yield 5'-phosphomononucleotides. Exonuclease VII consists of one large subunit and four small subunits. [DNA metabolism, Degradation of DNA].	2.41865e-150
NZ_CP012387.1\|WP_020862505.1\|147477_148347_-\|deoxyribonuclease-IV	gnl\|CDD\|179214	PRK01060, PRK01060, endonuclease IV; Provisional.	4.01977e-127
NZ_CP012387.1\|WP_020862504.1\|146339_147452_-\|lipoprotein	gnl\|CDD\|234767	PRK00448, polC, DNA polymerase III PolC; Validated.	0.00935916
NZ_CP012387.1\|WP_020862488.1\|125537_127628_-\|lipoprotein	gnl\|CDD\|173412	PTZ00121, PTZ00121, MAEBL; Provisional.	2.42944e-12
NZ_CP012387.1\|WP_020862501.1\|144313_144529_-\|exodeoxyribonuclease-VII-small-subunit	gnl\|CDD\|273536	TIGR01280, xseB, exodeoxyribonuclease VII, small subunit. This protein is the small subunit for exodeoxyribonuclease VII. Exodeoxyribonuclease VII is made of a complex of four small subunits to one large subunit. The complex degrades single-stranded DNA into large acid-insoluble oligonucleotides. These nucleotides are then degraded further into acid-soluble oligonucleotides. [DNA metabolism, Degradation of DNA].	6.53311e-06
NZ_CP012387.1\|WP_020862506.1\|148339_149092_-\|riboflavin-kinase	gnl\|CDD\|214901	smart00904, Flavokinase, Riboflavin kinase. Riboflavin is converted into catalytically active cofactors (FAD and FMN) by the actions of riboflavin kinase, which converts it into FMN, and FAD synthetase, which adenylates FMN to FAD. Eukaryotes usually have two separate enzymes, while most prokaryotes have a single bifunctional protein that can carry out both catalyses, although exceptions occur in both cases. While eukaryotic monofunctional riboflavin kinase is orthologous to the bifunctional prokaryotic enzyme. the monofunctional FAD synthetase differs from its prokaryotic counterpart, and is instead related to the PAPS-reductase family. The bacterial FAD synthetase that is part of the bifunctional enzyme has remote similarity to nucleotidyl transferases and, hence, it may be involved in the adenylylation reaction of FAD synthetases. This entry represents riboflavin kinase, which occurs as part of a bifunctional enzyme or a stand-alone enzyme.	2.89707e-39
NZ_CP012387.1\|WP_020862496.1\|137798_138716_+\|DNA-adenine-methylase	gnl\|CDD\|223415	COG0338, Dam, Site-specific DNA methylase [DNA replication, recombination, and repair].	2.99589e-27
NZ_CP012387.1\|WP_020862499.1\|142948_143506_+\|dephospho-CoA-kinase	gnl\|CDD\|238980	cd02022, DPCK, Dephospho-coenzyme A kinase (DPCK, EC 2.7.1.24) catalyzes the phosphorylation of dephosphocoenzyme A (dCoA) to yield CoA, which is the final step in CoA biosynthesis.	7.52592e-35
NZ_CP012387.1\|WP_020862492.1\|132102_134937_-\|preprotein-translocase-subunit-SecA	gnl\|CDD\|237258	PRK12903, secA, preprotein translocase subunit SecA; Reviewed.	0
NZ_CP012387.1\|WP_020862495.1\|136792_137809_+\|DNA-adenine-methylase	gnl\|CDD\|225927	COG3392, COG3392, Adenine-specific DNA methylase [DNA replication, recombination, and repair].	1.28918e-66
NZ_CP012387.1\|WP_020862493.1\|135027_135603_+\|YigZ-family-protein	gnl\|CDD\|376491	pfam01205, UPF0029, Uncharacterized protein family UPF0029.	1.35261e-43
NZ_CP012387.1\|WP_020862500.1\|143507_144314_-\|TlyA-family-RNA-methyltransferase	gnl\|CDD\|224110	COG1189, COG1189, Predicted rRNA methylase [Translation, ribosomal structure and biogenesis].	9.92721e-90
NZ_CP012387.1\|WP_020862489.1\|127857_130347_-\|lipoprotein	gnl\|CDD\|223496	COG0419, SbcC, ATPase involved in DNA repair [DNA replication, recombination, and repair].	9.30222e-14
NZ_CP012387.1\|WP_020862498.1\|140716_142012_+\|ATP-binding-protein	gnl\|CDD\|224292	COG1373, COG1373, Predicted ATPase (AAA+ superfamily) [General function prediction only].	4.42008e-57
NZ_CP012387.1\|WP_020862497.1\|138693_140277_+\|AlwI-family-type-II-restriction-endonuclease	gnl\|CDD\|312855	pfam09491, RE_AlwI, AlwI restriction endonuclease. This family includes the AlwI (recognizes GGATC), Bsp6I (recognizes GC^NGC), BstNBI (recognizes GASTC), PleI(recognizes GAGTC) and MlyI (recognizes GAGTC) restriction endonucleases.	2.94452e-32

>NZ_CP012387.1|WP_020862497.1|138693_140277_+|AlwI-family-type-II-restriction-endonuclease
MRKVEEHKPISFSTTMRNPERMSQFIACMKDFEGHILTDELIMQIVRKVIKNKLYKPNYIKENCAINNIYNDESSTFSNVQLDDIVNNSPQNHKEAGFAKGWSSRFDTWYKLCKEFGFIYYDMDKKIEISSSGHMLCDAYLLNSKYDDLNNSGKKIQKIFLNALMKYQTNNPFRRNLNQNAPIPLLLNVLNLLALNSYSTGLHRREIPFLMCWENNDYERLYEFIINFRNKYGFKASDEIIYEECLKLLKSSNKKRFKMSQIIKEGVDDFIRKLRITGIFSLRGLGRFVDINKLESESVDYIIKNYTKYNIFSNKYDFYKYMSEIDTKILEFQEIAANHEINNIRIKTLRKISQKYSVEQIHKELRNLQLNKNSEDEYFKLIDSPTRLEFLTSIAIIQKFPQYEIHPNYSIDDEGNPTFTAKGGVADIEIYDTNLNSIVEVTLMKSRQQAANEIPAITRHLKKQRDDYGNNNVFSLFIAPNIHEDTVYMCEFTRYKEKLGIYPYTIVDFVQKIQTTNSLLELEYNLN
>NZ_CP012387.1|WP_020862496.1|137798_138716_+|DNA-adenine-methylase
MKNNIRSPFFYVGDKYKIMPQIVKFFPEKINNYYEPFLGGGSSAMYTKANKYFLNDINKSIIDLHKYLSSYSKNKNLLLNNLFKLIKKYRLSCSYLSITVPDELKKKYVKTYYSKFNKESYIELRNDYNKKNDSLKLYLLLIYGFNHMIRFNQQGKFNLPVGNVDFNKNVYQALMTYLEFADDNKIEFSNNDYIDFIKEIDFKEGDFIYLDPPYLISNSEYNRNWTIIDEQNLYDLIDNLDRKKVYFGLSNMLTHKGRKNHLLEKRMKKYYIHEIKSNYISRFDNKIKKDSKEVYITNYEKSRRT
>NZ_CP012387.1|WP_020862495.1|136792_137809_+|DNA-adenine-methylase
MRLTSRRYIGSKAKLLDWIFSNIDNNVKGNSFFDIFAGTGCVIEKALTSYDSVIINDILSSNKVVYDAFWGDIVINIDIINKYKLMFNSLDSIIDHNYFSINYGDKYFGVNDSKKIGYIRELIENDFKKNYINRREKNILLASLIYSIDKIANTVGHYEAYRKVEIIDNRFKFDLIDIPNKNINKKVEIYKEDANRLARKIYSDIVFVDPPYNSRQYSRFYHVIENLVEWEKPELFGIALKPAPQKMSEYCRNNAPAVFDDLITNLNCKYIVVTYNNTYNSKSSSSKNKIKLEEILNSLNKRGKTQIFSSDHRFFNAGKTSLPNHKEYLFITEVTCEK
>NZ_CP012387.1|WP_020862494.1|135677_136589_+|5'-3'-exonuclease
MITNETKPILLIDGYHLLHKGYYGTLKRTIVSKNKDGIVINAIYSFVANILKFVQSDRYHSVIVAFDFDENCWRKELYSEYKAKRKPTPIDLVPQLQIARDFLTSANISWYEKYNYEGDDVIGSICRIANKLGYDVCILTNDKDIYQLVNNKTSIITNISKKEKTKIIKPQQVYEHFLCQPNQVADIKAILGDQSDNIKGVKYIKRKQAENLINKYENVENILAHINELNEPLKTIISENKQLIIDNKKITKILTNVKLGRINFKPTKITYYGLIRFLKEQEMYAFIKPIRRYLDRTNKNLKK
>NZ_CP012387.1|WP_020862493.1|135027_135603_+|YigZ-family-protein
MKTIKKEIYKNEFIIKNSKFITIATNINSKDELEEFLNKYSDINATHNCYAYMIYDQKLIGGYNDDHEPKNTAGKPIFNVISKNNLVNIVILVIRYFGGIKLGASVLTRTYSNAASLIIKDLEIIEIKTYYQYLISFDIKNLKLVNQWINQNNIEIISKDFSLNVVFKIRSTSKITSCNFFKIIDFKTIKN
>NZ_CP012387.1|WP_020862492.1|132102_134937_-|preprotein-translocase-subunit-SecA
MVSDKRLLKKFGKIADKIIALEPQMRQLKDEDFILKTQEFKQMLEDGKSLDDILIEVYAVAREAARRVLGLNAYKVQLIGGIILNSGDIAEMRTGEGKTLTGIFPAYLNALSGKGVHIVTVNEYLSKRDSEINGQVFDLLGISVGLNGSSLTKTEKREAYNKDITYTTNAELGFDYLRDNMVSDYSLKVQRKLNYCIIDEADSVLIDEARTPLIISGGTSTRINLYKAANNFALTLKEHDDLDIDLESKQVYLNEQGMKKANEFFSLKNLFAIENTEIFHLIMNALKAQFAFKEGVEYTVRDNEILLIDQFTGRIMHGRSYSDGLQQALQAKENVDIEEETVTLATITYQNFYRLYSKIAGMTGTAKTEEEEFIKIYNTRVIQTPTNKPVIRKDEPDLTFGTKNAALKKLVEDVLEAHEKGAPILIGTTSVESSEQIARYLKKANLKFETINAKNHDREAEIVSKAGEIGAITLATNMAGRGTDIKLAKGVAELGGLRVFGVERNEARRIDNQLRGRSGRQGDPGLSRFYISMDDDLMMRFTAPKTRQRFKALGDDYIKSKMFTRAVTNAQKKLEGMNFDQRKNVLDYDNILAQQREIIYAQRDDILEANDLSVVIEKMQITAAYELIEKHSTLVHGEKTINKKELLDAIDGTLVPKNKFRVDDFNNKEKMDLAVEIAEGMMQLYKARISDIPDDVIIGMERKIILDSFDKYWTKHLDIAGKLKSGIYLQQYAQNNPLAIYVEQATDLFNKMKINIANEVVENLANVILRVVEDEEQREERIEVTDKDIEEILFETGLQPSDINNKAINQRFDELEEEFKDDKQKLRRLRIQRDVMLGLVLELERRAEMIISPQNDQQAITQLIKELQNDIDIASITIDQIHQNFNNMVEQINDPEKLKHLVIAKDVLLQLVARMDDIKEQEKQTRKKKKKKPHEDESSKTKIG
>NZ_CP012387.1|WP_020862491.1|131271_131988_-|hypothetical-protein
MQKRTIKSDTIFYSVILFLNLLTNFIYWITHAFNVVYVDEPTNLDIVLALDSASIAIWGLWISTFYAGICLYHSFIKKQLYQAYLLQLFIISMLISTGLIFIGISIINKTANINNWSALLRVVNVHFLLPTSMLLYLIFFRTNMIISKKSKLVGMWRILAVGLSYISWITYRTVPNVQVNLINKPFLYTSLQPSNIGWAIFMSLSFSSFILYFLTYLIIVLINNKINDKYGGCDAKTI
>NZ_CP012387.1|WP_020862490.1|130517_131288_-|hypothetical-protein
MLKRFNQFRQQRSFKLELIISSILLFFAISCLVLYFITKSVGLYNKKTLSADVIFLQDITFLSEWYAVFVMIFCSFKISRMLTSKQVYLYKYTEYSFTSWSIFIFLLYIAGFIMGQAIINDDKDFPTLYRALAIHVFIPITWITYFILFPLNDQKTKKQLWLGCLQTFTILCFYSLWLLLRLLPGISLDDKIWINKIPYSFISPYNIGVIKYIFVNIGIFSVFIGGYILTYYSNKFIYKRITTSKNIDKTKEIITK
>NZ_CP012387.1|WP_020862489.1|127857_130347_-|lipoprotein
MKKLLTILGSIMISTSGAALVVACKTPATKQPTNSNENTNQNEPTRPSEKDKDQTDPKKPVEPVNPSSKPENNQTKPTENYDPKTYKDTTIFNRHFVSGNPSSWVGTIHNSSFIYGSPFKPNNETKPNESTTPIEPKKPVDPTPSTKPNDNNRNDSNSNQSRPLTPLQPSIPTNKPETKPVSPTTTWYSVYNDSATGADINLNPTKEQIEKEEKRLEDWVKEYLDKNKRENQALFDYLIKIEYDRIFRDSPTGADINFYLTKEQIEAENKKQEDQLKAILDKNYKDNFANLMAIKASQTIKELFSDEFSDLVKQAVQRYKHHGDTHARESAKITEEIFSDEFSNKVKEAVERYKKHGDTHARESAKATIELFSDEFSDLVKQAVQRYKHHGDTHARESANAAEKLFNDKYNLVNEYKHNLETKLAKLNEEVNTHILERTRIEKEYNNKEKELEELATNNLVTLKKEYETGKQNLESRKTENETKLDRITLELPKLKDQKEKIKEEIKDSTELLEEAKLLLKENQDKQVEHNKVLNQAKDLEHQIDSINKQIESKNKLVTDNNNKEKELLDIEKELDKELSEEKVIIKQLDDENKLYEKIIDDLKKETYDSDLWFYDYGDWTLWTGFNHNKIARLKNYIYGNKELKKEVPNIIKNLEKELEITKQQNIEKIKQLKEQNTKIQAEISEITKSLEPLNAEKNKIDKQLSDINSEVVKTNKNIELYTNNLRTLEEEITSNSELQKQIIAQIDQYTSDQLSLEKQKEEILNSIKEFENSTNKIILESKQQYEDELLKLEKQAHSLESKEDEKIKEIEKTIAKLKESIKLLNQKY
>NZ_CP012387.1|WP_020862488.1|125537_127628_-|lipoprotein
MKKLLAILGTIAISSTGASLVIACNNPNSKPSVEPDKTTPKNKPKETAKEETDKNSTNKTDKNSKESSDKNNTVLTKRSWNSVFNDSLTGYDIIYKLDETVLQNNKHYKFFVNSSSNLVSDLFDDKFAEEVKEAKNRWDKIQAKKTKLEKERLYKEFTTSSANATEDYFKTLEKIAELEAKAEAKKKELEKWEAKLAEEFKNSASSTTEDYFKTLEKISELEAKAKEKEKEAENRTKAEEKAEKEKVDNLIDAEINAELASDLTEDYFKTLEKIAELEAKAEAKKKELEKWEAKLAEEFKNSASSTTEDYFKTLEKISELEAKAKEKEKEAENRTKAEEKAEKEKVDNLIDAEINAELASDLTEDYFKTLEKIAELEAKAEAKKKELEKWEAKLAEEFKNSASSTTEDYFKTLEKISELEAKAKEKEKEAENRTKAEEKAEKEKVDNLIDAEINAELASDLTEDYFKTLEKIAELEAKAEAKKKELEKWEAKLAEEFKNSASSTTEDYFKTLEKISELEAKAKEKEKEAENRTKAEEKAEKEKVDNLIDAEINAELASDLTEDYFKTLEKIAELEAKAEAKKKELEKWEAKLAEEFKNSASSTTEDYFKTLDTTKEVSEWNSEKEKLIQLISNINKQVEELKESGKDINSVIVTVESNLESYKNNIKEHKNSKDFWRFEMWSHWLEDVLANLKKQN
>NZ_CP012387.1|WP_020862498.1|140716_142012_+|ATP-binding-protein
MVIKRDQYLDKLISKKHNGRVKIITGIRRCGKSYLLFNLFKDYLLDNGVDQSQIITMNLDDPLNVKYHNPLELYNYFLNKTTNKEIQYYVFIDEIQNCQAIKNPYFKEDSKLIDFTGVLIGLMLHENIDIYVTGSNSKMLSSEIVTEFRDRGDEIKVYPLTFKEIYESKQVKNFDLKTYFIYGGMPFVYKIDSSNERAIYLKNLFKTTYIRDILERYNVNNDQLILETLLNFISSNIGSLTNPLKLANRFLSEQKTKISSNTISKYIRYFEESFIISKAKRYDVKGAKYFTTPLKYYFTDIGLRNAWLNFSELDRSHILENIVYNELKIRGFNVDVGYLLYDQKSSDSRNIHNLEIDFIANLIDLKYYIQVALNIDEADKKEQEIRPLLKVNDNYKKVVIVYDDIFEHYDNNGILYIGLKKFLLDPEALNS
>NZ_CP012387.1|WP_008362926.1|142671_142947_+|hypothetical-protein
MSYYYRHNFSFSYHGLQRAKERLKLKDKKDYEVKEICLEHIRNSTKSFMSGNEIYISASNTNIFFVVNKTNNLIITVTEISAEKQLRMHGI
>NZ_CP012387.1|WP_020862499.1|142948_143506_+|dephospho-CoA-kinase
MIIGIYGKIGSGKTYISNKFINFHPEFKIINADNVSKKLLEDSKIKSKLFEIDNNIIKNDIVDKKYLRKKLFTNKKLKQQVDSLLWPLISKQIQKEIKNNPNTNYIIEAALLFELNLTNLDLIVKVKSSLLKSIFRVLKRDKTNIRDILRIRRNQNKSIKRKKPDLVISNFYQLEFYIQKNRLLI
>NZ_CP012387.1|WP_020862500.1|143507_144314_-|TlyA-family-RNA-methyltransferase
MKLRLDEYIYKNNLTQSRNKAKEHILNKEVYVNNIAIIKPSFLVDSNDLIEIRSTKLEYVSRAYEKLKKAINKWNIDLTNKICLDIGASTGGFTQCCLDNNASLVYAVDVGTDQLHSSLLNNLKVINMSQYNFRNAKKQDFLKSIDFVCCDVSFISLEKIFLPLKDILEFNTSGVFLIKPQFELQPKNIKNGRINSKLDHKQAILKVISYANNNSFDVINLDYSPILGNKKQNIEYLAYVIKKENNYKIWKEDQINQLVNIAWKELKK
>NZ_CP012387.1|WP_020862501.1|144313_144529_-|exodeoxyribonuclease-VII-small-subunit
MSNKSKSYDELISEIKEDTKKLSSNEISVEQAMEIFEQNIEKIKLAKEKLTQYKGQIYKVMQDDELEEFKD
>NZ_CP012387.1|WP_020862502.1|144518_145928_-|exodeoxyribonuclease-VII-large-subunit
MEKILTVQELNEALKTLIENKQEFKDIYVQGELSNLTFNKSGHIYFSIKEQDAAINCMMWKTNAYKIQSLNLEDGMQIICYGRLTYYIPTGRVSFEVRDIKIHGIGDLQKIFEQRYKELEQKGWFDPNLKKPIPEFVKNVGIITADSGAAIYDLIRTIHRRLPLINIFLFPAQVQGDKAEKDIANKIKQANDFKVQLDVLIVGRGGGSYEDLWAFNELEVLQAIKNSQIPIISAVGHEPDWVLSDYVADIRAATPTAAGELVSKSIIEIKNQLKHYYQNYKTLILNKLDFFDEKLNNYKKEQTKYIKNNFSFKYLQLKQLSIDNTKWTKNKINLVIDKLENYKQSINNSTLHIINSQNKTLKNYLIADEQKILNYLKKQISEFNYTISSFKGHINQILKYEELSFNTLENKLNSLDPLKPLQNGYSIVTNLNHQKIRSYKQVKLNEDLKVILTDSKLTVTIKEVKINEQ
>NZ_CP012387.1|WP_020862503.1|145929_146328_-|transcription-antitermination-factor-NusB
METKISFSKKRKLLIQTFYKYQLLNASIDYIHQDILDDVQNINNKDVLFEIEQIAKKQTDLINHININVSSSWKWDRIPAVIRAILIVGTYEILYTNTPKPVTINEMVKYVKEIEPDFDYKFVNAVLDKLVK
>NZ_CP012387.1|WP_020862504.1|146339_147452_-|lipoprotein
MKKLLSIITGFSLLITPSLFAISCSSKVQVISKFDDITSIKNTGAFKNNQAFISRNELKEIVNSNNTTNSSTASSTAVMTSTSTTSTGTQPNNNDAKYASERLKALAANNFTKNKKQAWDSLQNTSMTFYKKVEPTAVNVLGYEQITKDNVEKLEKNLKTVFLVFKDNTKETEKLEVELLPEINNGNKVIDNGSLYLDLLEKPENLKLANQKSIIEVLRPEITKIKVVLQNTKNNNSTNKEDIKNTEVFNLLIKQLSIYLANTVKYFNSESGIITTNPTFSYKTRSNQIYDYIVKNKKDELYKKLETAFTSEFNKINFIDIFKDFQFDENNSNDNKKITTKIIKSSTNSSTSSSNSSTTTTTEPSSTTTR
>NZ_CP012387.1|WP_020862505.1|147477_148347_-|deoxyribonuclease-IV
MNKVLLGCHVSMNKQNNYLVGSVNEAISYKANTFMIFTGPPQSTLRTNTNHLYINQMHELMNSYKIDAKDLVVHAPYIINIANSVDQNKWKFAVDFLIQEIKRCEEIKIPTLVLHPGSHTTGNYKDSLNQIIKALDIVSNYQVNVKIALETMSGKGTEVCSKLEDFKYILDNVKNKDKVGVCLDTCHLHDAGYDLSKWDEFKEQMKQNFDLNKVLCIHLNDSKNMISSHKDRHANIGYGYVGFDTLVNVVFDKDFSNISKILETPYIDKKPPYKIEIEDLLNKTFTNRL
>NZ_CP012387.1|WP_020862506.1|148339_149092_-|riboflavin-kinase
MNNQIIALFCDFKYITTKLLNKFNKNQLIIFGYSLNKDDFDYICSDYQLEIFKNQNYKFIDLKNENIDQLVKKYQISKIHITKSFKNYDHFLNFFPNTITEDDLLDINNIKKALINADINTFYKIAGFNYTFSGIVTHCNHLGRTIGFPTANILTNDSLVIKNGVYLVKVIIGDKNIQFGMGDHWINRNNLKVFETYIFNFSNDIYNSKITFELLDYIRDNQKINSLDQLKTLLNNDKKECLKRLEKYNE

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP012387_2

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP012387_2

229403-229493

Orphan

Consensus_repeat	Method
AATAATTAAGGTGTATTTCCACCTTTTTT	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP012387_2

>merge|NZ_CP012387|2|229403-229493|CRISPRCasFinder
AATAATTAAGGTGTATTTCCACCTTTTTTGTTCATTATAATTTTATCATAAAAATACCTACGAATAATTAAGGTGTATTTCCACCTTTTTT

>NZ_CP012387|2|2|229403-229493|CRISPRCasFinder
AATAATTAAGGTGTATTTCCACCTTTTTT	GTTCATTATAATTTTATCATAAAAATACCTACG
AATAATTAAGGTGTATTTCCACCTTTTTT

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP012387.1\|WP_013729329.1\|242986_243478_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_017698021.1\|218559_219570_+\|ABC-transporter-permease	unknown	unknown	gnl\|CDD\|224094
NZ_CP012387.1\|WP_020862561.1\|239020_240820_+\|lipoprotein	unknown	unknown	gnl\|CDD\|270303
NZ_CP012387.1\|WP_023905929.1\|243492_245910_+\|ABC-transporter-permease-subunit	unknown	unknown	gnl\|CDD\|224096
NZ_CP012387.1\|WP_020862559.1\|235048_236848_-\|alpha-glycosidase	unknown	unknown	gnl\|CDD\|200477
NZ_CP012387.1\|WP_020862550.1\|221285_223154_+\|ABC-transporter-ATP-binding-protein	unknown	unknown	gnl\|CDD\|185037
NZ_CP012387.1\|WP_020862555.1\|230530_232228_-\|LppA-family-lipoprotein	unknown	unknown	gnl\|CDD\|274602
NZ_CP012387.1\|WP_020862549.1\|219583_221284_+\|ATP-binding-cassette-domain-containing-protein	unknown	unknown	gnl\|CDD\|223521
NZ_CP012387.1\|WP_017698022.1\|216587_217082_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020862554.1\|229615_230497_+\|Cof-type-HAD-IIB-family-hydrolase	unknown	unknown	gnl\|CDD\|319818
NZ_CP012387.1\|WP_020862547.1\|213823_216514_-\|alanine--tRNA-ligase	unknown	unknown	gnl\|CDD\|234701
NZ_CP012387.1\|WP_020862552.1\|226689_227985_-\|ATP-binding-protein	unknown	unknown	gnl\|CDD\|224292
NZ_CP012387.1\|WP_020862557.1\|232627_234310_-\|LppA-family-lipoprotein	unknown	unknown	gnl\|CDD\|274602
NZ_CP012387.1\|WP_020862551.1\|223170_226272_+\|lipoprotein	unknown	unknown	gnl\|CDD\|173869
NZ_CP012387.1\|WP_020862562.1\|241114_242905_+\|lipoprotein	unknown	unknown	gnl\|CDD\|270450
NZ_CP012387.1\|WP_020862560.1\|236966_238763_-\|alpha-glycosidase	unknown	unknown	gnl\|CDD\|200477
NZ_CP012387.1\|WP_020862548.1\|217299_218544_+\|ABC-transporter-permease	unknown	unknown	gnl\|CDD\|223674
NZ_CP012387.1\|WP_020862553.1\|228079_229384_-\|ATP-binding-protein	unknown	unknown	gnl\|CDD\|224292
NZ_CP012387.1\|WP_129868080.1\|226435_226642_+\|type-II-toxin-antitoxin-system-RelB/DinJ-family-antitoxin	unknown	unknown	gnl\|CDD\|274102
NZ_CP012387.1\|WP_020862558.1\|234419_235049_-\|beta-phosphoglucomutase	unknown	unknown	gnl\|CDD\|213672

Protein	Function_ID	Function_description	E-value
NZ_CP012387.1\|WP_017698021.1\|218559_219570_+\|ABC-transporter-permease	gnl\|CDD\|224094	COG1173, DppC, ABC-type dipeptide/oligopeptide/nickel transport systems, permease components [Amino acid transport and metabolism / Inorganic ion transport and metabolism].	5.06323e-47
NZ_CP012387.1\|WP_020862561.1\|239020_240820_+\|lipoprotein	gnl\|CDD\|270303	cd13585, PBP2_TMBP_like, The periplasmic-binding component of ABC transport systems specific for trehalose/maltose and similar oligosaccharides; possess type 2 periplasmic binding fold. This family includes the periplasmic trehalose/maltose-binding component of an ABC transport system and related proteins from archaea and bacteria. Members of this group belong to the type 2 periplasmic-binding fold superfamily. PBP2 is comprised of two globular subdomains connected by a flexible hinge and bind their ligand in the cleft between these domains in a manner resembling a Venus flytrap. The majority of PBP2 proteins function in the uptake of small soluble substrates in eubacteria and archaea. After binding their specific ligand with high affinity, they can interact with a cognate membrane transport complex comprised of two integral membrane domains and two cytoplasmically located ATPase domains. This interaction triggers the ligand translocation across the cytoplasmic membrane energized by ATP hydrolysis.	0.00464598
NZ_CP012387.1\|WP_023905929.1\|243492_245910_+\|ABC-transporter-permease-subunit	gnl\|CDD\|224096	COG1175, UgpA, ABC-type sugar transport systems, permease components [Carbohydrate transport and metabolism].	5.22718e-56
NZ_CP012387.1\|WP_020862559.1\|235048_236848_-\|alpha-glycosidase	gnl\|CDD\|200477	cd11338, AmyAc_CMD, Alpha amylase catalytic domain found in cyclomaltodextrinases and related proteins. Cyclomaltodextrinase (CDase; EC3.2.1.54), neopullulanase (NPase; EC 3.2.1.135), and maltogenic amylase (MA; EC 3.2.1.133) catalyze the hydrolysis of alpha-(1,4) glycosidic linkages on a number of substrates including cyclomaltodextrins (CDs), pullulan, and starch. These enzymes hydrolyze CDs and starch to maltose and pullulan to panose by cleavage of alpha-1,4 glycosidic bonds whereas alpha-amylases essentially lack activity on CDs and pullulan. They also catalyze transglycosylation of oligosaccharides to the C3-, C4- or C6-hydroxyl groups of various acceptor sugar molecules. Since these proteins are nearly indistinguishable from each other, they are referred to as cyclomaltodextrinases (CMDs). The Alpha-amylase family comprises the largest family of glycoside hydrolases (GH), with the majority of enzymes acting on starch, glycogen, and related oligo- and polysaccharides. These proteins catalyze the transformation of alpha-1,4 and alpha-1,6 glucosidic linkages with retention of the anomeric center. The protein is described as having 3 domains: A, B, C. A is a (beta/alpha) 8-barrel; B is a loop between the beta 3 strand and alpha 3 helix of A; C is the C-terminal extension characterized by a Greek key. The majority of the enzymes have an active site cleft found between domains A and B where a triad of catalytic residues (Asp, Glu and Asp) performs catalysis. Other members of this family have lost the catalytic activity as in the case of the human 4F2hc, or only have 2 residues that serve as the catalytic nucleophile and the acid/base, such as Thermus A4 beta-galactosidase with 2 Glu residues (GH42) and human alpha-galactosidase with 2 Asp residues (GH31). The family members are quite extensive and include: alpha amylase, maltosyltransferase, cyclodextrin glycotransferase, maltogenic amylase, neopullulanase, isoamylase, 1,4-alpha-D-glucan maltotetrahydrolase, 4-alpha-glucotransferase, oligo-1,6-glucosidase, amylosucrase, sucrose phosphorylase, and amylomaltase.	0
NZ_CP012387.1\|WP_020862550.1\|221285_223154_+\|ABC-transporter-ATP-binding-protein	gnl\|CDD\|185037	PRK15079, PRK15079, oligopeptide ABC transporter ATP-binding protein OppF; Provisional.	8.90541e-78
NZ_CP012387.1\|WP_020862551.1\|223170_226272_+\|lipoprotein	gnl\|CDD\|173869	cd08504, PBP2_OppA, The substrate-binding component of an ABC-type oligopetide import system contains the type 2 periplasmic binding fold. This family represents the periplasmic substrate-binding component of an ATP-binding cassette (ABC)-type oligopeptide transport system comprised of 5 subunits. The transport system OppABCDEF contains two homologous integral membrane proteins OppB and OppF that form the translocation pore; two homologous nucleotide-binding domains OppD and OppF that drive the transport process through binding and hydrolysis of ATP; and the substrate-binding protein or receptor OppA that determines the substrate specificity of the transport system. The dipeptide (DppA) and oligopeptide (OppA) binding proteins differ in several ways. The DppA binds dipeptides and some tripeptides and is involved in chemotaxis toward dipeptides, whereas the OppA binds peptides of a wide range of lengths (2-35 amino acid residues) and plays a role in recycling of cell wall peptides, which precludes any involvement in chemotaxis. Most of other periplasmic binding proteins are comprised of only two globular subdomains corresponding to domains I and III of the dipeptide/oligopeptide binding proteins. The structural topology of these domains is most similar to that of the type 2 periplasmic binding proteins (PBP2), which are responsible for the uptake of a variety of substrates such as phosphate, sulfate, polysaccharides, lysine/arginine/ornithine, and histidine. The PBP2 bind their ligand in the cleft between these domains in a manner resembling a Venus flytrap. After binding their specific ligand with high affinity, they can interact with a cognate membrane transport complex comprised of two integral membrane domains and two cytoplasmically located ATPase domains. This interaction triggers the ligand translocation across the cytoplasmic membrane energized by ATP hydrolysis. Besides transport proteins, the PBP2 superfamily includes the ligand-binding domains from ionotropic glutamate receptors, LysR-type transcriptional regulators, and unorthodox sensor proteins involved in signal transduction.	6.11553e-11
NZ_CP012387.1\|WP_020862549.1\|219583_221284_+\|ATP-binding-cassette-domain-containing-protein	gnl\|CDD\|223521	COG0444, DppD, ABC-type dipeptide/oligopeptide/nickel transport system, ATPase component [Amino acid transport and metabolism / Inorganic ion transport and metabolism].	6.5072e-118
NZ_CP012387.1\|WP_020862553.1\|228079_229384_-\|ATP-binding-protein	gnl\|CDD\|224292	COG1373, COG1373, Predicted ATPase (AAA+ superfamily) [General function prediction only].	2.18584e-56
NZ_CP012387.1\|WP_020862554.1\|229615_230497_+\|Cof-type-HAD-IIB-family-hydrolase	gnl\|CDD\|319818	cd07516, HAD_Pase, phosphatase, similar to Escherichia coli Cof and Thermotoga maritima TM0651; belongs to the haloacid dehalogenase-like superfamily. Escherichia coli Cof is involved in the hydrolysis of HMP-PP (4-amino-2-methyl-5-hydroxymethylpyrimidine pyrophosphate, an intermediate in thiamin biosynthesis), Cof also has phosphatase activity against the coenzymes pyridoxal phosphate (PLP) and FMN. Thermotoga maritima TM0651 acts as a phosphatase with a phosphorylated carbohydrate molecule as a possible substrate. Escherichia coli YbhA is also a member of this family and catalyzes the dephosphorylation of PLP, YbhA can also hydrolyze erythrose-4-phosphate and fructose-1,6-bis-phosphate. Members of this family belong to the haloacid dehalogenase-like (HAD) hydrolases, a large superfamily of diverse enzymes that catalyze carbon or phosphoryl group transfer reactions on a range of substrates, using an active site aspartate in nucleophilic catalysis. Members of this superfamily include 2-L-haloalkanoic acid dehalogenase, azetidine hydrolase, phosphonoacetaldehyde hydrolase, phosphoserine phosphatase, phosphomannomutase, P-type ATPases and many others. HAD hydrolases are found in all three kingdoms of life, and most genomes are predicted to contain multiple HAD-like proteins. Members possess a highly conserved alpha/beta core domain, and many also possess a small cap domain, the fold and function of which is variable. HAD hydrolases are sometimes referred to as belonging to the DDDD superfamily of phosphohydrolases.	9.2288e-59
NZ_CP012387.1\|WP_020862547.1\|213823_216514_-\|alanine--tRNA-ligase	gnl\|CDD\|234701	PRK00252, alaS, alanyl-tRNA synthetase; Reviewed.	0
NZ_CP012387.1\|WP_020862552.1\|226689_227985_-\|ATP-binding-protein	gnl\|CDD\|224292	COG1373, COG1373, Predicted ATPase (AAA+ superfamily) [General function prediction only].	6.34649e-51
NZ_CP012387.1\|WP_020862557.1\|232627_234310_-\|LppA-family-lipoprotein	gnl\|CDD\|274602	TIGR03490, Uncharacterized_lipoprotein_lpp, mycoides cluster lipoprotein, LppA/P72 family. Members of this protein family occur in Mycoplasma mycoides, Mycoplasma hyopneumoniae, and related Mycoplasmas in small paralogous families that may also include truncated forms and/or pseudogenes. Members are predicted lipoproteins with a conserved signal peptidase II processing and lipid attachment site. Note that the name for certain characterized members, p72, reflects an anomalous apparent molecular weight, given a theoretical MW of about 61 kDa.	3.0076e-131
NZ_CP012387.1\|WP_020862555.1\|230530_232228_-\|LppA-family-lipoprotein	gnl\|CDD\|274602	TIGR03490, Uncharacterized_lipoprotein_lpp, mycoides cluster lipoprotein, LppA/P72 family. Members of this protein family occur in Mycoplasma mycoides, Mycoplasma hyopneumoniae, and related Mycoplasmas in small paralogous families that may also include truncated forms and/or pseudogenes. Members are predicted lipoproteins with a conserved signal peptidase II processing and lipid attachment site. Note that the name for certain characterized members, p72, reflects an anomalous apparent molecular weight, given a theoretical MW of about 61 kDa.	2.18256e-174
NZ_CP012387.1\|WP_020862562.1\|241114_242905_+\|lipoprotein	gnl\|CDD\|270450	cd14747, PBP2_MalE, Maltose-binding protein MalE; possesses type 2 periplasmic binding fold. This group includes the periplasmic maltose-binding component of an ABC transport system from the phytopathogen Xanthomonas citri and its related bacterial proteins. Members of this group belong to the type 2 periplasmic-binding fold superfamily. PBP2 proteins are comprised of two globular subdomains connected by a flexible hinge and bind their ligand in the cleft between these domains in a manner resembling a Venus flytrap. The majority of PBP2 proteins function in the uptake of small soluble substrates in eubacteria and archaea. After binding their specific ligand with high affinity, they can interact with a cognate membrane transport complex comprised of two integral membrane domains and two cytoplasmically located ATPase domains. This interaction triggers the ligand translocation across the cytoplasmic membrane energized by ATP hydrolysis.	0.00253297
NZ_CP012387.1\|WP_020862560.1\|236966_238763_-\|alpha-glycosidase	gnl\|CDD\|200477	cd11338, AmyAc_CMD, Alpha amylase catalytic domain found in cyclomaltodextrinases and related proteins. Cyclomaltodextrinase (CDase; EC3.2.1.54), neopullulanase (NPase; EC 3.2.1.135), and maltogenic amylase (MA; EC 3.2.1.133) catalyze the hydrolysis of alpha-(1,4) glycosidic linkages on a number of substrates including cyclomaltodextrins (CDs), pullulan, and starch. These enzymes hydrolyze CDs and starch to maltose and pullulan to panose by cleavage of alpha-1,4 glycosidic bonds whereas alpha-amylases essentially lack activity on CDs and pullulan. They also catalyze transglycosylation of oligosaccharides to the C3-, C4- or C6-hydroxyl groups of various acceptor sugar molecules. Since these proteins are nearly indistinguishable from each other, they are referred to as cyclomaltodextrinases (CMDs). The Alpha-amylase family comprises the largest family of glycoside hydrolases (GH), with the majority of enzymes acting on starch, glycogen, and related oligo- and polysaccharides. These proteins catalyze the transformation of alpha-1,4 and alpha-1,6 glucosidic linkages with retention of the anomeric center. The protein is described as having 3 domains: A, B, C. A is a (beta/alpha) 8-barrel; B is a loop between the beta 3 strand and alpha 3 helix of A; C is the C-terminal extension characterized by a Greek key. The majority of the enzymes have an active site cleft found between domains A and B where a triad of catalytic residues (Asp, Glu and Asp) performs catalysis. Other members of this family have lost the catalytic activity as in the case of the human 4F2hc, or only have 2 residues that serve as the catalytic nucleophile and the acid/base, such as Thermus A4 beta-galactosidase with 2 Glu residues (GH42) and human alpha-galactosidase with 2 Asp residues (GH31). The family members are quite extensive and include: alpha amylase, maltosyltransferase, cyclodextrin glycotransferase, maltogenic amylase, neopullulanase, isoamylase, 1,4-alpha-D-glucan maltotetrahydrolase, 4-alpha-glucotransferase, oligo-1,6-glucosidase, amylosucrase, sucrose phosphorylase, and amylomaltase.	0
NZ_CP012387.1\|WP_020862548.1\|217299_218544_+\|ABC-transporter-permease	gnl\|CDD\|223674	COG0601, DppB, ABC-type dipeptide/oligopeptide/nickel transport systems, permease components [Amino acid transport and metabolism / Inorganic ion transport and metabolism].	2.14716e-44
NZ_CP012387.1\|WP_129868080.1\|226435_226642_+\|type-II-toxin-antitoxin-system-RelB/DinJ-family-antitoxin	gnl\|CDD\|274102	TIGR02384, Putative_antitoxin_RelB, addiction module antitoxin, RelB/DinJ family. Plasmids may be maintained stably in bacterial populations through the action of addiction modules, in which a toxin and antidote are encoded in a cassette on the plasmid. In any daughter cell that lacks the plasmid, the toxin persists and is lethal after the antidote protein is depleted. Toxin/antitoxin pairs are also found on main chromosomes, and likely represent selfish DNA. Sequences in the seed for this alignment all were found adjacent to toxin genes. The resulting model appears to describe a narrower set of proteins than pfam04221, although many in the scope of this model are not obviously paired with toxin proteins. Several toxin/antitoxin pairs may occur in a single species. [Cellular processes, Toxin production and resistance, Mobile and extrachromosomal element functions, Other].	4.22791e-10
NZ_CP012387.1\|WP_020862558.1\|234419_235049_-\|beta-phosphoglucomutase	gnl\|CDD\|213672	TIGR01990, bPGM, beta-phosphoglucomutase. This model represents the beta-phosphoglucomutase enzyme which catalyzes the interconverison of beta-D-glucose-1-phosphate and beta-D-glucose-6-phosphate. The 6-phosphate is capable of non-enzymatic anomerization (alpha <-> beta) while the 1-phosphate is not. A separate enzyme is responsible for the isomerization of the alpha anomers. Beta-D-glucose-1-phosphate results from the phosphorylysis of maltose (2.4.1.8), trehalose (2.4.1.64) or trehalose-6-phosphate (2.4.1.216). Alternatively, these reactions can be run in the synthetic direction to create the disaccharides. All sequenced genomes which contain a member of this family also appear to contain at least one putative maltose or trehalose phosphorylase. Three species, Lactococcus, Enterococcus and Neisseria appear to contain a pair of paralogous beta-PGM's. Beta-phosphoglucomutase is a member of the haloacid dehalogenase superfamily of hydrolase enzymes. These enzymes are characterized by a series of three catalytic motifs positioned within an alpha-beta (Rossman) fold. beta-PGM contains an inserted alpha helical domain in between the first and second conserved motifs and thus is a member of subfamily IA of the superfamily. The third catalytic motif comes in three variants, the third of which, containing a conserved DD or ED, is the only one found here as well as in several other related enzymes (TIGR01509). The enzyme from L. lactis has been extensively characterized including a remarkable crystal structure which traps the pentacoordinate transition state. [Energy metabolism, Biosynthesis and degradation of polysaccharides].	4.37984e-71

>NZ_CP012387.1|WP_020862553.1|228079_229384_-|ATP-binding-protein
MENMIIPRDFYLNQLLDKKDNGRVKVITGIRRCGKSELLFTLYKDYLLSTGVKKKQIIALQLDGDENIKYRDPLALGSYIRKQIKSKSKRYYVFIDEIQFCYAVFNPYVKEKEPSITFVDTVLGLMKIPNIDLYITGSNSKMLSSEILTQFSDRGDQIHVQPFSFSEIYHLFENSQDALAHYLNYGGMPEIYKLKTEEQKVQHLKQLFKTTYIRDVLLKYDIKNEEQILDKLLDFVSSVVGSLVSFNNLSKQLAANDQIKISPNTIQKYLSYFEESFVLSNARRYDIKGSEYFRSPSKYYFADIGLRNARLNFRQIEDNHLTENVIYNELIKRGYNVDVGMVEYEVNKANTRQKRQAEVDFVANLGHKRYYIQYADNINTKEKREQETNSLLRIKDNFKKIVVVKDNIIAKHDDNGILYLGLKQFLLEPNAIDI
>NZ_CP012387.1|WP_020862552.1|226689_227985_-|ATP-binding-protein
MQINRDYYLNKLISKKNNNKIKVITGIKNVGKSYLLFNIYKNYLLSIGINEDQIITLKLDKWENANYRKLDSLYNYIKQRTSNPNKTYYVFIDEIQYCETIKQTNQSGYEQILTFVDVILSFYDNPNIDLYITGSNSKMLSSDILTNFRGRSSQIKVYPLVFSEVNYLFKNDDEALDHYINYGGLPEVYLNQTIEEKKEYLTNQFEEIYLKDIKERYNIQKEITILETLLKFVSSAIGSFTNPTKLQNRFKSEMKTDISSNTIANYLSYFENSFILSHIKKYDVKGNKHFSTINKYYFTDIGLRNACINYRQIESNHIIENIIYNELVKRNYSVYVSSVEYQTNSENKRTTKQLEVDFVIQKASKKYYIQFAMNVYTKQKKEQEINSLLRIKDNFKKIVIVYDDIEPRYDENGILYIGLKQFLLDENIIDF
>NZ_CP012387.1|WP_129868080.1|226435_226642_+|type-II-toxin-antitoxin-system-RelB/DinJ-family-antitoxin
MKQQAETIFKQLGLTTNEAITLFFKATIKQNHLPFELEFNKETLQAIKEAEELLKDPNTKIIQVLKNF
>NZ_CP012387.1|WP_020862551.1|223170_226272_+|lipoprotein
MKKVLGMTLLGSIIATAVASAVSCSVGISLDKILNRKNSNTRVLRELTNYSLANLNSATNNTSNDADIIANLQDVLLAVNNHDHYEGALAEYWDHNKDSDYWKFRLRKNAYWTKIENSKQVKGDLITGQDLFNTFRYVLNKNNLALTTEHFLTNFKYVPQLMDFIDKLSDPKYDKSNGQAKPDKLYDSRFNKDLPGDLRTNELRSSYWIDRAILAFNIEPTNEEKAKNLALDLSMSTKQLAKKSFEEGKIVDNGKSKEKNDNSNGLDSSIFDIGFHLSKKISYFESVISYLAFAPIPEVALLYAEDSGQKSNIYAGTNYGKPLARKSGYNGLWYSGPYVIQDYFPGSNLNLTKNEFYYNKENVHIEKILYSYVNKADAATRRFLFETGDVSSTRINANDLAGYKKYVGSDESNPVFEGTNVLKQKPTTTWAFGFNFNTKETSIYDDIKLDQEGSLVPTKRRVRTPEEDSILNRAIALKSLRIMTRFVLNRSLYAKFFSEAKDGNNHPVSSQLRNTFTSKYVSTYNDKEHKVLDKKSQNTVADYADFLAKDYYDITKYDDNNKKLNNTNSVSSTPVRTRRATPSGTSESSSASTEQQSWSDWMIKVLQKHSLYDESRLTSWANRFGKVKDKKDLKNTEKVSVYSEGNDAFLENDLLAFTAFLKEDQLQSKNGGQDGTFDLKRDPNKVEFKNPELAKEFGKLIGVYDKDFDPKKDYQNQDSKLSTLYKKINLLKQQVKEDLKNTSGITSNKPITIPFLLDPTGADDFKIKIQRLFGAFNYLVRNKGNGDIDSPFVFDIDKPIDQSAYLKQRRDSKFGLGAFGWSPDYDDPTNYLATLKYGGVYEHIQGWKKLFNGSELKTTNGSNKKGIKLTLKKSDGTSEKAFKELKDALQFFTNELTEIDENEVDIYKRYTRLAQLENFYTLSSAIIIPTHTHQADTLPIISYLDEFSKPTWPTGSHARRLVGVRMFDKIVTKEQFKKQKENFDKETLNGYRSVYPKTFDSKSNKNIYFDQFKGNWREEWKKEYESKNKKLNK
>NZ_CP012387.1|WP_020862550.1|221285_223154_+|ABC-transporter-ATP-binding-protein
MIKKKNEAILKVRDLLIEFGNGRNKLKAVKGVTFDVYKGETFGLVGESGSGKTTIGRAIIGIQPISDGAIYFENKLLRGKSPDVYKINQKIARHLYIMQQNQLTTSLSLNDYSNEFKRVYYKYVQSKFFDFKTQELKDYEDGKSRIIKEGVNLNTTKLVSVKKNANLSIVIQAITDNLKRLLKIIRLQEKASRITKNISKHTSVKVELQDAINKYQDFVHDSILKVKDLENTIYNTLQEMLAIRNDVNEGKYTSVTKFFDQMGSRLKLVIKSQKLITPQLEDASHDQLMNLALTCPKYKNNYYLKKLKQRIEYLNLNNKTKLAQEYESVIQTVENSDFYDNLKTAEIFKSPNKKELKENKKDMQMIFQDPSSSLNERMAVEEIIKEGLDNFPELYSNDEVKKAYQQWFNQKNPENKIVEISEIDKKDIKRFLINQLLETVGLLPEHLSRYPHEFSGGQRQRIGIARALIMKPKFVVADEPISALDVSIRAQIMNLLAKFQKQFDLTYIFIAHDLSVVRFATDRIAVIYRGDIVELAESNELFDLPLHPYTRSLLSAIPLPDPVQESKKVHFVYQPEVEHHDYLVDFPKWVEVSKNHFVYANEREIKAYKKQIKAYKEQLKNK
>NZ_CP012387.1|WP_020862549.1|219583_221284_+|ATP-binding-cassette-domain-containing-protein
MKNVILSIKDLVVKFRVRSKVLTSIRNISFDIYDGETVAIVGESGSGKSVLTKTLTNMLESNGYIANGSIMYYPNKATRENESAVFKKDTDLVEFHKNSLESESRKGIKKYNNKKIKDALLTIKELEESTIESLNLKIDELQQKADLLKKYEFTNSTKKLVKRNEYLEQIKQLKEQIEWKKDPKKLDFEIQQLEKTIQTAKKEIYNFKTVNIYKKFRYFQIINLINKVNNNQLEDINKLEPHIKWLDEIEYKNNFESLALEILYDIRSNQTKKLDQEKLETLKELWDFIKRFNFWIKRSTDKNLQHLRGGTIATIFQDPMTSLNPLLSVGYQISEVLRNHSKLNRAEAKVEAINLMKRVGIPNAEKRYKDLPGKYSGGMRQRVVIAIALACRPKVLICDEPTTALDVTIQAQILDLIKELKEEYKFTVIFITHDLGVVANIADRVAVMYAGQIIEYGTTQDVFFNSKHPYTWALLSSLPQLGTKGEELYSISGTPPSLFKEIKADAFAPRNTFALAVDYKYEPPMFKISDTHYAKTWLLDPRAPKIKRPKQLNNLKKAVSDSKVGE
>NZ_CP012387.1|WP_017698021.1|218559_219570_+|ABC-transporter-permease
MKTKQLEQPDFSALLDSEREAFFKRHGLDIYQIDHSLFELVGSQAQTSETIITKPYSYWKAVGKILITSKVFIICSIILLALLLTSIIVPYGKEAIPLKTPGVTQEHPSAQHWFGLGRNGEDYWIEIWLGLRSSLSFAFVMTFLQLSIGIIMGLIWGYYRKLDILFYQLTSLILVIPQLILIIVIMSVFGIGYWPMILGIVIQAWIGPAFSIRILVLSIRDADYNIASITLGTRSDKIIRKNVLPKILPVLIQVSTFSIPTAIAIESTLAYFDRGFVDGKVNTSLGKILQSIMQSSEWQVYPHLIVLPILFICIISTLFFLVLKVFADSLDPKNHR
>NZ_CP012387.1|WP_020862548.1|217299_218544_+|ABC-transporter-permease
MKSTLKTKQEVLNLNSELLLDDFSLLNETNQQHKVSKWTTFKYWYYDTSANIYKYFLRHPLYGYSFKRILYGLITLLLSIIILYVVIRLITPDTKYLPPDIEKTGLSRAQQDKLLEDRMKRFGVYGPLIPQILTYLKNITPFIPKQIVLGSEVTILQNGNAIIDSSKLITETRWVYLGVTTATTIAEEGSDALSIFLKAMPYSFAIGSVSVLISYALAILIGVRAAKKKGKLFDNVFNGISALLLAIPSIVIIIGTFIFSVAVLGNSGIYNTGSFATRFWPIFAIVVINLPGIATFVRRYIVDEMTVDYAKFALAKGTSSNKTYYVHIFRNAGVRIIRSIPSEIILTVFGSSMIVETQWAIPGMGRLIKESAGGNDFFVFLGFTVLSSFVSIFAKLLADLVHVLLDPRVSLTKD
>NZ_CP012387.1|WP_017698022.1|216587_217082_-|hypothetical-protein
MKKSKVFKELKDIDKFTKEQHEKQVNKSISQVYDSDDFKMNFYDYQQAKKLRLIGWLIVFLIFIIGSLIGVLVGYLTLNVSSLDNWKGINYFNVLYTTILFFIGFIIGVIKNRQATKFFNDRRRRYQKTLELSEAKLIRLKKIFYLSGLLMLVLTIILFLVFKI
>NZ_CP012387.1|WP_020862547.1|213823_216514_-|alanine--tRNA-ligase
MKKLSTNQIRKIWLDFFISKNHYFLETVSLIPVDDPSLLWINSGVATLKPYFDGRKTPPSPRLTNSQKAIRTNDIENVGVTARHHTMFEMLGNFSIGDYFKKEAIELAWELLTDKNYFDIDKDKLYITVFNEDTEAYNIWKDVIKIDEDHIFRLSRKTNFWDVGQGPCGPNTEIFYDRGEIWDPNKIGPRLISDDIENDRYIEVWNIVFSQFNNDGNDNYTELPRKNIDTGAGLERFASIFQNTPTNFETDIFYPTIKKVEQLTNDQFKYSIDNYFNPNKKQTRINTAFKVIADHIRATVFAISDGVFPGNKDRGYIIRRLIRRSCVFGKELGIKQAFLYKLVDSVIESMKEFYPYLIDKKTLVEQTIKDEEEKFLKTLSKGYDLLENIIKTKNTVSDKDALLLFESYGFPIEQTIEISELSNVTVDIEGFKKLLEQTKQATRNARKDLKAWDKQNELFTKLKVESEFTGWSETSRDNAKVIYMFTDQKQVESITDQEAFVILDKTPFYAEKGGQAADSGIIFNDQMKGFVIDVQQGPMHQNIHRIKVQGTLKVNDLVNCRVDEEKRIYTMKNHSGTHMIHYALREVLGTSVMQSGSYNDENGLRMDFTYHRLPTNQELLKAQNLVLEKIKNKIDRQTYFCSLEESVKKHQALAFFTEKYDEIVRVIKFGDFSSELCGGTHVNNTSEIEDFIITGIESKGSGLYRIKCLTSFKTVNEYLNEQFKIYKDQAEIIIDKYNQNKDLLKNDQLENIYLQIKNITINKDNLLVIKDLLDKLKEINKDYDKKVNDLITANKLLKYKDLTPSLNKDNINEIRLETTDLNIKDLKQLADDLRNKYDDLIVILLSSTSENNFVVVAVSQSLQNKYKAIDIFNNLEGYETKGGGNANLAQGKFVKK
>NZ_CP012387.1|WP_020862554.1|229615_230497_+|Cof-type-HAD-IIB-family-hydrolase
MKLKDLNLKRLILIDLDGTTLTNQNDQIHKITKKAILDAQKKGHVVCIVTGRPYRAVEHIYKELKLTTLLANFDGAHIHDPNNKLMKRVVLPINCEIIKQIINEPVIKGNVENILIEYYDKSLLWKTDKELEDFFHLNKAKNSKDFQFIKASPYTDWKSPSNNLVLKLKSDKHKDEVIRVLTKYQDAIKIQSDILYGITTSKTKPVITLTNKNADKGFASIFLAQYYNKDIRDVIAFGDQLNDLEMLKTVGCSVAMKNGVNSLKFVAKGITHYTNDEGGLGHYLNLLLAGKEV
>NZ_CP012387.1|WP_020862555.1|230530_232228_-|LppA-family-lipoprotein
MRKFNKLFLTILPISSISAFSVVSCTTNTKNNNQIPTIPNNKKPENQTQPEQPSDKKPESTEEHTNKKPNENTNDQKQPNNSEKSDAEPNPGKPENKPNNSHNPKQPEQPKKPEHNDSNSNNNTNNNSNADQPQGDEPQDEPWNKVDFSDINKLDKEVKFEFFTTYSRMDAKSAWVQIQGRQPAIFKEIIFKGKNEILNRYEIEFDSQKVPNIVDEKGTIDNVGIKFSKNGKSKTREFVFTGFRKLENKVDKGKNKDEYIKPKTNIDKSLSGIFPSLVAYMLLYSEETQSNNKYDRNIKQSGNVINFDELKNKNLELFGEYFVGFSVGTKELLFDYKNEYNKIYKDKIVAARYDDINGILELEVQVSNTDEYENRNDPTKSYKFTFKGFRSIDFDNPNKNVLSISLQQRFLKKLVDDKILKTIIDQLVQHNHFNHKAPVSNINNSNLKGELFEKLTVDIIDDENHLYKSSQTLKIDLFKKENNNKSILGLKNQMSIYPFHSRITKDSIKNIYITINNKNSTKELELEAEIEIPIYSSTLTDLTDHTYAAEKPLKITVKQSVKLNQ
>NZ_CP012387.1|WP_020862557.1|232627_234310_-|LppA-family-lipoprotein
MRKFNKLFLTILPISSISAFSVVSCTTNTKNNNQIPTIPNNKKPENQKQPNDKKPGSTEEHTNKKPNENTNDQKQPNNSEKSDAESNPGKPENKPNNSHNPKQPEQPEHNDPNSNNTTDNNNSTNNDEPQADQPQHNQEDDSSNNTEEIFSEIDALKKEIEFNFYTTYKNKDALTSWIEIKSRKQAIFKEVIFSRNIDILEKYQIEFDSQNDPEIIKENGIISNVKIKFTKNGKSKVYEFTFTGFKEEDKIDSKNNKDIYIKQKDKIDVKLAGLYPSLLAYMLLYVEQSGTNIYDRDIKQSGNVINFDDLINNNQDLFDYNFSGFSVGTKDLLFDYNRKDEKLYKDKIVEAKYDDINGTLGLKVEISNRDDNHSNESTITKEFNFNGFRKIDIDNYKNNPFTFSLLPKNLSEIIKNDKIRKTLEESGVDIHKNQVDEFGGFYSKDNIWETLIFKNLLVDLTDNDHHTYRSNKTLKVDFSGSDRNYKSILGLKSNQSLYPFHTIITKDSIKNILVTIKDKKFTLDFELHIPIYSTSFSNLLSHAGSDKTLLVRVSQTTKID
>NZ_CP012387.1|WP_020862558.1|234419_235049_-|beta-phosphoglucomutase
MKFKGVIFDLDGVITDTAPLHYLAWSQAVKTIGITNLDKSFLDKLRGISRKESLQVILDFYNLKLDQSQFNNLLEQKNLLYKKALQNIDKTWILPGIIDFIKDLKKHNIKICLGSSSFNAKDILTKLELINEFDYLVDPSEIKHSKPASDIFIKASQLLGLDVKECVVIEDAIAGVQASLNANIFCIGINVEANIKLKSTADLSINLLK
>NZ_CP012387.1|WP_020862559.1|235048_236848_-|alpha-glycosidase
MKVIDRVAIHHQQRSNMAYCYDKDYIHIILRTKKDDLKKVVIHHGDPFLRGHYLLGSDYIDLKPKEMTKSGSTKLYDYWFVEVKPEFKRLTYFFELFGIEDDHCYFGEKGFYETDDFKMINTGGWGFNYAWMNPNDVYQAPDWINDTIWYQIFPERFANGNKNNDPKNTLAWNSTDPSYNSFFGGDLQGIIDHLDHLVELGVNGLYLCPIFKAKSNHKYDTIDYLQIDPNFGDKKTFKKLVEECHKRNIKVMLDAVFNHAGYWNKFWQDVLKNQENSKYKDWFYINKFPLQEKIIDKNNQEKTVNNYYTFAFHEVMPKINTTNKDAKKYLLKVANYWIKEFDIDAWRLDAANEVDHEFWRDFRKTVNKNKPIYILGEIWGYAHPWLKGDQFDGVTNYMITSPICELVTKWIKPSKFNDKTTEVLNNYPRNVFKGMLNCLTSHDTTRLLTLCNNDVRKFKLAYSLVFMLAGAPSIYYGDEIGLDGAHDPLNRKCMNWNKDQWNHEIFNYLKKLIQIRKQNPVLGSYGTLKYTLIDDDKNYLEFIKYDDNNTYLILVNNSDEKLEVKKEELVNKIDLISDQIQTNNIVSLEPISMKVFKIK
>NZ_CP012387.1|WP_020862560.1|236966_238763_-|alpha-glycosidase
MVNIERAAILHIPKSNMAYCYDKDRIHIVLRAKKNNLKEVIFHCSEPFEPKVVVETNNYDLNLEKTAMRKVGSTEIYDYWFISVKPPFKRLSYYFELASENERIYYSQKGFYPLEKIKSVQTSQFSFPWMNEIDIFDVPTWVKDTIWYQIFPERFANGNPEISPKNVLAWNSEAPAANNFFGGDLQGIIDHLDHLVELGVNGLYLCPIFKARTNHKYDTIDYFEIDPHFGDKKTFKKLVEECHKRNIKIMLDAVFNHFGYWHPYWQDVLKNQEKSKYKDWFYINKFPVEKLDENLTENTSLDLNYYTFAFTGYMPKVNTSNPEVKKYLLEVARYWVEEFDIDAWRLDVANEIDHHFWREFRQVVNQKKRTYILGEVWSDSNPWLKGDQFDGVMNYVLTRQIIDFVATREIDVRRFKNRVTNVIFLYQKNIWPGMFNCLASHDTARLLTLCENDPNRLKLAYSILFTLSGSPSIYYGDEIGINGEHDPDCRKCMIWDKSQWNLDIFNHLKNLIKVRKENPTIGSYGFLEFKSYDEEKQYLEYIKTDTKTNYLILVNNSDNQIEVEHADLINNTELLTNEKQTNSKVVLKPFSMKIFKLN
>NZ_CP012387.1|WP_020862561.1|239020_240820_+|lipoprotein
MKKILTMLTSLVVVGGSALTVLACKTTNNTDIVVQANDKWVPIYQQAANKVNKRFEEQGYKWRVKLKEIGLFDEKKLIDGRGVRDKGISDIFAIPLDRYPQYINQNTLKDLTEYIKKDLIKTKEDEDRFGIKIDNSKSGVDAIKLEKNVNTWKTVLGSDLKGNRLYGMIPMSIENMIWLFDEDRLGIKKEKGDDNKLYAYLVGSELEKVKNQLEKYEEKDGVGKKLIGKPKASIENLIILNKAQTNDYKFENLNEIEDKENVNKGAPLAFVDAGASFQGGMFLNSILNKRADDISKLKADNSSLGMVWVNKNKSLNSTNINDFDSIWENDMFKEDFNQTTQTIVDYVKSLGGHITEIYGGAAGQINQILDDALRDGTIAMTLVGPWEVSSKLETMRKAPKNKGHKFGFASIGDISFNKGKNKLTGFAGGYGWGIKSSISNTKLKNNKGEEMDKTSAAIEFIKEISKKDYATEMAFVDGKISAYSDVADFLIEELKQGNNIPPLNEKGKKKTNEELKAEKENRQIIGEAYRSIIDGYEKTGKDADVAPRADNELFGIYWEAYTTAFGSTFNKKQNKGMKEKFADIFRTTYKKQKSQYKFH
>NZ_CP012387.1|WP_020862562.1|241114_242905_+|lipoprotein
MKKILTMLASIVVVGGSALTVLACKTRNNTDIVVQANDKWMPIYQKAADKVNKRFEEQGYKWRVKLKQIDIFAEKGLIDLRGVRDKGVSDVFAVPLDRFPQYLNQNTLKDLTEYIKTGIAGDSEAKERFGLDIVEGKTGVDAIKLTKNQNSWKTALGSDIKGKRQYGMIPMSIENMVWIFNENRLGIKKEKVGDKEYSYLVGTEVDKIKDKLDKYDDKSQANGRLKDKPKASIENLIKLNESQTNAYKFEDSKEIDTSKVNKGAPLAYIDAGGSFHGGMFLNSILNKRAEDIAAEKSESSSLGMVWVKKGKAINSTNKEDFDSIWENEKFKNDFDNTTKTIIDYVKSLGGHINEIYGGAAGQIGQILDDALRDGTTVMSLVGPWEVSSKLETMKKAPKNKDGKFGFASIGDITFNGDSKLTGFAGGYGWGIKSSISNLKLKNNKGEEMDKTAAAIEFIKEISKKDYATEMAFVDGKISAYKDVADNLIKELKEGTNIPELNDKGVKKTTEEIKAEKENRKIIGEAYESIVKGYEKTGKDADVAPRADNEMFGIYWGVYGTALGSTFNKKQNPGMKKQFSEIFRTTYESEKLKYKFH
>NZ_CP012387.1|WP_013729329.1|242986_243478_+|hypothetical-protein
MDFQQAFGHKTNIKKYNVYFILAICLVFVVMLSTAMLIDYRLIVVKQQNLSKEALKNPHAYFLKTWMIRYLLNVVLVIIFAIYTTLAMNRITVGYVYIGLWLVIWFGFAFGELILTKKITYPSIISIVLFVLVIISFYFIIKDISELKRSLRYQKMKKREYRF
>NZ_CP012387.1|WP_023905929.1|243492_245910_+|ABC-transporter-permease-subunit
MNHIEFYKSLKTKEEVFNELKKVKYSDFEKEFEELDQTQKNIANSSYTFSNKELAKILLEFAKNNIHNNMYAKLKENFAMYLNKTADNKFVFDIKAIEQSFVNKDEDYIQDMFKIKARLQLSQIIYDARNQEIKNLKTKANSYYVAYLKFLNDFTYKYKKKFISITYKIAKRKVQELRLLFSTNDYTFHIKSHNKNATTFIEEKNAISQKIKQELNEIKNLDPITKAKRTSEIYQQGIEYNYDWEVASLNAKAKEKFLIKKQQIDSDFIDKINKAKQDYVEISKNKKQHDELTKKVIIQANEDFKTQLEFATTKSEKKNLKLEHKQNIKEIKSDNAVKKAKDNWKNLKHNYKVEKNKNRLEYTSEIENIKNNLPIEYPVWKQVLSIIFGWIPGVGPLINGQYKKAIVMFLTLPLFVIFGAYAFGIGNVGGNGLLGLIDFGADNPDGDGRFYLIEGIISLIIAFWICISIFSTWMDSKNNAKRMRIGSRASTFSQTRKFLKSHGIPYILSIPAIIGIMFIVLVPIISTILIAFTNYGKGNDPGRPGQIIKWVGFDNFKSIFGGEYFPSFLYVIGWTFTWVIATTISVIVVGSLFALLVNNERLKGKRIFRLIYILPWAVPAFIMIMVFAILLSSIEFNTFTYKWIGVSGWTSQQTQARIVLILLQTWLGHSYMFLLITGVLQGISKDLYDSSTIDGASKWKQLTRITLPLILTQVAPLLVGQFVFNFGNFGIIYLFGANPQALNAKGEPYPGQPGITDILISFVFKLSTHPDRYTYGIAASFIIVSSFIVVGTSANGFRKMKAFKN

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP012387_3

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP012387_3

258530-258626

Orphan

Consensus_repeat	Method
AAGGAATTTCTGTGTATTTACACA	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP012387_3

>merge|NZ_CP012387|3|258530-258626|CRISPRCasFinder
AAGGAATTTCTGTGTATTTACACACTTTTTCCTTATGAAAAAATCTTAAAACAAGATAATGCTCAATTAGCATAAGGAATTTCCGTGTATTTACACA

>NZ_CP012387|3|3|258530-258626|CRISPRCasFinder
AAGGAATTTCTGTGTATTTACACA	CTTTTTCCTTATGAAAAAATCTTAAAACAAGATAATGCTCAATTAGCAT
AAGGAATTTCCGTGTATTTACACA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP012387.1\|WP_023905932.1\|269013_269586_+\|16S-rRNA-(guanine(966)-N(2))-methyltransferase-RsmD	unknown	unknown	gnl\|CDD\|223813
NZ_CP012387.1\|WP_020862564.1\|249659_251957_+\|glycoside-hydrolase-family-65-protein	unknown	unknown	gnl\|CDD\|237517
NZ_CP012387.1\|WP_011387092.1\|267023_267383_-\|50S-ribosomal-protein-L20	unknown	unknown	gnl\|CDD\|179959
NZ_CP012387.1\|WP_011387091.1\|265594_266650_-\|spermidine/putrescine-ABC-transporter-ATP-binding-protein	unknown	unknown	gnl\|CDD\|213267
NZ_CP012387.1\|WP_020862570.1\|258753_259374_+\|chromate-transporter	unknown	unknown	gnl\|CDD\|224970
NZ_CP012387.1\|WP_020862566.1\|254333_256127_-\|oligoendopeptidase-F	unknown	unknown	gnl\|CDD\|272947
NZ_CP012387.1\|WP_023905929.1\|243492_245910_+\|ABC-transporter-permease-subunit	unknown	unknown	gnl\|CDD\|224096
NZ_CP012387.1\|WP_013729332.1\|248466_249552_+\|ABC-transporter-ATP-binding-protein	unknown	unknown	gnl\|CDD\|226359
NZ_CP012387.1\|WP_129868284.1\|258292_258451_-\|ATPase	unknown	unknown	unknown
NZ_CP012387.1\|WP_020862573.1\|268352_268955_-\|peptide-deformylase	unknown	unknown	gnl\|CDD\|366575
NZ_CP012387.1\|WP_020862565.1\|251958_253563_+\|alpha-glucosidase	unknown	unknown	gnl\|CDD\|200472
NZ_CP012387.1\|WP_020862567.1\|256126_256810_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|341186
NZ_CP012387.1\|WP_020862571.1\|261507_264618_-\|extracellular-solute-binding-protein	unknown	unknown	gnl\|CDD\|270381
NZ_CP012387.1\|WP_020862572.1\|264602_265595_-\|ABC-transporter-permease	unknown	unknown	gnl\|CDD\|224097
NZ_CP012387.1\|WP_011166422.1\|267401_267593_-\|50S-ribosomal-protein-L35	unknown	unknown	gnl\|CDD\|234676
NZ_CP012387.1\|WP_017698001.1\|259373_260051_+\|chromate-transporter	unknown	unknown	gnl\|CDD\|376780
NZ_CP012387.1\|WP_020862568.1\|256825_258181_-\|leucyl-aminopeptidase	unknown	unknown	gnl\|CDD\|376407
NZ_CP012387.1\|WP_013729335.1\|253585_254305_+\|GntR-family-transcriptional-regulator	unknown	unknown	gnl\|CDD\|225099
NZ_CP012387.1\|WP_053263283.1\|245924_248465_+\|ABC-transporter-permease-subunit	unknown	unknown	gnl\|CDD\|226354
NZ_CP012387.1\|WP_011166421.1\|267618_268164_-\|translation-initiation-factor-IF-3	unknown	unknown	gnl\|CDD\|234582

Protein	Function_ID	Function_description	E-value
NZ_CP012387.1\|WP_020862564.1\|249659_251957_+\|glycoside-hydrolase-family-65-protein	gnl\|CDD\|237517	PRK13807, PRK13807, maltose phosphorylase; Provisional.	0
NZ_CP012387.1\|WP_011387092.1\|267023_267383_-\|50S-ribosomal-protein-L20	gnl\|CDD\|179959	PRK05185, rplT, 50S ribosomal protein L20; Provisional.	2.69096e-60
NZ_CP012387.1\|WP_011387091.1\|265594_266650_-\|spermidine/putrescine-ABC-transporter-ATP-binding-protein	gnl\|CDD\|213267	cd03300, ABC_PotA_N, ATP-binding cassette domain of the polyamine transporter. PotA is an ABC-type transporter and the ATPase component of the spermidine/putrescine-preferential uptake system consisting of PotA, -B, -C, and -D. PotA has two domains with the N-terminal domain containing the ATPase activity and the residues required for homodimerization with PotA and heterdimerization with PotB. ABC transporters are a large family of proteins involved in the transport of a wide variety of different compounds, like sugars, ions, peptides, and more complex organic molecules. The nucleotide binding domain shows the highest similarity between all members of the family. ABC transporters are a subset of nucleotide hydrolases that contain a signature motif, Q-loop, and H-loop/switch region, in addition to, the Walker A motif/P-loop and Walker B motif commonly found in a number of ATP- and GTP-binding and hydrolyzing proteins.	9.31357e-158
NZ_CP012387.1\|WP_020862570.1\|258753_259374_+\|chromate-transporter	gnl\|CDD\|224970	COG2059, ChrA, Chromate transport protein ChrA [Inorganic ion transport and metabolism].	3.30206e-27
NZ_CP012387.1\|WP_020862566.1\|254333_256127_-\|oligoendopeptidase-F	gnl\|CDD\|272947	TIGR00181, Oligoendopeptidase_F_homolog, oligoendopeptidase F. This family represents the oligoendopeptidase F clade of the family of larger M3 or thimet (for thiol-dependent metallopeptidase) oligopeptidase family. Lactococcus lactis PepF hydrolyzed peptides of 7 and 17 amino acids with fairly broad specificity. The homolog of lactococcal PepF in group B Streptococcus was named PepB (, with the name difference reflecting a difference in species of origin rather activity; substrate profiles were quite similar. Differences in substrate specificity should be expected in other species. The gene is duplicated in Lactococcus lactis on the plasmid that bears it. A shortened second copy is found in Bacillus subtilis. [Protein fate, Degradation of proteins, peptides, and glycopeptides].	0
NZ_CP012387.1\|WP_023905929.1\|243492_245910_+\|ABC-transporter-permease-subunit	gnl\|CDD\|224096	COG1175, UgpA, ABC-type sugar transport systems, permease components [Carbohydrate transport and metabolism].	5.22718e-56
NZ_CP012387.1\|WP_013729332.1\|248466_249552_+\|ABC-transporter-ATP-binding-protein	gnl\|CDD\|226359	COG3839, MalK, ABC-type sugar transport systems, ATPase components [Carbohydrate transport and metabolism].	3.8589e-149
NZ_CP012387.1\|WP_023905932.1\|269013_269586_+\|16S-rRNA-(guanine(966)-N(2))-methyltransferase-RsmD	gnl\|CDD\|223813	COG0742, COG0742, N6-adenine-specific methylase [DNA replication, recombination, and repair].	2.855e-38
NZ_CP012387.1\|WP_020862573.1\|268352_268955_-\|peptide-deformylase	gnl\|CDD\|366575	pfam01327, Pep_deformylase, Polypeptide deformylase.	3.0698e-38
NZ_CP012387.1\|WP_013729335.1\|253585_254305_+\|GntR-family-transcriptional-regulator	gnl\|CDD\|225099	COG2188, PhnF, Transcriptional regulators [Transcription].	1.61665e-21
NZ_CP012387.1\|WP_020862567.1\|256126_256810_-\|hypothetical-protein	gnl\|CDD\|341186	cd17495, RMtype1_S_Cep9333ORF4827P-TRD2-CR2_like, Type I restriction-modification system specificity (S) subunit Target Recognition Domain-ConseRved domain (TRD-CR), similar to Crinalium epipsammum S subunit (S.Cep9333ORF4827P) TRD2-CR2 and Corynebacterium genitalium sp. nov. S subunit (S.CgeORF10704P) TRD2-CR2. The recognition sequences for Crinalium epipsammum S subunit (S.Cep9333ORF4827P) and Corynebacterium genitalium sp. nov. S subunit (S.CgeORF10704P) are undetermined. The restriction-modification (RM) system S subunit consists of two variable target recognition domains (TRD1 and 2) and two conserved regions (CR1 and CR2) which separate the TRDs. The TRDs each bind to different specific sequences in the DNA. RM systems protect a bacterial cell against invasion of foreign DNA by endonucleolytic cleavage of DNA that lacks a site specific modification. The host genome is protected from cleavage by methylation of specific nucleotides in the target sites. In type I systems, both restriction and modification activities are present in one enzyme complex composed of one DNA specificity (S) subunit (this family), two modification (M) subunits and two restriction (R) subunits. This model contains both TRD1-CR1 and TRD2-CR2. This subfamily of TRD-CR's shows similarity to TRD1-CR1 of Aminobacterium colombiense DSM 12261 S subunit (S.Aco12261I), which recognizes 5'... GCANNNNNNTGT ... 3'. This subfamily may also include TRD-CR-like sequence-recognition domains of various type II restriction enzymes and methyltransferases and type I DNA methyltransferases.	0.00417401
NZ_CP012387.1\|WP_020862571.1\|261507_264618_-\|extracellular-solute-binding-protein	gnl\|CDD\|270381	cd13663, PBP2_PotD_PotF_like_2, The periplasmic substrate-binding component of an uncharacterized active transport system closely related to spermidine and putrescine transporters; contains the type 2 periplasmic binding fold. This group represents the periplasmic substrate-binding domain that serves as a primary polyamine receptor of an uncharacterized ABC-type transport system from gram-negative bacteria. Polyamine transport plays an essential role in the regulation of intracellular polyamine levels which are known to be elevated in rapidly proliferating cells and tumors. Natural polyamines are putrescine, spermindine, and spermine. They are polycations that play multiple roles in cell growth, survival and proliferation, as well as plant stress and disease resistance. They can interact with negatively charged molecules, such as nucleic acids, to modulate their functions. Members of this family belong to the type 2 periplasmic-binding fold superfamily. PBP2 is comprised of two globular subdomains connected by a flexible hinge and bind their ligand in the cleft between these domains in a manner resembling a Venus flytrap.	4.7961e-82
NZ_CP012387.1\|WP_020862572.1\|264602_265595_-\|ABC-transporter-permease	gnl\|CDD\|224097	COG1176, PotB, ABC-type spermidine/putrescine transport system, permease component I [Amino acid transport and metabolism].	8.70891e-49
NZ_CP012387.1\|WP_011166422.1\|267401_267593_-\|50S-ribosomal-protein-L35	gnl\|CDD\|234676	PRK00172, rpmI, 50S ribosomal protein L35; Reviewed.	1.6801e-14
NZ_CP012387.1\|WP_017698001.1\|259373_260051_+\|chromate-transporter	gnl\|CDD\|376780	pfam02417, Chromate_transp, Chromate transporter. Members of this family probably act as chromate transporters. Members of this family are found in both bacteria and archaebacteria. The proteins are composed of one or two copies of this region. The alignment contains two conserved motifs, FGG and PGP.	2.27106e-12
NZ_CP012387.1\|WP_020862568.1\|256825_258181_-\|leucyl-aminopeptidase	gnl\|CDD\|376407	pfam00883, Peptidase_M17, Cytosol aminopeptidase family, catalytic domain. The two associated zinc ions and the active site are entirely enclosed within the C-terminal catalytic domain in leucine aminopeptidase.	1.03554e-138
NZ_CP012387.1\|WP_020862565.1\|251958_253563_+\|alpha-glucosidase	gnl\|CDD\|200472	cd11333, AmyAc_SI_OligoGlu_DGase, Alpha amylase catalytic domain found in Sucrose isomerases, oligo-1,6-glucosidase (also called isomaltase; sucrase-isomaltase; alpha-limit dextrinase), dextran glucosidase (also called glucan 1,6-alpha-glucosidase), and related proteins. The sucrose isomerases (SIs) Isomaltulose synthase (EC 5.4.99.11) and Trehalose synthase (EC 5.4.99.16) catalyze the isomerization of sucrose and maltose to produce isomaltulose and trehalulose, respectively. Oligo-1,6-glucosidase (EC 3.2.1.10) hydrolyzes the alpha-1,6-glucosidic linkage of isomaltooligosaccharides, pannose, and dextran. Unlike alpha-1,4-glucosidases (EC 3.2.1.20), it fails to hydrolyze the alpha-1,4-glucosidic bonds of maltosaccharides. Dextran glucosidase (DGase, EC 3.2.1.70) hydrolyzes alpha-1,6-glucosidic linkages at the non-reducing end of panose, isomaltooligosaccharides and dextran to produce alpha-glucose.The common reaction chemistry of the alpha-amylase family enzymes is based on a two-step acid catalytic mechanism that requires two critical carboxylates: one acting as a general acid/base (Glu) and the other as a nucleophile (Asp). Both hydrolysis and transglycosylation proceed via the nucleophilic substitution reaction between the anomeric carbon, C1 and a nucleophile. Both enzymes contain the three catalytic residues (Asp, Glu and Asp) common to the alpha-amylase family as well as two histidine residues which are predicted to be critical to binding the glucose residue adjacent to the scissile bond in the substrates. The Alpha-amylase family comprises the largest family of glycoside hydrolases (GH), with the majority of enzymes acting on starch, glycogen, and related oligo- and polysaccharides. These proteins catalyze the transformation of alpha-1,4 and alpha-1,6 glucosidic linkages with retention of the anomeric center. The protein is described as having 3 domains: A, B, C. A is a (beta/alpha) 8-barrel; B is a loop between the beta 3 strand and alpha 3 helix of A; C is the C-terminal extension characterized by a Greek key. The majority of the enzymes have an active site cleft found between domains A and B where a triad of catalytic residues performs catalysis. Other members of this family have lost the catalytic activity as in the case of the human 4F2hc, or only have 2 residues that serve as the catalytic nucleophile and the acid/base, such as Thermus A4 beta-galactosidase with 2 Glu residues (GH42) and human alpha-galactosidase with 2 Asp residues (GH31). The family members are quite extensive and include: alpha amylase, maltosyltransferase, cyclodextrin glycotransferase, maltogenic amylase, neopullulanase, isoamylase, 1,4-alpha-D-glucan maltotetrahydrolase, 4-alpha-glucotransferase, oligo-1,6-glucosidase, amylosucrase, sucrose phosphorylase, and amylomaltase.	0
NZ_CP012387.1\|WP_053263283.1\|245924_248465_+\|ABC-transporter-permease-subunit	gnl\|CDD\|226354	COG3833, MalG, ABC-type maltose transport systems, permease component [Carbohydrate transport and metabolism].	8.20955e-88
NZ_CP012387.1\|WP_011166421.1\|267618_268164_-\|translation-initiation-factor-IF-3	gnl\|CDD\|234582	PRK00028, infC, translation initiation factor IF-3; Reviewed.	6.17492e-69

>NZ_CP012387.1|WP_129868284.1|258292_258451_-|ATPase
MKEQQTRSLNNANDSFKKIVVVYEDIIPWHDNDGIYYVGLKEFLLDESILNN
>NZ_CP012387.1|WP_020862568.1|256825_258181_-|leucyl-aminopeptidase
MLKFNDKKEELTLVCLTDVKNKKYVVDTDLSTSFISEEKTIYMLIKKDQKDLFRKLKIAFKNFVLENKYNINIDVDSFFNLLNECDCKEKLINTIYETIAFETFDKVSYKKDNKPNEVVYNLLTSFDVKDLEQKEAIKMEFVNFARMLQDTPPNIATSEYLAEKVVQKAKEIEGIKVTVLGKKEATKLGMNLFLAVNAGSPYEPQAVVLDYVGDENEPKKALVGKGITFDSGGYNLKPAKYLEGMKFDMSGAAIMLSTVMALAKMKAKVNVVGIGMFTDNRIGSTATLPQSVVKSMNGLTVEIDDTDAEGRLVLADGITYVIREKQATEIWEASTLTGSVVSALGSYATGVFTHCNKRWQLVESISEFSGERMWRLPLYEEHLEEVRNDAINADITNATKNYEAESSKAASFLNEFREDKPYVHFDIAGTDSIKGRGQGVLVRTLFEIFNK
>NZ_CP012387.1|WP_020862567.1|256126_256810_-|hypothetical-protein
MKLKNWTFYKAKQFVKLNESNEILKDLAVLVLRPDINKEKTLLAIGLDKKVVNSLIIDLQNKVFEENELFEIFKENIGFVSTEEISEIDAKGLNLSTPIHPDNIKSIIKIYNLFLNVEPIEFDTKDYQDLETIQNQEDVFTNVDFENIPLPALLQTLNVGMENYKQRVEEIFELDGKESINKKLELVNIQSNLIAFFDQALRKMDEIITKLSEQNAELIKKLESQEK
>NZ_CP012387.1|WP_020862566.1|254333_256127_-|oligoendopeptidase-F
MKRPEALKEYKWDFDYLYKNQDEWKKDLDYLVEISKEFKNFKNKLHEKETFLKCLDLEEKVDFITNKLSTYTRMGDTNQADEVYRTLEALLMNVLQDIEIETSFISPETKKIGFETISKWLKETKDYQRYLYGYKKFFEQAKHILSEHDEELLSKISKGYTAISGMYDTLAYADRQEETINYKGVDQVLTNSLFLEILQDSDPIKDQDLRLKASEIFSKNFSLKKHSFALIYEGILQSDHEDTKLRNYDSSLQASLSSDSVSVDIYLKLLEVGKKYIKPLEDFLLLTKKHFKLDKFYPSDRQLKLVKEYNQTFTVEQAKEHIKKALSILGEEYLKNLEIAWGPNKIDYYEDTNKRDGAYSTGGHGVDPIILMNWDDKLNSVNTLAHECGHSVHTLFSEQNQVYPLSQYPIILAEVASTINEHLLFDYMYKNAKLKEEKIYLLQKRIFNLVSTFYRQIQFADFEYRASQLVSKQTPLTSEVLNNLFKEVETDYGYKVFDKLDDNIKSGYGWPRISHFFHSPFYVYKYAIDVTASYKLYDDIKNGNIQTTLDFLKAGGHKEPLEIMLDAGIDFNKEQTYLPLINGISEHIKELEELLKE
>NZ_CP012387.1|WP_013729335.1|253585_254305_+|GntR-family-transcriptional-regulator
MQDKKNKEITERQKIVNYLLDLIEHKKVDLKTPLPSEYFLVTKFKVSRGTVRSAFSDLKTKGLIKSSKGAGYFINPDFSFNRIKSIRNQLLSNKQEVIIETELDTSNLITIIHKLHLNLDINPDDYFSYIKVFYVDDLPVRYAKSFINKNLFENEIDSEKIRSSLIEYLEQNNIEPFKLTCVLESKLKDQMTRNLLVDNHQDYVICRYSILYDKDDNIVEITQHTINIDHFETSYIKYL
>NZ_CP012387.1|WP_020862565.1|251958_253563_+|alpha-glucosidase
MANYWWKNTVVYEMYLQSFKDSNNDGIGDLDGAIEKLEYLKELGIGAIWLTPIYDSPLVDNGYDISNYQSINQIYGGLEKFKKFVDKANELNIGIIMDLVLNHTSDQHEWFKQSRSSKTNPYRDYYIWRDQPNDITSAFGGSAWTYDETTNQYYFHMFAKEQPDLNWENPKVREEIAKMVKWWCDFGIMGFRLDVIELLGKKIDQKILSNGPMLHKYIQDLRKNSWDSNEFLTVGECWSADIDHAIQYSNEKNEEFSMVFNFEPITSFFNKINKYKTMDVDFLEFKQIYQKWQQGLHNKGWSGLFLSNHDLPRMVSRYGNDHKYRIDSAKTLLTTFFLMQGTPFIHQGDEIGMTNVKWTDLNKYKDVEIKNTYQSEVLEKQVLTYDEFIDGILVNSRDHARTPYQWDDSLYAGFSNHQPWIDINDNYKEINAKNDLKNPDGVYHYLKKLIKFREESSYSQLIIDAKFELLDPNNDKLFAYTRIDQNKSIKIIANWSDEQVDISHLINDYNKIILNTQVDFKQNTLKPWQTIIVE
>NZ_CP012387.1|WP_020862564.1|249659_251957_+|glycoside-hydrolase-family-65-protein
MKTNIDVNIKRLFEVDPWKLVENKLPDNGYDFRLSESITSLGNEYLGMRGNFEETYSGDTHKGCYVGGLWYPDKTIVGWWKNGYPNYFGKVINAVNLLGLNVVIDNVELDLFKQTPSSYKRTLDLKQGILSREFVTNINNKEIKVETERFVSIDTKELVAIKYSITSNKDISLDLTSYINGDVINRDSNYKTKFWTHLDSLANDHSQLVVSKMIENNFDIQRFSYACYATNSYNLKTKDIVFDQSNLYAKTTYKFDLKANQTLIFYKLVTLVHSLNYSEDQLKENAIQINNQINQFDYEQLKEKHTSLWEKRWLTSDVKIIGSDLDQQAIRFNLFQLFCTYYGNDDRLNIGPKGFTGEKYGGATYWDTEGYCLPLYLKTSDPKISRNLLKYRHNHLTKAIENAKLLGFKGALYPMVTFNGVECHNEWEITFEEIHRNAAMVYAIYNYTNYTGDFDYIKEFGMDVMVEVSRFWADRVHYHSIKDKYFIHGVTGPNEYENNVNNNWLTNLMCQWVLSYTLEMLDKLNLDKSKWNLSTNETNKWVDIINKIYLPYDKDLDIFVQHDTFLDKDLKHKDLLSKDERPLNKNWSWDRILRSVYIKQADVLQGIYYLWDKFTKEQITKNFKFYEQFTVHESSLSPCVHSIIAARIDLMDKAYEFYNRTARLDLDNYNNDTDDGLHITSMTGSYLAIVEGFGGMLVRNDIPCFSPKLPKQWNGYEFNINFRDRVLKVKHHKTEVEIQLIKGQSLKINLFDKEYLLETNIKIEV
>NZ_CP012387.1|WP_013729332.1|248466_249552_+|ABC-transporter-ATP-binding-protein
MKVELRNISKKYEGNSFYTLENIDLTINDNDFCVILGPSGCGKTTLLRIIAGLNSITKGDLLFDGVKVNNLLPKDRDIAMVFQSYALYPHYNVYKNLAFGLEMKKEKKEIINHRVRGAAKLLNIEKYLFKKPKELSGGQQQRVALGRAIVRKPKLFLMDEPLSNLDAKLRESMRTELVSIHRILGTTTIYVTHDQLEAMTMATKIVLMNNQVIQQVGKPEEFYNKPNNLFVAKFIGTPTMNVLEGKLENNYFISNINNYKVELSDEELELIKKEEVTKLYLGIRSEDAQLVKTTDKTANIVASVINTELLGMNKQVTCELTPGNNFVITTSKDNNIKIDDKVGIKIHKYHLFNGITENRIG
>NZ_CP012387.1|WP_053263283.1|245924_248465_+|ABC-transporter-permease-subunit
MKTEVKQNVDQKALVFSSLLKPVEKYDFSSFKKSNNWNIIKTKLLEDEQIKSTNKIKDYQLFIKSNYIVGNIVDIYKKFTTDSKLIEGLLLLLVANSFSTFNDKNNFNISNANKTMNQIIESKYVQKEIINEINVYEKQKSLKDFDHFDFKNLELYEFLNSWKKINAIIVTYFKKINLEKLGKILASEFLLTYETHKEAMDFVSLNIIQHEHLSEDYAFNKINDLLEQAFNELVNKNVENITIQETIILALKKSLTYQVDTHKKSWWEKLVENRKSKEKFRLYCSEEINERLAKELRLLTNPKVLDKSETKKEEQNEKFVHYNTLKINNKSYKIDAESLKFAKLIFKEKDLIDFQASLSETYFRSKHLNFNKYYNHLYIIKLSSLAYLYALKNKDNKINFNKAKELFELLILKTAYEISESFAKKIEKIIFNEEHLENEFFKKTKIDQLGRYKNWSKVVAINIAVYKELNLNTKIIQSATIYEILKNEIYVWESVKKSDSLLSKDLVNYNEISQYQNELIFIIEQELKKEKNNAYVKYVRFLTETFGKLYLSDKPPLSIYGKIGLAFIYLVLIAWALIIIVPITQVVLQAFNWYSANESTSTAGKLGTLGRFDFKRFAFSFANFSYLFERTFFGYWLLNSLVIATITMIFMVLITAMVGYAFSRFRFKGKRISLMTVMLIQMIPTVSSFIVFYVMFQLLQETVHITGQIMLILIYVGGGIPGNVFVLKGYLDNISTDIDDAAKIDGCSIWQVFTKIIFPLAKPMLSVIALWSFIGPFGDVLLPQLLLDNQRDWTMATGLNSLLNRSGEIAQGAFAAGSLLVAVPISTLFIMLQGNIIGGLSGGVKG
>NZ_CP012387.1|WP_023905929.1|243492_245910_+|ABC-transporter-permease-subunit
MNHIEFYKSLKTKEEVFNELKKVKYSDFEKEFEELDQTQKNIANSSYTFSNKELAKILLEFAKNNIHNNMYAKLKENFAMYLNKTADNKFVFDIKAIEQSFVNKDEDYIQDMFKIKARLQLSQIIYDARNQEIKNLKTKANSYYVAYLKFLNDFTYKYKKKFISITYKIAKRKVQELRLLFSTNDYTFHIKSHNKNATTFIEEKNAISQKIKQELNEIKNLDPITKAKRTSEIYQQGIEYNYDWEVASLNAKAKEKFLIKKQQIDSDFIDKINKAKQDYVEISKNKKQHDELTKKVIIQANEDFKTQLEFATTKSEKKNLKLEHKQNIKEIKSDNAVKKAKDNWKNLKHNYKVEKNKNRLEYTSEIENIKNNLPIEYPVWKQVLSIIFGWIPGVGPLINGQYKKAIVMFLTLPLFVIFGAYAFGIGNVGGNGLLGLIDFGADNPDGDGRFYLIEGIISLIIAFWICISIFSTWMDSKNNAKRMRIGSRASTFSQTRKFLKSHGIPYILSIPAIIGIMFIVLVPIISTILIAFTNYGKGNDPGRPGQIIKWVGFDNFKSIFGGEYFPSFLYVIGWTFTWVIATTISVIVVGSLFALLVNNERLKGKRIFRLIYILPWAVPAFIMIMVFAILLSSIEFNTFTYKWIGVSGWTSQQTQARIVLILLQTWLGHSYMFLLITGVLQGISKDLYDSSTIDGASKWKQLTRITLPLILTQVAPLLVGQFVFNFGNFGIIYLFGANPQALNAKGEPYPGQPGITDILISFVFKLSTHPDRYTYGIAASFIIVSSFIVVGTSANGFRKMKAFKN
>NZ_CP012387.1|WP_020862570.1|258753_259374_+|chromate-transporter
MNKKEYTKPPTFWNIFLFILLITFVGFGGGNAIMPVIKRYAVDKYKWLDEDEFHQNVVLTNMLPGPAAIQTTAYIAFKSLSKFKAYLVVSLASMPHTFFAVGLIFAFNKIPTQYLVVVQLGVLVAITGALLGFGYNYFKKGKKVMKLSLWLVLFFTTLLFSLFVPTPYNVPVLVMILVIAIYSTIFIIRSKKSKKIESNEIKKGMK
>NZ_CP012387.1|WP_017698001.1|259373_260051_+|chromate-transporter
MLSFIAFLVTLVLLVFVSLSVFGGGQVFMPIFVWLWKSLNSWFKIEISEEFINTVFAVSNSTPGILSPKFAAITGYMIAQGQWWGFVAMIFTYLAFVLPAIFMMMIAIKYSQKFHQSTFFKKLIDIMNPVVAGIIIALAIEIFISCMFPYFVFNESVSEYWKFIDPNKPSYSMKFFTGWRLIALYCYVPIGIIISLFLYLKKVPIFGLIFANIIFCLILFEPWLG
>NZ_CP012387.1|WP_020862571.1|261507_264618_-|extracellular-solute-binding-protein
MKKLLKRSYFAFVLLFIYAPILAMVVFSFNNGDTTIKWTHASFSWYESFFKNSPFIKSIITSLFVAVISTIVSLVIGTLAAIGLSRVSRVTRNKWVSVANIPLINADVITAVSLMIVFLIMGLKFGLLTLIMAHISFNVPYVLVTIMPRLKKIDPSLIDASYDLGAKNHQVMFKVILPILKPAIITAAAIAFAMSFDDFIISYFTGGMQTNVSTFIYTAKKTRPFIFVFGTCLVLVIALSIITWNAINLIKQSRLETKQKLINNNYKLKTISKLNKQLDELNQILKTKTIIKKSHNLSLWIKYFILKTKLYFYKLKSLDKKISKLQWKQYKLKSKIQKEERYYSRLKKSEKKLKQLIKQFSSEKDVKKAAKLSLQIETLQEKVEFLKDQIEVIKEREQTANLKVKKLQNKIKLLKQDLSEEVNPSKKTINWYNKKIKYFEEWIIELEEGKDYYKLKLVVEKLKDLKNIKNNKISDLTDQLNELINRIYVPVLITKDIDLKIQNTTDIESLNNLNHKREVIIDKFTKLYNRKIDKTTLLIQKVNQKTDKLKTRLLPSSNENASHFKSFISRSWKAILITFIGIGAFSGLTAAYVLNNIYDLVVANWGEYIDPSLIGEFEQQASQKHNRRIRINYQIYNSNEILYNKLHTVDYDIMIPSDYMVQRLASENYLQKIDYSKLNIWGEFNEKNFNKDIKSKDFEKLQVNKSLLELMAKSPIHLEDETKEVITKNPNGTYLSTNSILDYSIPYLWGDLVIVVNPTQENIKFLEDNQIKFKNQKDDENNNENKVEIDNSSLSWDILWKAAAAGKKVALNNDPKNVFMLGSQKLYQKVNLTKKSEIDEVGKELSQLLSNSGVSLHSDDLISLVVREKFDFAVMYNGDAAYANYVHNEGDDDYEKAGNSINFIYGRPNKKNKKNNRHESTNVFSDNIVLYKDAQNLDLAYEFINFLYENSTKISDYVGVTSPLDSAIEEMTAAPKEGNKEDEGGTYQDFKNIYDPITHQNNGSKYETNNEQLSFTYNGKIDEYLVNSFNNLLANK
>NZ_CP012387.1|WP_020862572.1|264602_265595_-|ABC-transporter-permease
METKNLKDNNVIENKIINQDELEHVIETIEKQKKRESARLKVKDINHYLSKTKLFHFTKDKVWPILAPFILVMVILVILPLVSILIYAFIQPADGITLFKISFEKFVKLFTSNGILYSLFLSILYAIVAGMLCVLIGYPIALMMAQMKSKILARNMWVIVTMPMWISMLLKVLGLQTLFYLLADFAIGTPIAIIIGMTYMFLPFAIAPIYDSLESRQTDLEEAALDLGASKFRTFWSITLRSSMPGVLTAFSLVLVQAATSLIVVHYMGGGRIYLVSAAIESYFFQGNDFGYGAAVSVVLAILVFGLMLVMKLISNKFEMKGNKRKWKNS
>NZ_CP012387.1|WP_011387091.1|265594_266650_-|spermidine/putrescine-ABC-transporter-ATP-binding-protein
MENNILELRNVTKEYDGQVVLKGISFNVKEGEFITLLGPSGCGKTTILKIIGGSQKPNSGEILFEDKNLIPIPINKRQFNTIFQSYALFPHLNVFDNVAFGLTIKKTKKDIIEREVMRQIRQVGLEGYENKKIDELSGGQKQRVAIARALVMKPKVLLLDEPMAALDVKLRKTMQEELKRLQQDIGITFIMVSHDQEEALSMSDRIVVMNQGTIQQIGTPEEIYNEPENAWVANFIGSSNIITDGIFLEDNKIKFDGKVFECIDTNFGENESSIDIIIRPEDIIIKNPNNGFFNAKVIKTTFKGIHWEVVVETSKKRQWIIHTINEYDIDQQVSIKWKPANVHVMWKEVDN
>NZ_CP012387.1|WP_011387092.1|267023_267383_-|50S-ribosomal-protein-L20
MARVKYGKVTRARRKRWIKLAKGYFGTKKSSYKKAHEQVIRSMAYAFIGRKERKRDFRSLWIVRINAAVRPEGLSYSTFMHGLKLANININRKMLSELAINNSEEFKQIVQQAKKALNK
>NZ_CP012387.1|WP_011166422.1|267401_267593_-|50S-ribosomal-protein-L35
MPKMKTKKSLAKRVTVKSNGTLKRAKAYRSHRATGKTTKQKRQLSKATIISKVDMKNLKGLLQ
>NZ_CP012387.1|WP_011166421.1|267618_268164_-|translation-initiation-factor-IF-3
MENRNRNSRPIKNQDPVNEFIRAHQVLVIDEDKQNLGVMSKRQALEIARSKNLDLYQVGVQPDGTVITRIVNFGKLKYEQQKKSKEAKKHQTKIENKEIRITVNIGKHDLETKARKAKEFLEEGSRVKVSLKFRGREVVYLDLGQQTLNNFFELVSDVGKMEKEAKLNGKFLDMYIVPKKN
>NZ_CP012387.1|WP_020862573.1|268352_268955_-|peptide-deformylase
MDKSYLLQDQIPSNSWLVKDHKKEIIRTKSTKIIDPTNLSNDEELVLKKLIDFVTFSQDENNNNINNKDYLRPAVGLAAPQIGVNKDMFYVRFQLDNNKIEQYAMINTKLISTSTQIACLKNGEGCLSVDNDHLGFVPRHYKIVVQGYDWLTKQYLTLTLRNYQAIVFQHEMDHNIGVLYYDHINKADPLYKDNSWIIIE
>NZ_CP012387.1|WP_023905932.1|269013_269586_+|16S-rRNA-(guanine(966)-N(2))-methyltransferase-RsmD
MIGVIMHIISGKYKKMKLQTLDSSITRPTLTRIKEDMFNIISNYFIFENKTSLDLFGGSGSLSIEGLSRGIKFAIINDLNKDANKIISFNLKKIPTSDYVLYQKDYLELLNLLKIQHQKVDLVYLDPPFKEIDYYYVVFDFLINNNLLNDWAIIISETNQKLDLTKIKDLNLLKFKDYNKKYLYIFRLEK

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP012387_4

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP012387_4

298843-298989

Orphan

Consensus_repeat	Method
AGTTGAAGAAAATGCTAGTGTAGTTGGTGCTACTCCAGTTTCAAA	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP012387_4

>merge|NZ_CP012387|4|298843-298989|CRISPRCasFinder
AGTTGAAGAAAATGCTAGTGTAGTTGGTGCTACTCCAGTTTCAAACGATGTGTTACCAAGCAGAGCACCAAAACCAAAAGCTGAAACTAAAAAAACAGAACAAGTTGAAGAAAATGCTAGTGTAGTTGGCGCTACTCCAGTTTCAAA

>NZ_CP012387|4|4|298843-298989|CRISPRCasFinder
AGTTGAAGAAAATGCTAGTGTAGTTGGTGCTACTCCAGTTTCAAA	CGATGTGTTACCAAGCAGAGCACCAAAACCAAAAGCTGAAACTAAAAAAACAGAACA
AGTTGAAGAAAATGCTAGTGTAGTTGGCGCTACTCCAGTTTCAAA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP012387.1\|WP_013729421.1\|292684_294049_+\|FAD-dependent-oxidoreductase	unknown	unknown	gnl\|CDD\|181958
NZ_CP012387.1\|WP_020862596.1\|304680_305103_+\|pantetheine-phosphate-adenylyltransferase	unknown	unknown	gnl\|CDD\|184424
NZ_CP012387.1\|WP_020862589.1\|290282_292202_+\|threonine--tRNA-ligase	unknown	unknown	gnl\|CDD\|234752
NZ_CP012387.1\|WP_020862587.1\|286032_287196_-\|type-2-glycerol-3-phosphate-oxidase	unknown	unknown	gnl\|CDD\|380302
NZ_CP012387.1\|WP_020862599.1\|309782_311570_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020862588.1\|288581_290018_+\|pyruvate-kinase	unknown	unknown	gnl\|CDD\|235619
NZ_CP012387.1\|WP_017697977.1\|295099_296212_+\|pyruvate-dehydrogenase-(acetyl-transferring)-E1-component-subunit-alpha	unknown	unknown	gnl\|CDD\|213783
NZ_CP012387.1\|WP_020862592.1\|297229_298555_+\|2-oxo-acid-dehydrogenase-subunit-E2	unknown	unknown	gnl\|CDD\|237001
NZ_CP012387.1\|WP_020862594.1\|301465_302647_+\|acetate-kinase	unknown	unknown	gnl\|CDD\|234680
NZ_CP012387.1\|WP_020862595.1\|302715_304671_+\|lipoprotein	unknown	unknown	gnl\|CDD\|366776
NZ_CP012387.1\|WP_020862590.1\|294051_295056_+\|lipoate--protein-ligase	unknown	unknown	gnl\|CDD\|161920
NZ_CP012387.1\|WP_020862598.1\|307827_308454_+\|dihydroxyacetone-kinase-subunit-L	unknown	unknown	gnl\|CDD\|274099
NZ_CP012387.1\|WP_013729425.1\|287530_288511_+\|6-phosphofructokinase	unknown	unknown	gnl\|CDD\|235111
NZ_CP012387.1\|WP_017697966.1\|308461_308857_+\|PTS-dependent-dihydroxyacetone-kinase-phosphotransferase-subunit-DhaM	unknown	unknown	gnl\|CDD\|184702
NZ_CP012387.1\|WP_017697973.1\|300484_301453_+\|phosphate-acetyltransferase	unknown	unknown	gnl\|CDD\|366685
NZ_CP012387.1\|WP_020862597.1\|305196_306918_+\|phosphoenolpyruvate--protein-phosphotransferase	unknown	unknown	gnl\|CDD\|224006
NZ_CP012387.1\|WP_013729410.1\|306999_307464_+\|PTS-glucose-transporter-subunit-IIA	unknown	unknown	gnl\|CDD\|376324
NZ_CP012387.1\|WP_020862591.1\|296211_297201_+\|alpha-ketoacid-dehydrogenase-subunit-beta	unknown	unknown	gnl\|CDD\|223101
NZ_CP012387.1\|WP_011166475.1\|308901_309528_-\|30S-ribosomal-protein-S4	unknown	unknown	gnl\|CDD\|235411
NZ_CP012387.1\|WP_013729427.1\|284498_286016_-\|glycerol-kinase-GlpK	unknown	unknown	gnl\|CDD\|198361

Protein	Function_ID	Function_description	E-value
NZ_CP012387.1\|WP_013729421.1\|292684_294049_+\|FAD-dependent-oxidoreductase	gnl\|CDD\|181958	PRK09564, PRK09564, coenzyme A disulfide reductase; Reviewed.	2.07615e-119
NZ_CP012387.1\|WP_020862596.1\|304680_305103_+\|pantetheine-phosphate-adenylyltransferase	gnl\|CDD\|184424	PRK13964, coaD, pantetheine-phosphate adenylyltransferase.	8.72473e-71
NZ_CP012387.1\|WP_020862589.1\|290282_292202_+\|threonine--tRNA-ligase	gnl\|CDD\|234752	PRK00413, thrS, threonyl-tRNA synthetase; Reviewed.	0
NZ_CP012387.1\|WP_020862587.1\|286032_287196_-\|type-2-glycerol-3-phosphate-oxidase	gnl\|CDD\|380302	NF033460, glycerol3P_ox_II, type 2 glycerol-3-phosphate oxidase. This FAD-dependent enzyme (EC 1.1.3.21), glycerol-3-phosphate oxidase, also called L-alpha-glycerophosphate oxidase, converts sn-glycerol 3-phosphate plus oxygen to glycerone phosphate plus hydrogen peroxide, which contributes to virulence. This form, called type 2, is shorter than type 1 and is found exclusively in Mycoplasmas and other members of the Mollicutes.	0
NZ_CP012387.1\|WP_020862588.1\|288581_290018_+\|pyruvate-kinase	gnl\|CDD\|235619	PRK05826, PRK05826, pyruvate kinase; Provisional.	0
NZ_CP012387.1\|WP_017697977.1\|295099_296212_+\|pyruvate-dehydrogenase-(acetyl-transferring)-E1-component-subunit-alpha	gnl\|CDD\|213783	TIGR03181, PDH_E1_alph_x, pyruvate dehydrogenase E1 component, alpha subunit. Members of this protein family are the alpha subunit of the E1 component of pyruvate dehydrogenase (PDH). This model represents one branch of a larger family that E1-alpha proteins from 2-oxoisovalerate dehydrogenase, acetoin dehydrogenase, another PDH clade, etc. [Energy metabolism, Pyruvate dehydrogenase].	0
NZ_CP012387.1\|WP_020862592.1\|297229_298555_+\|2-oxo-acid-dehydrogenase-subunit-E2	gnl\|CDD\|237001	PRK11856, PRK11856, branched-chain alpha-keto acid dehydrogenase subunit E2; Reviewed.	1.52526e-160
NZ_CP012387.1\|WP_020862594.1\|301465_302647_+\|acetate-kinase	gnl\|CDD\|234680	PRK00180, PRK00180, acetate kinase A/propionate kinase 2; Reviewed.	0
NZ_CP012387.1\|WP_020862595.1\|302715_304671_+\|lipoprotein	gnl\|CDD\|366776	pfam01732, DUF31, Putative peptidase (DUF31). This domain has no known function. It is found in various hypothetical proteins and putative lipoproteins from mycoplasmas. It appears to be related to the superfamily of trypsin peptidases and so may have a peptidase function.	1.10927e-51
NZ_CP012387.1\|WP_020862590.1\|294051_295056_+\|lipoate--protein-ligase	gnl\|CDD\|161920	TIGR00545, Probable_lipoate-protein_ligase_A, lipoyltransferase and lipoate-protein ligase. One member of this group of proteins is bovine lipoyltransferase, which transfers the lipoyl group from lipoyl-AMP to the specific Lys of lipoate-dependent enzymes. However, it does not first activate lipoic acid with ATP to create lipoyl-AMP and pyrophosphate. Another member of this group, lipoate-protein ligase A from E. coli, catalyzes both the activation and the transfer of lipoate. Homology between the two is full-length, except for the bovine mitochondrial targeting signal, but is strongest toward the N-terminus. [Protein fate, Protein modification and repair].	2.17929e-76
NZ_CP012387.1\|WP_020862598.1\|307827_308454_+\|dihydroxyacetone-kinase-subunit-L	gnl\|CDD\|274099	TIGR02365, dha_L_ycgS, dihydroxyacetone kinase, phosphoprotein-dependent, L subunit. Two types of dihydroxyacetone kinase (glycerone kinase) are described. In yeast and a few bacteria, e.g. Citrobacter freundii, the enzyme is a single chain that uses ATP as phosphoryl donor and is designated EC 2.7.1.29. By contract, E. coli and many other bacterial species have a multisubunit form (EC 2.7.1.-) with a phosphoprotein donor related to PTS transport proteins. This family represents the subunit homologous to the E. coli YcgS subunit.	2.78081e-80
NZ_CP012387.1\|WP_013729425.1\|287530_288511_+\|6-phosphofructokinase	gnl\|CDD\|235111	PRK03202, PRK03202, ATP-dependent 6-phosphofructokinase.	2.58593e-175
NZ_CP012387.1\|WP_017697966.1\|308461_308857_+\|PTS-dependent-dihydroxyacetone-kinase-phosphotransferase-subunit-DhaM	gnl\|CDD\|184702	PRK14484, PRK14484, phosphotransferase mannnose-specific family component IIA; Provisional.	2.6101e-54
NZ_CP012387.1\|WP_017697973.1\|300484_301453_+\|phosphate-acetyltransferase	gnl\|CDD\|366685	pfam01515, PTA_PTB, Phosphate acetyl/butaryl transferase. This family contains both phosphate acetyltransferase and phosphate butaryltransferase. These enzymes catalyze the transfer of an acetyl or butaryl group to orthophosphate.	1.9393e-141
NZ_CP012387.1\|WP_020862597.1\|305196_306918_+\|phosphoenolpyruvate--protein-phosphotransferase	gnl\|CDD\|224006	COG1080, PtsA, Phosphoenolpyruvate-protein kinase (PTS system EI component in bacteria) [Carbohydrate transport and metabolism].	0
NZ_CP012387.1\|WP_013729410.1\|306999_307464_+\|PTS-glucose-transporter-subunit-IIA	gnl\|CDD\|376324	pfam00358, PTS_EIIA_1, phosphoenolpyruvate-dependent sugar phosphotransferase system, EIIA 1.	3.30862e-58
NZ_CP012387.1\|WP_020862591.1\|296211_297201_+\|alpha-ketoacid-dehydrogenase-subunit-beta	gnl\|CDD\|223101	COG0022, AcoB, Pyruvate/2-oxoglutarate dehydrogenase complex, dehydrogenase (E1) component, eukaryotic type, beta subunit [Energy production and conversion].	4.10785e-157
NZ_CP012387.1\|WP_011166475.1\|308901_309528_-\|30S-ribosomal-protein-S4	gnl\|CDD\|235411	PRK05327, rpsD, 30S ribosomal protein S4; Validated.	1.49902e-106
NZ_CP012387.1\|WP_013729427.1\|284498_286016_-\|glycerol-kinase-GlpK	gnl\|CDD\|198361	cd07786, FGGY_EcGK_like, Escherichia coli glycerol kinase-like proteins; belongs to the FGGY family of carbohydrate kinases. This subgroup is composed of mostly bacterial and archaeal glycerol kinases (GK), including the well characterized proteins from Escherichia coli (EcGK), Thermococcus kodakaraensis (TkGK), and Enterococcus casseliflavus (EnGK). GKs contain two large domains separated by a deep cleft that forms the active site. This model includes both the N-terminal domain, which adopts a ribonuclease H-like fold, and the structurally related C-terminal domain. The high affinity ATP binding site of EcGK is created only by a substrate-induced conformational change, which is initiated by protein-protein interactions through complex formation with enzyme IIAGlc (also known as IIIGlc), the glucose-specific phosphocarrier protein of the phosphotransferase system (PTS). EcGK exists in a dimer-tetramer equilibrium. IIAGlc binds to both EcGK dimer and tetramer, and inhibits the uptake and subsequent metabolism of glycerol and maltose. Another well-known allosteric regulator of EcGK is fructose 1,6-bisphosphate (FBP), which binds to the EcGK tetramer and plays an essential role in the stabilization of the inactive tetrameric form. EcGK requires Mg2+ for its enzymatic activity. Members in this subgroup belong to the FGGY family of carbohydrate kinases.	0

>NZ_CP012387.1|WP_020862592.1|297229_298555_+|2-oxo-acid-dehydrogenase-subunit-E2
MFKVKFADIGEGLTEGTVAEVLVKVGDVVKEGQSLYFVETDKVNSEIPAPVAGKIAVINIKAGQEIKVGDVVMEIDEGSGASVASEPKAEAKQEAKVEVVEENASVVGATPVSNDLIVRKQASTVTKSSTIKATPLARKVAADLNIDLSLVTPTGPNQRILVADIKNYHSSSAQPASQPAPTPTLVASQPAPAPTPAITPAIKVVEPSAPLSWDEVPMNGVRKATVKAMTKSHTEIAAFTGMKNTDITETHKMRTELKDHAAASGIKLTYLAFIIKAVAKSLRDMPNINVRGDFANNKIQFMHNINIGIAVDTPNGLMVPVIKGADHLSVFEIAIKISELANKAKDGKLTRAEMTEATFTVSNFGSVGLDYATPIINSPESAILGVGTMSQTPLYINGELQKRFIMPLSMTCDHRIIDGADAGRFLIKVQDYLSKPVLLFM
>NZ_CP012387.1|WP_020862591.1|296211_297201_+|alpha-ketoacid-dehydrogenase-subunit-beta
MAIINNIKAVTDALDCAMQRDPNVIVFGEDVGTEGGVFRATQGLAVKFGNDRCFNAPISEAMFAGVGLGMAMNGMKPVVEMQFEGLGLASLQNIFTNISRMRNRTRGKYTAPMVIRTPMGGGIRALEHHSEALEAVFAHIPGVQIVCPSTPYDTKGLILAAIDSPDPVIVVEPTKLYRAFKQEVPDEHYIVPIGEAYKIQEGNDLTVVTYGAQTVDCQKAIALLKETHPNATIDLIDLRSIKPWDKKMVVESVKKTGRLLVVHEAVKSFSVSAEIITTVNEECFEYIKAPLSRCTGYDVITPFDRGEGYFQVNPKKVLVKMQELLDFKF
>NZ_CP012387.1|WP_017697977.1|295099_296212_+|pyruvate-dehydrogenase-(acetyl-transferring)-E1-component-subunit-alpha
MTYLGKFDPLKNEKVCVLDKDGKVINPKLMPKISDQEVLEAYKIMHLSRRQDIYQNTMQRQGRLLSFLSSTGQEACEVAYINALNKKTDHFVSGYRNNAGWLAMGQLIRNIMLYWIGNEAGGKAPEGVNCLPPNIVIGSQYSQATGIAFAEKYKKTGGVVVTTTGDGGSSEGETYEAMNFAKLHEVPCVFVIENNKWAISTARSEQTKSINFAVKGIATGIPSIIVDGNDYLACIGVFKEVVEYVRKGNGPVLVECDTYRLGAHSSSDNPDVYRPKGEFEEMSKFDPLIRLKQYLIDKKVWSDEQEEKLVAEHDKLVADEFAWVEQNKNYDLIDIFKYQYDKMDIFLEEQYKEAKEFFEKYPESKEGGHH
>NZ_CP012387.1|WP_020862590.1|294051_295056_+|lipoate--protein-ligase
MINLLISKYHDPAMNLAIEEYLTYHYKAKEPIVFFWQNANTIVVGRNQNAFAEINLEAAQKDNVKIVKRNTGGGTVYQDLGNVCYSLIVDNSTDDVDYQKALQPIITYLNQKNINAIFSGRNDMVIDGYKVSGNAQLKTNEKTLVHGTLLFDVDLSKMPKYLVVDPEKLKHQQIRSKPARVKNIKEFFKDINIDIDLNTFINDVVSSYVQNEKIKWIELTDQEKQYIQSRKETKFDQWDWTFGKNTVFSLVKKQYLESKGFITLNLDVDNGVITNIKIYGDFLGTQGTEKLEAKLIGVKFNKKDVENILNQFDLEAIFAKNFTSDDITNLLFKD
>NZ_CP012387.1|WP_013729421.1|292684_294049_+|FAD-dependent-oxidoreductase
MKVIVLGTNHAGTTAVRTLKRLDPTCEVTTYDKNDAISFLGCGIALWVKGEVKDPNMLFYATPEILRSEGVNVFMNHEVLSVDDKAKTVTVKDLKTGEVKTDNYDKLIVATGTWPLIPPIPGIDLEGVQICKNYHHAKKILEHNLDKSYKKIAVVGAGYIGVELVEAFNEYGKDVTLIDVANRIMPVYYDQEFTDLMQEKMTKAGVKLSLGAKVIEFKGENGKVTQVVTDKGNIDVDYVIFSVGVRPQSAILEGICDLDDRKAIVTNDFMQTTNPDIYAIGDCAQVYNKAMNKNVPIQLATTAVRTGVIAAFNVIKGNGLKSPGFTGANGISVFGLHMASVGISVEAAKRMGYDIDFINFKDLDRPEFMSTANEVLFKVVWDKKTRKIIGAQVASEKNHTEVMYMLALGIQKDLTIDELPLVDIFFLPHFNKPFNFISLAGLEVLGLNYFKKEK
>NZ_CP012387.1|WP_020862589.1|290282_292202_+|threonine--tRNA-ligase
MKIKLLDGSIKEYNQEISIKDISSEIGLKNVIGAKINDQLFDINYLIKNDCDLELITNKSKEYDLMLNLTAAFITSYAINSFKSISQAENFYNADEMEFSTTFDTEPRLVLDDLKNIQTNINNLLTSNLEIKSNIYDLNKALEILNNDYQKHLAKQMYEKYNYVKVYSINDFYMVIDKALILNSNFIKIIDIEQLTGSYWLNDKNNIMLQRVHGLCATSSSELKNKKVILEDRRSRDHRLINKTLNIFGFDQLVGAGLPLWLPNGFIVKNEIEKYLRQKEWEYDYIPVETPPIGTVELYKTSGHWDHYGEDMFQPFNGGKGSDEQFILRPMNCPHHIAVYKQEQRSYRDLPLRICEHAIQHRFESSGSLTGLERVRGMKLTDSHIFVRSDQIEDEFRSTYKLISEVLKTFNIQIDYLSLSLRDPNDKVKFYKDDLMWDKAESSLEKVLIDLGLKYEKRIGDAAFYGPKLDIQIKTAQNHEITVSTIQLDFLMPNKFDLTYIDKDQKLVRPIMIHRGLIGTYERFIATLLEQTKGVLSLWLAPKQVEIIPISESNLEYANLIHQKLKKEFIRSHIDLRDERLSYKIRDAQTKKVPYQLVLGNKEVENNTITYRQYGSDAQITVPIQEFIDMLKQQINDKK
>NZ_CP012387.1|WP_020862588.1|288581_290018_+|pyruvate-kinase
MTKETLQKRMKRTKVITTIGPSTHSAEAIKELFNNGMTTIRLNFSHGSYEEHGYRIKAAKKISKALNKPISIILDTKGPEIRLGKFKDNKQEVVKGQSITIYTDTYSYLNKECVQGEMTVAYDMSVDLKPGDMILIDDGKLELTVDSVEPQIIKATAFNHHIVKTNKRVNLPGIDFSLPFLSEKDEKDILFGCEQGVDYIAASFVNTAENVRQIKEILNKANANHIQIISKIESQVGLDNIDEIIEESDGIMIARGDLGLEIPYYDVPYWEKIIIRKCREKGKIVIVATQMLETMTENPSPTRAEVTDVYFATELGADATMLSGESAAGDYPFLTVHTMSTINKRAEVEFYNKIYYQVQLDNARNSTSGPRAEIADLLATKTKDGEYKYAIVLSKTGELLKTISKFRPNVTILGVSPDKKLWTSFGVWHSIFMNKVDTLDNLDNNIEKLSEIAKSWGAKLGEKVLVVRSTAIKEIEVI
>NZ_CP012387.1|WP_013729425.1|287530_288511_+|6-phosphofructokinase
MIKKIGILTSGGDAPGMNNAIAGVVKTAASKGIEVYGINDGYKGLVNGWFEKLNVEKTLDILSRGGTYLGSARLPEFKELEVRQKAVANLKKAGIEALVVIGGDGSYMGAQKLTEMGINCIGLPGTIDNDISSTDYTIGFHTALNTIVEAVDRIRDTMQSHNRADVVEIMGNGCGDLVTYTAVATGAEIFSPAEDLLTIEQMGQKAKQFRLLGKKSLIILVSEKSYGISAEEIAEKIQKISGYETKATVLGHIQRGGRPTAMDRYIAFTAGMFAVEKLAEGKGGLFIGLENNKLVARDIDSTLNMKKEDKKPFINYLREINGYFSK
>NZ_CP012387.1|WP_020862587.1|286032_287196_-|type-2-glycerol-3-phosphate-oxidase
MKQTKVDICIIGGGIIGASVARELAKFHKKIVVLEANPRLALETSSHNSGLVHGGFDPRPETLNAKLNVLGKKRYEDWIKEMDFPYLRIDSTIVAFNDEEMKHVHMLYDRGLINGLDPKEMEIIDAKELQKREPNISKQAVGALVCNSSIAIDPVVLTTTLMRNAIKNGVELKVNSKVVDIKKVDNIFEIKTAKDEIIQAEVIVNVAGHYADIIANMVGYGDFKLTTRRGEYRILDKSEAGIVNSVVFMVPTIHGKGVIVAPMLDGRVMVGPTALDGVPKEETLLVTQQQYDNIGKIGKHLIPNINMDKTCTVYAGSRPIDVETNDFVIRPAKADKKFINVAGMKSPAIASAPAIADMVCDLVKSAFDKLDKKANWQPKEEAILPWK
>NZ_CP012387.1|WP_013729427.1|284498_286016_-|glycerol-kinase-GlpK
MTDSKKYILTLDEGTTSARALITDKQGNIIAVEQSEFTQYFPKEGWVEHDAIEIWNTQRSALVQVLNKSGIDPSQIEAIGITNQRETAVIWNKETGLPIYNAIVWQDQRTADYCQTFDKDTLEMVKERSGLIINPYFSGTKVKWILDNVPNARQLAKDGKLMFGTINTWLIYRLTGGEVFVTDHTNAQRTLLYNIHTNDWDDELLKLFDIPRNILPEIKSCSEVYGYTFKGLFSKGNEQRIKIASSIGDQQSALFGQLCLEKGQVKVTYGTGCFILTNTGEEIVKSNHGLLTTVAYSFKDKVYYALEGSVMIAGAAVQWLRDNLRIVYNAIETEWYAGQVKDDRRVYVVPSFTGLGSPYWDSFSRGAIFGLDRGTRREHIVRATLEAIAYQANDVVDAMGKDMKKPIEIFKVDGGAANNKFLMQFQSNISQSKVIKPTNVETTAMGAAFMAGLAVGYWENVEELKKTYKVHFELTPELSKPEVDKLIKGWKVAVQRTFKWVEEIE
>NZ_CP012387.1|WP_017697973.1|300484_301453_+|phosphate-acetyltransferase
MYTLEEIKNQLVLKSEKKSIVFPEGESEIIQSVAKTLVDEKLGLPILLFKSSKEVPSEIKNNSSIKTICLDEFDTKEFSEEFVKLRKGKATIEVAHQVMQLPNYVGAMLVKLNQADCMLSGLNNTTADTIRPALQIIGTKPGYNIASSIFIMSKGDENYIFTDCALNIKPTSEQLVEITQMAVDFAKTLNVKNVEAALLSYSTNGSGKGEDVDRVHKAVEILKSSQNDYVCEGEIQFDAAFDKKTRDKKFKNCLLTKQTPDIFVFPDINAGNIGYKIAQRMGGFEAIGPFVLGLNQPVNDLSRGATFIDVLNTAIMTLHLSY
>NZ_CP012387.1|WP_020862594.1|301465_302647_+|acetate-kinase
MILVINSGSSSIKFKLFDTSKTIEPILDGLAERIGIDGFLKFEHNNQKYKFEDTLPDHEHAIQLILNKLLELKIISNIDEINGVGFRVVHGGEISHSSIITDEILSKIQDSVKLAPLHNPAAIIAIKAVKKLMPNTNMVACFDTAFHQTMPEVNYLYTVPYKWYEEFGVRKYGFHGISYEYIVNKSSEILNKKKENLNLIVCHLGNGASISCIKDGKSYDTSMGLTPLAGLMMGTRSGDIDVSICEYIAKQTNTDIFTITQTLNKQSGLLGLSQVSADMRDVLEQYDKNDKKAVIAVEKYVQIVADFIVKYANYLDSIDAVVFTAGIGENADVIRDLICKKVKLLDLQIDQDKNQAKYSDYKLISSEESKIPVYAIRTNEEKMICLDTLNLIK
>NZ_CP012387.1|WP_020862595.1|302715_304671_+|lipoprotein
MKKSLKYLSSLSLILVPLVTISCTHTNKIKPGFIPTINSSNKKDIIDLNNQLEEFKSILENNPKIDKNLKDKIIKKTKEINSKSISSNKLSNINNILSELKNSSNDFNSDNLLSFLKKVKELLLELEINELVNEIDQHINKITNDKQNNQLIINADSNVEDKFIEGSVYSPANHSYPEFVNKFTTVSAEEIYKELYDRTFSIKFLTKLNNGGSLSNGTGTGWLLDYHKYNNENKYKLFLATNLHVLSEFSNSLTEEQNKEFNYYDPSNNKVIAIGLGKAENVNDFSSKNNKTDFQNKITKYYLSNQDFKSYSLIDYSNSNSELTTAISEPKIVFGAVDFMNRKAVEKYDDAIKQSAEGYYNYKKANLNDDEKIAWEDYFKTKNIPIMVDFAVFEIDVDLSKTDDTLKSWINDAIKGLDNYLERLKNTNNLPNQDKNISNHLQSKDYISALFTKDNNSNNLYNAKDIYIAGYPANNKTTYWMKNNPTEISSDKSDIDWRTSKSNKDIFGFANEFESSISIVPNFGIFDNYWHRVFANFYGYQYNVNFSSLYYGASGSLAYNEFGQMIGIYNGVKSNVEFGDLLQSATIAPFLQSDNIKVGDNVIYAYNLIDGTDKTRYKYQKSSFRENLQKLYPNGFSDNSKSTKLFDNIFN
>NZ_CP012387.1|WP_020862596.1|304680_305103_+|pantetheine-phosphate-adenylyltransferase
MKTAIYPGSFNPFHKGHLNILKKAILLFDKVYVVVSKNVNKSLEPDLQSRVENIKNLIKDFNNVEIIINENKLTTTIAKELNASFIIRGLRSQADFEYEIKYYDGFKSLDPNIEVVYFISDYDKRSLSSTILKEIEFYKK
>NZ_CP012387.1|WP_020862597.1|305196_306918_+|phosphoenolpyruvate--protein-phosphotransferase
MSKQIKGIAASDGISLAKALVIKEIKLDVQKQLIDDVDQQIAKLEQAINQTITDLKKIQKITLEKLGEEKAAIFDAHQDIANDPAIKEEVVQLIKTEKVNAEYALFIVSNNYFEMFSQLEDPYFKERSADIKDVSSRIISHILGLEIHDLSTIDKEVIIISDDLTPSQTAQLDKKFVKGFLTNVGGRTSHAAIMARSLEIPAILGLKNITELVKTDDLIALDGSSGIVELDLNDNDIKNYQTKVKQYLELKDQLKKFKDKPSLTKDKIKKLIEANIGSTNDIQSVLDSGAEGIGLFRTEFLYMNNDHFPTEEEQFEAYKKVVSQIDHLVVFRTLDIGGDKKLSYFKFDEEMNPFLGYRAIRFTLDRKDIFKDQIRALLRASAFGKLGIMFPMIATIDEFKQAKAFVEECKLELDKENIKYDKQVQIGMMVEIPSAAILADQFAKYADFFSIGTNDLIQYSFASDRMNQNVSYLYQPLNPSLLRLIQLTISGAHKHNKWVGMCGEMAGDSKALPILLGLDLDAFSMSATSVLKARSLMSKIESIKAKELANKALECQTSQQVNDLVEEFLKNLD
>NZ_CP012387.1|WP_013729410.1|306999_307464_+|PTS-glucose-transporter-subunit-IIA
MWFFNKNLKVLAPCDGKIITLDEVEDDVFRERMLGDGFAIYPTSNDFHAPVSGKLVTAFPTKHAFGIQTKNGVEILLHIGLDTVSLDGNGFESYVIQDQEVNAGDKLVTVDLQEVSKKVPSIKSPIIFTNNGGKTLEIVKMGEVKKGDVVAILK
>NZ_CP012387.1|WP_020862598.1|307827_308454_+|dihydroxyacetone-kinase-subunit-L
MSLKIEAVKQILLKIAEVIDNNKEELTKLDQIIGDGDHGHNLSRGFLKVKEDLENNLYTDISSMFKKVGMVLVSNVGGASGPLYGTAFLKTSMSLNDKTEMNIDDFSVCLNDAVSGIKLRGKANIGDKTMVDVLEPVSDLIKELISKNESAKEILNKAVQLAYLKVEETKNIIAKKGRASYLGQRSVGHIDPGSYSSYLILKCISENI
>NZ_CP012387.1|WP_017697966.1|308461_308857_+|PTS-dependent-dihydroxyacetone-kinase-phosphotransferase-subunit-DhaM
MVGIVVISHSNKIANGVVDLAKQMANEVKIIPAGGTKDNLIGTDIDLIIDAINKAWDPNDGVILLFDLGSALMNAQMAIEMLEPDKQNKIKIIDAALVEGTILAAINSSMNKNIDQIQQELINLKLNKIEE
>NZ_CP012387.1|WP_011166475.1|308901_309528_-|30S-ribosomal-protein-S4
MSRFIGSTFKKSRRFGFSILETGKEFSKGKKRITTPGQHGKERAKVKVSEYGQQLQEKQKVKFMYGLSERQFRNTFAKAKKMQGILGTNFLVLLESRLDNIVYRLGFSATRQGARQLVNHGHILVNGKKVDIPSYLLSVGDLVEVKASMKKNEKVLEALQNNEATLEFVKVNKNEVKGEFVRLPERTELSSEISESLIVEWYNRLIKK
>NZ_CP012387.1|WP_020862599.1|309782_311570_+|hypothetical-protein
MWFELMLIITKLSETKAINIVFLTIFLLAFFCSLFTIFKLYVYRNTLKKLHFTFLNIEKTLKHPLANRLVRMQFIVTNSNNQNLSKALEIWKIKYNQIYNVELDILIKQTKEHFDLNSYSKKILFRVLSIKNFYRTRKLYKTSKAIYQKVNLMYSETQQVTNIEFLLRDYRIILQNHINDLFDIVFKEQENNELNIDKKIINNYQESIFKKMIVCEYYIKIGNFKEAFSKLNLLSNNVIEYIKFLDDHYKITKFLEFNGILDSKLQEIKNKVQLDVNQKNNQLIKYQINLLEQQFIDQKQAVEKLLFHGKNNQAFLIIETLIKNIQNLDVILKYDQQILSLFETNVKNIRTILLSFNTELLKTEELINFNNNLNNDISDIKIQFDQLKTSFNNITTEFDKEYQKISSNFIQFNSLIVDYVNYIRNVLIDIKKHYTQLIDIKTLLKNKSLVLRDLETKYDNIKTLLFLSQAIIKKYEKVINWSVYKELINNKFLIINFIYKNLELEANTFTNDYDALLVLNNQLDNQIEQVEQLHLNIEQVVVIYKIAQQIIIYIAKNLAYISNNNAFEEILTKFKEKNHKKVINLAIHLIRKNQL

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP012387_5

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP012387_5

586441-586621

Orphan

Consensus_repeat	Method
TCATATCAGTAACATTTGAAGTATCTCA	CRISPRCasFinder

2 spacers

The CRISPR arrays of NZ_CP012387_5

>merge|NZ_CP012387|5|586441-586621|CRISPRCasFinder
TCATATCTTTTACTTTAAAAACATTTCATTTTGAAATATCCTGATTAAACTCAGTTGCTCCTGCAAACATTTCACTCATATCAGTAACATTTGAAGTATCTCAATCTAATATGTCTGAACTATTAAATTCATTACGTCCATAAAATAGACTATTCATATCAGTAACATTTGAAGTATCTCA

>NZ_CP012387|5|5|586441-586621|CRISPRCasFinder
TCATATCTTTTACTTTAAAAACATTTCA	TTTTGAAATATCCTGATTAAACTCAGTTGCTCCTGCAAACATTTCAC
TCATATCAGTAACATTTGAAGTATCTCA	ATCTAATATGTCTGAACTATTAAATTCATTACGTCCATAAAATAGACTAT
TCATATCAGTAACATTTGAAGTATCTCA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP012387.1\|WP_020862775.1\|584174_584969_+\|alpha/beta-hydrolase	unknown	unknown	gnl\|CDD\|223669
NZ_CP012387.1\|WP_020862774.1\|583378_584173_+\|alpha/beta-hydrolase	unknown	unknown	gnl\|CDD\|223669
NZ_CP012387.1\|WP_008362785.1\|598628_598793_+\|30S-ribosomal-protein-S21	unknown	unknown	gnl\|CDD\|234707
NZ_CP012387.1\|WP_020862780.1\|588733_589453_+\|ABC-transporter-ATP-binding-protein	unknown	unknown	gnl\|CDD\|224054
NZ_CP012387.1\|WP_020862782.1\|590336_591293_-\|L-lactate-dehydrogenase	unknown	unknown	gnl\|CDD\|133427
NZ_CP012387.1\|WP_020862772.1\|581988_582846_-\|hypothetical-protein	unknown	unknown	gnl\|CDD\|223915
NZ_CP012387.1\|WP_023905954.1\|594005_595652_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020862783.1\|591344_592502_-\|N-acetylglucosamine-6-phosphate-deacetylase	unknown	unknown	gnl\|CDD\|238434
NZ_CP012387.1\|WP_020862785.1\|593416_594001_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020862771.1\|579795_580974_-\|NADH-dependent-flavin-oxidoreductase	unknown	unknown	gnl\|CDD\|240086
NZ_CP012387.1\|WP_020862773.1\|582847_583192_-\|glycine-cleavage-system-protein-H	unknown	unknown	gnl\|CDD\|133457
NZ_CP012387.1\|WP_011166709.1\|580973_582011_-\|lipoate--protein-ligase	unknown	unknown	gnl\|CDD\|223173
NZ_CP012387.1\|WP_129868159.1\|578319_579731_-\|IS3-family-transposase	unknown	unknown	gnl\|CDD\|222853
NZ_CP012387.1\|WP_023905952.1\|584971_585772_+\|alpha/beta-hydrolase	unknown	unknown	gnl\|CDD\|223669
NZ_CP012387.1\|WP_020862768.1\|572245_574114_+\|glycerol-ABC-transporter-glycerol-binding-protein	unknown	unknown	gnl\|CDD\|367390
NZ_CP012387.1\|WP_020862786.1\|595803_597804_+\|hypothetical-protein	unknown	unknown	gnl\|CDD\|372315
NZ_CP012387.1\|WP_020862781.1\|589452_590208_+\|ABC-transporter-permease	unknown	unknown	gnl\|CDD\|366444
NZ_CP012387.1\|WP_020862787.1\|597875_598313_-\|lipoprotein	unknown	unknown	gnl\|CDD\|234750
NZ_CP012387.1\|WP_025220914.1\|574702_578269_+\|BspA-family-leucine-rich-repeat-surface-protein	unknown	unknown	gnl\|CDD\|308794
NZ_CP012387.1\|WP_023905953.1\|592595_593405_+\|hypothetical-protein	unknown	unknown	unknown

Protein	Function_ID	Function_description	E-value
NZ_CP012387.1\|WP_020862775.1\|584174_584969_+\|alpha/beta-hydrolase	gnl\|CDD\|223669	COG0596, MhpC, Predicted hydrolases or acyltransferases (alpha/beta hydrolase superfamily) [General function prediction only].	8.19874e-23
NZ_CP012387.1\|WP_020862774.1\|583378_584173_+\|alpha/beta-hydrolase	gnl\|CDD\|223669	COG0596, MhpC, Predicted hydrolases or acyltransferases (alpha/beta hydrolase superfamily) [General function prediction only].	2.84374e-24
NZ_CP012387.1\|WP_008362785.1\|598628_598793_+\|30S-ribosomal-protein-S21	gnl\|CDD\|234707	PRK00270, rpsU, 30S ribosomal protein S21; Reviewed.	4.22612e-05
NZ_CP012387.1\|WP_020862780.1\|588733_589453_+\|ABC-transporter-ATP-binding-protein	gnl\|CDD\|224054	COG1131, CcmA, ABC-type multidrug transport system, ATPase component [Defense mechanisms].	1.21758e-59
NZ_CP012387.1\|WP_020862782.1\|590336_591293_-\|L-lactate-dehydrogenase	gnl\|CDD\|133427	cd05291, HicDH_like, L-2-hydroxyisocapronate dehydrogenases and some bacterial L-lactate dehydrogenases. L-2-hydroxyisocapronate dehydrogenase (HicDH) catalyzes the conversion of a variety of 2-oxo carboxylic acids with medium-sized aliphatic or aromatic side chains. This subfamily is composed of HicDHs and some bacterial L-lactate dehydrogenases (LDH). LDHs catalyze the last step of glycolysis in which pyruvate is converted to L-lactate. Bacterial LDHs can be non-allosteric or may be activated by an allosteric effector such as fructose-1,6-bisphosphate. Members of this subfamily with known structures such as the HicDH of Lactobacillus confusus, the non-allosteric LDH of Lactobacillus pentosus, and the allosteric LDH of Bacillus stearothermophilus, show that they exist as homotetramers. The HicDH-like subfamily is part of the NAD(P)-binding Rossmann fold superfamily, which includes a wide variety of protein families including the NAD(P)-binding domains of alcohol dehydrogenases, tyrosine-dependent oxidoreductases, glyceraldehyde-3-phosphate dehydrogenases, formate/glycerate dehydrogenases, siroheme synthases, 6-phosphogluconate dehydrogenases, aminoacid dehydrogenases, repressor rex, and NAD-binding potassium channel domains, among others.	0
NZ_CP012387.1\|WP_020862772.1\|581988_582846_-\|hypothetical-protein	gnl\|CDD\|223915	COG0846, SIR2, NAD-dependent protein deacetylases, SIR2 family [Transcription].	5.65564e-10
NZ_CP012387.1\|WP_020862783.1\|591344_592502_-\|N-acetylglucosamine-6-phosphate-deacetylase	gnl\|CDD\|238434	cd00854, NagA, N-acetylglucosamine-6-phosphate deacetylase, NagA, catalyzes the hydrolysis of the N-acetyl group of N-acetyl-glucosamine-6-phosphate (GlcNAc-6-P) to glucosamine 6-phosphate and acetate. This is the first committed step in the biosynthetic pathway to amino-sugar-nucleotides, which is needed for cell wall peptidoglycan and teichoic acid biosynthesis. Deacetylation of N-acetylglucosamine is also important in lipopolysaccharide synthesis and cell wall recycling.	1.4119e-130
NZ_CP012387.1\|WP_020862771.1\|579795_580974_-\|NADH-dependent-flavin-oxidoreductase	gnl\|CDD\|240086	cd04735, OYE_like_4_FMN, Old yellow enzyme (OYE)-related FMN binding domain, group 4. Each monomer of OYE contains FMN as a non-covalently bound cofactor, uses NADPH as a reducing agent with oxygens, quinones, and alpha,beta-unsaturated aldehydes and ketones, and can act as electron acceptors in the catalytic reaction. Other members of OYE family include trimethylamine dehydrogenase, 2,4-dienoyl-CoA reductase, enoate reductase, pentaerythriol tetranitrate reductase, xenobiotic reductase, and morphinone reductase.	2.40654e-175
NZ_CP012387.1\|WP_020862773.1\|582847_583192_-\|glycine-cleavage-system-protein-H	gnl\|CDD\|133457	cd06848, GCS_H, Glycine cleavage H-protein. Glycine cleavage H-proteins are part of the glycine cleavage system (GCS) found in bacteria, archea and the mitochondria of eukaryotes. GCS is a multienzyme complex consisting of 4 different components (P-, H-, T- and L-proteins) which catalyzes the oxidative cleavage of glycine. The H-protein shuttles the methylamine group of glycine from the P-protein (glycine dehydrogenase) to the T-protein (aminomethyltransferase) via a lipoyl group, attached to a completely conserved lysine residue.	1.98356e-22
NZ_CP012387.1\|WP_011166709.1\|580973_582011_-\|lipoate--protein-ligase	gnl\|CDD\|223173	COG0095, LplA, Lipoate-protein ligase A [Coenzyme metabolism].	7.08837e-63
NZ_CP012387.1\|WP_129868159.1\|578319_579731_-\|IS3-family-transposase	gnl\|CDD\|222853	PHA02517, PHA02517, putative transposase OrfB; Reviewed.	7.10932e-44
NZ_CP012387.1\|WP_023905952.1\|584971_585772_+\|alpha/beta-hydrolase	gnl\|CDD\|223669	COG0596, MhpC, Predicted hydrolases or acyltransferases (alpha/beta hydrolase superfamily) [General function prediction only].	5.55959e-26
NZ_CP012387.1\|WP_020862768.1\|572245_574114_+\|glycerol-ABC-transporter-glycerol-binding-protein	gnl\|CDD\|367390	pfam03202, Lipoprotein_10, Putative mycoplasma lipoprotein, C-terminal region.	0.00431547
NZ_CP012387.1\|WP_020862781.1\|589452_590208_+\|ABC-transporter-permease	gnl\|CDD\|366444	pfam01061, ABC2_membrane, ABC-2 type transporter.	0.000206026
NZ_CP012387.1\|WP_020862787.1\|597875_598313_-\|lipoprotein	gnl\|CDD\|234750	PRK00409, PRK00409, recombination and DNA strand exchange inhibitor protein; Reviewed.	0.000247214
NZ_CP012387.1\|WP_025220914.1\|574702_578269_+\|BspA-family-leucine-rich-repeat-surface-protein	gnl\|CDD\|308794	pfam03382, DUF285, Mycoplasma protein of unknown function, DUF285. This region appears distantly related to leucine rich repeats.	1.00696e-49
NZ_CP012387.1\|WP_020862786.1\|595803_597804_+\|hypothetical-protein	gnl\|CDD\|372315	pfam12785, VESA1_N, Variant erythrocyte surface antigen-1. This family represents the N-terminal of the variant erythrocyte surface antigen 1, versions a and b, of Babesia. Babesia bovis is a tick-borne, intra-erythrocytic, protozoal parasite of cattle that shares many lifestyle parallels with the most virulent of the human malarial parasites, Plasmodium falciparum. Babesia uses antigenic variation to establish consistent infections of long duration. The two variants of VESA1, a and b, are expressed from different but closely related genes, and variation is achieved through the involvement of a segmental gene conversion mechanism and low-frequency epigenetic in situ switching of transcriptional activity from the VESA1 gene-pair to a possible other gene pair.	0.00856972

>NZ_CP012387.1|WP_023905952.1|584971_585772_+|alpha/beta-hydrolase
MKKIIYDYDYIFKDNNNDTENIIFCHGFNASINVFNIFKNYWTKSNYYALQFPGNNNVKPIKDHEISVLQFAKLVVEFVKNNNLKNVTLIGHSMGGGTISLAYQLAPELFKKLVYVCPMNKASEDVNNNFLHDYFPKTFEEFTTDFLGSLYYDPSFLTRDPKWMRLAKWHFSGNDYNTKELTDLGKTLVSKELHEQIYQAIKTIKIPTLLILGEKDGVVNREPCLKYYQDEVKNVITTWIPKTGHMVFEEDWDSFIKILEPFLLNK
>NZ_CP012387.1|WP_020862775.1|584174_584969_+|alpha/beta-hydrolase
MKKLIYDYDYVFKNNNNSDLNIIYVHGFNSSYKAFEIFEKYWTKTNYYSIQFPGSQLVKPAKDHKVTVEGFAQLLIDFIEQNQIKNVVAVGKSMGGGTLAIAYKMRPDLFKKLIFITPMNKTQLPLYPRYKINYFPKTFDEYVNNTLTSLYYDPSFLTSNKEWMEKAKQNFNPEMYDNDLIIKLGTPKAKTFELIEKGLDSITIPTLLILGEKDGVILRDECLDYFKKHVKNVESHWIKKTGHRVFEENFDEFIKIVENFLKIC
>NZ_CP012387.1|WP_020862774.1|583378_584173_+|alpha/beta-hydrolase
MNLIYDYNYVFKNNNNDNESIIFVHGYNSSPRTFEIFEKYWTRSNYYALQFPGSNLVKAVKDHKVTVEGFAQLLIDFIEQNQIKNVVAIGHSMGGGVISIAYKMRPDLFKKLIFITPMNKPQRALYEQYKIDYFPKTFDEYINNTLSSLYYDPSILTSNQEWMKQAKQEFDPYVYNNDVIVELGEPKDRTFELIEQGLDAIKIPSLLILGEKDGVILRDECLDYFKQHVKGVEMHWMKKTGHMVFQENFEEFIKIVENFLNKTN
>NZ_CP012387.1|WP_020862773.1|582847_583192_-|glycine-cleavage-system-protein-H
MKKVIKFLVIEKIDDKNEYYLRMTSEMQDDIGTVSYLQFKNTDKKHLKEDDIFLALEASKAILNLKMPLDATVVKWNQKALENPKLISSHDDNENWIMVLSDIDQNKFMSLEDF
>NZ_CP012387.1|WP_020862772.1|581988_582846_-|hypothetical-protein
MNTNLSIEQLNDLINQNDSLIIAIGSEIYQTNKQLEFENNFSDFIKEFCFIDFKQASVYPFLDIKNYWAFFSRYIKLNYFDQKLDNSFIDLKNYLDNKNYFIITTNRDNSLELAGFDLNKIFYLDSKLNLLECSKKCSDELYINDDAILNMANNQKNLKVELEQIPVCKKCNSYLKVHQRFWCQVFIKDDEFVQTQNNYQKFINKNKDKKMLFWEIGINFNNQLTVKKPFWQMVEQFNKATYLAMNKKIYRIPLEIRSKTITYTNDLNLAIKNLEEVKNGTNRTN
>NZ_CP012387.1|WP_011166709.1|580973_582011_-|lipoate--protein-ligase
MVLIEPIRNGKYIKDGAYWLAIQIWAASNLKIDDTIVFPSIADPHIQMGYFQNPEVEVNFKYLKEKNLEIVRRATGGGTIYIDSNSVNICYLIPYKKGTEILGNYAKFYEPTIKILKELGAKNITQSGKNDLTIDGKKVSGAAMMLLDDVIYGGNSLLYNVDYDAMSQVLNPNRKKIEAKGVKSVSQRVAALSQYLDEPYRNLDIFEFKDLMIKKIFNVDDLKDVNRYIMTDKDWEQVDELIKTRYKNWEWTYGLSPRYEYNRDARLAIGTINFSLAIENQRIEKIKISGDFFAKKDLLELEKALIGTKMTHEDLLKAFNDADLQSYFFNEIKPEEVVKIILDEE
>NZ_CP012387.1|WP_020862771.1|579795_580974_-|NADH-dependent-flavin-oxidoreductase
MNKYQKLFEPFEINGFKLENRFVLSPMTLSLATLDGKITTQEADYVKRRAHSAPLQITGGVYFDEFGQLFEYGISAKSDDDIPSLTSLYQAMKTDSNCVILQLAHAGKFSKTSLKKYGYLYGPSYEKNHTPIEHEVLELSKDRIKQIIKDYKDATLRVIKAGFNGVEISMAQRLLMQTFFSQIINKRTDEYSATTFENRSRFCLEVVKAIREVIDKHAPKNFIFGFRATPEETYGDILGYTIEDFIQLVDKIIEIGKISYLAIASWGHDIYLNKVRSNTKYKNQLVNKVIYDVYKNKLPIISSGGINTPDKCLEALKYSDLVGLSSVFVADPEFVLKIKNDQIDQINLSVKHDQLKDLKIPESSFQDVVNMFSFCETIPSETIKTFENNSKE
>NZ_CP012387.1|WP_129868159.1|578319_579731_-|IS3-family-transposase
MSKLNLEKKLKIVKEAKKLNIKKSTYLANKYDISVDTVESLVNRFEAFGIEGLINKDKKPHYSAKLKLKIVLYKLETNHSYDEVAKKFNIIYSSTIAGWVKKYREYGFLGLNNNIGRPKKIMKNPNKKPAKIKKSQVKINNEQQIKELKEQVEYYKLEAEFWKKFPHLVDKRKINKEKTKVVLELLKTHKKVKISILLKIAKLPKSSFYEWKHKLENAIDKDKELKEMIVDIFNKSFETYGYRRLKIALKSKGHIVNHKKILRLTKELGVQCIKFRTKNRRYSSYKGTVGKIADNILKRNFHSLQANKLWCTDVTEFKVNGQKLYLSPIIDLYNDEIISYSIQTNPNLNLTNSMLDKALKKVKNTNGLLIHSDQGFHYQHISWAKKLEENNITQSMSRKGNCLDNAIIENFFGLLKQEIYYGEKYNSVEELTKRIHKYIYWYNNIRIKEKLKGLSPVQFRKQSCYNIEKF
>NZ_CP012387.1|WP_025220914.1|574702_578269_+|BspA-family-leucine-rich-repeat-surface-protein
MKFKGKTRGEDTYSKENEFDASKWNDTDFVVYEIGYYDDGNQIQSIKLPKGVVSVPKDLPREITSLKELFQDATEFNDPNIKNWDTSNVENMESMFEGATKFNQDLERWDTKNVSNMAFMFREAATFNGKISTWNTSKVTTMSAMFNDAKSFNQNINTKYSKNKNKYSVSWDVSNVDKMQEMFKGATSFNSDLYNWNTKKVTAMRDMFNGATSFNKDISNFDVEENGDFTDMFKDARSFNQNLSNWVIYDTKPGDIDSGASSWISYYKPRSKRDISNSIKKSNEGYLKTTNSLYDEEITKLIDKHKIEVEKQKAEAEARKRETEAREKAEAEARKQKEIPNKIKDIWNRNFKDKLNSAQKFKDIFKELQEKIKEDIDLKSISIKLVDSSLENKRFRFDPTDTTIDTRIKVEPQSLDILLDNQTIKLEPGSVKRAWKAVEFKGKTNGERASSKEDEWDISYWDDKDFEVYELGYYDDGEQIQAIKLPKDVKIVPDHLPKEITSTKELFAFSNQFNNENIKKWDMSNIEDTSGMFLGAAKFNQDLSDWDTSNVKNMSKMFLNAKEFNSKIFNKVENVTDMSSMFLNAIAFNQDLNSWKTEKVKNMNSMFLGATNFNQDLNEWNVENVTDMSYMFKNTTSFNNGLSKWKPKKAIDMSHMFEGAIKFDQDISKWNVSSAKNMQDMFKNASAFNKDLKDWNITSVSNMEGMFELATKFNGDISNWDTKNVESMSRMFKDAASFNKDISDWNTSNVKDMSYMFSDAISFNQNINTKDMSSKKAWDVSKVTDMEGMFSGAIKFNSELSKWNTSNVNNMSKMFKNAKVFNNNISNFDIKNVKYFNNMFENASTFNQDLSKWSFKHLGNNKDIATESYDLNATSWKAEWKPDSSSNTPVEPAPVPQPQPKPAPVEPTPTPNPVEPAPAPTPIPQPQPVPTPPVKPIHPITTNKTSLLKVIKKDQLGEINYRSANEILKKLANLNKGVEIKDLYVRNIEKNSAIISAKKNGKYLGDVLVSFNIKKPDRIIWENSIFDDNDYWFFRNDQPKTPHTPIKPNNAAERSTFNNEDDWFLYPVITPHNSTPNKPVDPIKPNQPDQPVKPSDPTKPSDPKPTDSTKPITPTKPIQPTDNKKPESKPDQPKAPENKADNQVKPNNKPQTKNVNNKTAFVAVSAVSILAILAISSVVILIKKKKNK
>NZ_CP012387.1|WP_020862768.1|572245_574114_+|glycerol-ABC-transporter-glycerol-binding-protein
MRRKLLGLSAMALTMTAPFAAIACTTTKSDRILFATAQGAGWPLSLALRPLVKYYNETYKNEAGFVPVKFKFADNPTKDPEIETHGITNQFQLIKKTKEDIETHNTKALPNIVLGDQSGAYIINQDQRLLDISDQGIDKNTFSSKIAELHSILAGQHDTTKLYNIPFDNADTNALQINLRVMEKMFELIEKGGGTVEKGSEIYKKVESSKKEKNKNELPEKTIWSALKVKKEKNGTEGSFKDLKINDDTFKSLKALRDFAAKFTEGVEIDESKVKEDTISGEVLSIDYQEQEFYKELHSRINSDKPIFELDKSNDKNIPKVKYNLVQDDSTKQEFKKLWEEWNKSIKRVEYKKETPNKKVFQSMKFMANGIKEWGSWNIFRFQSAISLAASVGANQNKITDFTRKHPYFGDDIKNDPKFDTNNAKDADVFMDSQITPPKENKSGESAMTPPKTNPGIFDEGGSSILPINVGNEKLNNGTKKFLKWIYTGKNKISGIEEENWLTLAKTSGYIMPLKEVVTKETVKKLEEIISKLETDLKSKNDITKEPGYFTLNMLRSSLLSLKSLVKLENGESVARAMVTDDKAAEITGNVAKALIGQTNIDGKTDTSADALLSQFETIIKK
>NZ_CP012387.1|WP_020862780.1|588733_589453_+|ABC-transporter-ATP-binding-protein
MSLIEVKNISKKYNKKTVLGPINLKINKGESVAIFGANGAGKTTLCEIIANTKSQSSGEVLYDFKKEEIAFKIGINFQTQTYPNFINVKELIDFYKTLYKNIINKTYFDEMINKFKLKELFKQKISSLSGGQRQRVNLFVSLFNKPEIYIGDEITTGLDVKAQLEIIDLLKKEIKDKEMTLILVSHNLDEIKQLCDRMVFLDKGKIIDDAPIEKILNRYGTLLEYYLSKTNDLNKGEMQ
>NZ_CP012387.1|WP_020862781.1|589452_590208_+|ABC-transporter-permease
MLQQFKAMYNLLFNYWKKSFHNIFFSFVFPCMFLAILSKVPSLNINDLTPGIIASACPVVGIISLSISFSDLKQTIIYKRIAVLPLKPWIFIISIISFFTILTWLSAIWIFIFSLIFWHSQINLVNIHAGYIILGVFFLSIICSSIGVIIGSLAKDYMIANAFSMLFYLPPAFLSGMYLPIKVIIGSNVLKIISLFLPYTYPVTIINYGWNKTKSSFIFNSELWIFIVISLLLVIGFITIAILVYKLKKKK
>NZ_CP012387.1|WP_020862782.1|590336_591293_-|L-lactate-dehydrogenase
MKKTANKVVLIGAGAVGTSFLYAAINQGIAEHYVLIDAFPQPAEGNALDLSDTLAVIPHSFSSIKAGTYEDCKDADVVVITAGRPQKPGETRLEMVAGNAEIMKNIATEVKKSGFDGITVIASNPVDVITHVYQKVTGFDPHKVIGSGTTLDSARLRRLVGQKLNVKPESVQAYVAGEHGDSSVAIWSQANIMGRPILDYVKCGCLTLEDLDQIQKDTVDMAYKIINLKRATFYGIGACLTKIVNAVLRDEKSTLMVGAQLNGEYKNKGLYTGVPAIIGSNGWERIIEWDLTKEEQEKFDKSCETLHKTIDSVKHLFE
>NZ_CP012387.1|WP_020862783.1|591344_592502_-|N-acetylglucosamine-6-phosphate-deacetylase
MILKNAKIVLEDKIINNGYLIIKDKKIVEIGSDYKKKNGIDLNNQWLLPGFIDCHVHGGYGVDFETGNKNRFKHFADNIIKEGVTRYIQTSVTNSVKKNNQIYKEFGEFIKLNNGKAKCLGAHLEGPFISKFKKGAHQENLLLNPDIKLTKKWNKLSNNSLKIVTYASELDDGSYLQFLINNQIIPSIGHSNLKANQFEQVYLLGVRHITHLFNAMSGVDQHNPGLVVASFNHKDVLCEIISDGIHLDKEILKMIYNFKTADNLCIITDAMNAKGLDDGIYKLGDLEVYKKGIEIRLINNNALAGAGATYDHNIRVIKQVCDVKMTDLIKMTSINIAKQLNIFDTVGSIEVNKLADLVVLDDDLYVNKVLVEGKIVFKNSKNKKI
>NZ_CP012387.1|WP_023905953.1|592595_593405_+|hypothetical-protein
MKFDWRTKLKNSRFVNWKWYFQLFVMLLSGITLINAFFNGILKEQWYFESNNLYQPTRLINYDILLSFFSVQVSIITTIYLLIVVINYKNPKSNINTQRTRNIVLNWNLLDFMIFWIGIIGFKNTIAGQLPYLTKTQIFSTVITHFVVPLLLLFIYLFESGNNKYEIKKFYKNIKELFWVYSYPFFYTLFVLMRAQIYLKDKNIDNFIYPYEFLDFTTPYIGNSKIGYLILIWIIFVIWLTLNHLIILLINNLIFKIKNKKKEKIVTLN
>NZ_CP012387.1|WP_020862785.1|593416_594001_-|hypothetical-protein
MENKINHKTYKSLKYLLTISSVILAICLLLVFVQFTKAKPLFISLTPFISLLVILLILSFTCLLVYIIYRMKILKTSNYKYIKKEIIYLYTSFSLYIFSFILTVIYLIIALLIKNSESIRIMFYVVISIFFICIILSSIFETLSRLKEQILLYKQQYQSQQQLKLNKETDNKKQINKEVTNNNNNQSKNPFIED
>NZ_CP012387.1|WP_023905954.1|594005_595652_-|hypothetical-protein
MKKVFSYFLIILIFFTSLFFINNKNQNQVNLTYNTQFNDNDNNETNKNSIKEFLWGGKALRYFLYKNSTAQTNKSFNQFTDNLLANFERVFQKRTKRNFYKQQYITELQSEEFKHAILSSILVTSAYGSTSPEEFFAESFSRYVSANEKQKNLTWYLLEHFFTKTFYKLKQQNIGILPSNDKEINWKKIKNVIDSENDVKYKYELEPENHTLNSQYDRLNYFDLGYHTNQYGYNNGLYIFETINYIYKNTFAPQISNLDFLNLDRSVLNGDRFAHYYRDNYDIFSDYMKLNLYKPKNIITTNSNDQFFKDFDQLDAYWKEKSKFNFGKSSAIQIKQNLENIWNAIPKPKTLNKDYFDLDKLKTNTVHLFNTLQKVTHNNLDNIFINLILTNDDRFKVNNNLLDPKIKGITSTSFSKNTLSSSYSYVLIKADSFNKAENQEQYDRSWFASNNQFQTLNHEFGHVLDSFLALNSYQTQLNKNTFSSLSFWADHQQANLYHGNIVISKNRNWSLYSIFIIGVIGINLVLLILYIGYDKIFKPKNKKTIVIK
>NZ_CP012387.1|WP_020862786.1|595803_597804_+|hypothetical-protein
MAKKEVKQYLTDVLINKIDYYVSIKKFDFDTIKEMLAIDLIDYEPYMIQTIDKYIKYIIWLDQKNKNKSEAFLKFLDKYQQDLDDNSSLVENKNSLETNSDNLNDYQQRKKHQTWLDQYFRKQKAKYHVYEESPLDSQTKINNFEEFLQDQTNEEQVEEILDKDLDLVNLITSDNTFYQNSTINLDDLKTNSDESLKDDLDDILLANQKLDELEEIELDPEEFGTATINIDKWEAQNGSKNNQEIKQEVEPTLDEQDLTKDSWIEEKDLTSDLIKKIDITKDSWIENDQQINTSLDQKLISEPIVHTPEELVNNNQVEELSKEHWIEENAHLNEEDFNKEHELSTEHWVEEKQEDKCECDKACDQNLEECFDETCDQKTCCEAENTCQKEQDCECEKQDKCSDDSCCEENKCSENNSCENKNCDENNSCSIEECKTDKCCIENKCCVDNSNCQEECNKKDDCECSVTNCDCQSSCDQKQEELTEQLDHNVSNQTKINKLWINQPETDLNKTNDQEPLIKTNQNINNKIWTISPETDLKEYSNDKDFLDSKTDQEIINKTNQTNDLVDQETNNLDATLSQTDQTSNNEVITNQQVALNPNKNNETPKVIELNKPVKLYQQVKWNDKTYYVVGIKIKKDVFGHEIPVLRLESQDKPYEITEVKFIKKY
>NZ_CP012387.1|WP_020862787.1|597875_598313_-|lipoprotein
MKKLITILSSFGLVITTGTTAVACKNNQPSSLKPTAEDQNTSLTSTPENGELSSTGSIQNKEEEVTKIKGQLEKLKESEQKAKDLLKQIEEGNKKAKEATDQEKIKNELEKLNAQKPEVEKALKQIEEIKKGLEAKLKSLENKTN
>NZ_CP012387.1|WP_008362785.1|598628_598793_+|30S-ribosomal-protein-S21
MASVIVHDGETIEKALKRFQKVASSNKAEARKREYHLSKKEKRIYKQKQNRKYK

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP012387_6

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP012387_6

676972-677075

Orphan

Consensus_repeat	Method
CAACCAATTGGTAAATGAAACACTTCAAA	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP012387_6

>merge|NZ_CP012387|6|676972-677075|CRISPRCasFinder
CAACCAATTGGTAAATGAAACACTTCAAAAGTTAAATATATGAAAAATATGTTTTTTGGAGCAAAAAACTTTAACCAACCAATTGGTAAATGAAACACATCAAA

>NZ_CP012387|6|6|676972-677075|CRISPRCasFinder
CAACCAATTGGTAAATGAAACACTTCAAA	AGTTAAATATATGAAAAATATGTTTTTTGGAGCAAAAAACTTTAAC
CAACCAATTGGTAAATGAAACACATCAAA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP012387.1\|WP_020862837.1\|678876_680067_+\|ImmA/IrrE-family-metallo-endopeptidase	unknown	unknown	gnl\|CDD\|368753
NZ_CP012387.1\|WP_020862828.1\|664639_665242_-\|RdgB/HAM1-family-non-canonical-purine-NTP-pyrophosphatase	unknown	unknown	gnl\|CDD\|376602
NZ_CP012387.1\|WP_023905959.1\|678717_678858_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_017698376.1\|664081_664627_-\|tRNA-(cytidine(34)-2'-O)-methyltransferase	unknown	unknown	gnl\|CDD\|349967
NZ_CP012387.1\|WP_020862827.1\|659281_659884_-\|nucleotide-exchange-factor-GrpE	unknown	unknown	gnl\|CDD\|271355
NZ_CP012387.1\|WP_020862831.1\|672016_673258_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020862835.1\|677263_678181_+\|DUF285-domain-containing-protein	unknown	unknown	gnl\|CDD\|308794
NZ_CP012387.1\|WP_020862841.1\|682384_685108_+\|membrane-protein	unknown	unknown	gnl\|CDD\|274008
NZ_CP012387.1\|WP_052651906.1\|681796_682030_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020862829.1\|668138_670643_+\|MOLPALP-family-lipoprotein	unknown	unknown	gnl\|CDD\|275340
NZ_CP012387.1\|WP_020862843.1\|685489_685867_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020862840.1\|682126_682357_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020862833.1\|674292_676308_+\|type-IV-secretory-system-conjugative-DNA-transfer-family-protein	unknown	unknown	gnl\|CDD\|226036
NZ_CP012387.1\|WP_017698374.1\|660912_663054_-\|AAA-family-ATPase	unknown	unknown	gnl\|CDD\|274529
NZ_CP012387.1\|WP_020862832.1\|673430_674264_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020862830.1\|670959_671748_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020862842.1\|685214_685400_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020862836.1\|678195_678612_+\|single-stranded-DNA-binding-protein	unknown	unknown	gnl\|CDD\|239942
NZ_CP012387.1\|WP_020862838.1\|680304_681837_+\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_013729691.1\|659885_660908_-\|heat-inducible-transcription-repressor-HrcA	unknown	unknown	gnl\|CDD\|273017

Protein	Function_ID	Function_description	E-value
NZ_CP012387.1\|WP_020862829.1\|668138_670643_+\|MOLPALP-family-lipoprotein	gnl\|CDD\|275340	TIGR04547, putative_liporotein, MOLPALP family lipoprotein. Members of this family are surface lipoproteins, about 900 amino acids long on average, found only in the Mollicutes (Mycoplasma, Entomoplasma, Acholeplasma, Mesoplasma, Spiroplasma). Paralogs occur, such as MCAP_0360, MCAP_0361, and MCAP_0362 in Mycoplasma capricolum. This family shares significant N-terminal sequence similarity with STREFT (Secreted Thousand Residue Frequently Tandem), described by model TIGR04512; several members of the STREFT family have been misannotated as GnsA/GnsB family proteins. For proteins in this family, we suggest the name MOLPALP (Mollicutes Paralogous Lipoprotein) family lipoprotein [Cell envelope, Surface structures].	0
NZ_CP012387.1\|WP_020862837.1\|678876_680067_+\|ImmA/IrrE-family-metallo-endopeptidase	gnl\|CDD\|368753	pfam06114, Peptidase_M78, IrrE N-terminal-like domain. This entry includes the catalytic domain of the protein ImmA, which is a metallopeptidase containing an HEXXH zinc-binding motif from peptidase family M78. ImmA is encoded on a conjugative transposon. Conjugating bacteria are able to transfer conjugative transposons that can, for example, confer resistance to antibiotics. The transposon is integrated into the chromosome, but during conjugation excises itself and then moves to the recipient bacterium and re-integrate into its chromosome. Typically a conjugative tranposon encodes only the proteins required for this activity and the proteins that regulate it. During exponential growth, the ICEBs1 transposon of Bacillus subtilis is inactivated by the immunity repressor protein ImmR, which is encoded by the transposon and represses the genes for excision and transfer. Cleavage of ImmR relaxes repression and allows transfer of the transposon. ImmA has been shown to be essential for the cleavage of ImmR. This domain is also found in in metalloprotease IrrE, a central regulator of DNA damage repair in Deinococcaceae, HTH-type transcriptional regulators RamB and PrpC.	0.000173002
NZ_CP012387.1\|WP_020862828.1\|664639_665242_-\|RdgB/HAM1-family-non-canonical-purine-NTP-pyrophosphatase	gnl\|CDD\|376602	pfam01725, Ham1p_like, Ham1 family. This family consists of the HAM1 protein and hypothetical archaeal bacterial and C. elegans proteins. HAM1 controls 6-N-hydroxylaminopurine (HAP) sensitivity and mutagenesis in S. cerevisiae. The HAM1 protein protects the cell from HAP, either on the level of deoxynucleoside triphosphate or the DNA level by a yet unidentified set of reactions.	9.84197e-69
NZ_CP012387.1\|WP_017698376.1\|664081_664627_-\|tRNA-(cytidine(34)-2'-O)-methyltransferase	gnl\|CDD\|349967	cd18094, SpoU-like_TrmL, SAM-dependent tRNA methylase related to TrmL. tRNA (Um34/Cm34) methyltransferase TrmL catalyzes the methyl transfer from S-adenosyl-L-methionine (AdoMet) to the 2'-OH at position 34 in both tRNA(Leu)(CmAA) and tRNA(Leu)(cmnm5UmAA). It is part of the SpoU family of MTases, a subfamily of the SPOUT methyltransferase superfamily. The SPOUT methyltransferase superfamily is a large class of S-adenosyl-L-methionine (AdoMet or SAM)-dependent RNA MTases which are structurally characterized by a deep trefoil knot.	2.79056e-72
NZ_CP012387.1\|WP_017698374.1\|660912_663054_-\|AAA-family-ATPase	gnl\|CDD\|274529	TIGR03346, chaperone_ClpB, ATP-dependent chaperone ClpB. Members of this protein family are the bacterial ATP-dependent chaperone ClpB. This protein belongs to the AAA family, ATPases associated with various cellular activities (pfam00004). This molecular chaperone does not act as a protease, but rather serves to disaggregate misfolded and aggregated proteins. [Protein fate, Protein folding and stabilization].	0
NZ_CP012387.1\|WP_020862835.1\|677263_678181_+\|DUF285-domain-containing-protein	gnl\|CDD\|308794	pfam03382, DUF285, Mycoplasma protein of unknown function, DUF285. This region appears distantly related to leucine rich repeats.	9.67266e-58
NZ_CP012387.1\|WP_020862833.1\|674292_676308_+\|type-IV-secretory-system-conjugative-DNA-transfer-family-protein	gnl\|CDD\|226036	COG3505, VirD4, Type IV secretory pathway, VirD4 components [Intracellular trafficking and secretion].	6.94318e-31
NZ_CP012387.1\|WP_020862836.1\|678195_678612_+\|single-stranded-DNA-binding-protein	gnl\|CDD\|239942	cd04496, SSB_OBF, SSB_OBF: A subfamily of OB folds similar to the OB fold of ssDNA-binding protein (SSB). SSBs bind with high affinity to ssDNA. They bind to and protect ssDNA intermediates during DNA metabolic pathways. All bacterial and eukaryotic SSBs studied to date oligomerize to bring together four OB folds in their active state. The majority (e.g. Escherichia coli SSB) have a single OB fold per monomer, which oligomerize to form a homotetramer. However, Deinococcus and Thermus SSB proteins have two OB folds per monomer, which oligomerize to form a homodimer. Mycobacterium tuberculosis SSB varies in quaternary structure from E. coli SSB. It forms a dimer of dimers having a unique dimer interface, which lends the protein greater stability. Included in this group are OB folds similar to Escherichia coli PriB. E.coli PriB is homodimeric with each monomer having a single OB fold. It does not appear to form higher order oligomers. PriB is an essential protein for the replication restart at forks that have stalled at sites of DNA damage. It also plays a role in the assembly of primosome during replication initiation at the bacteriophage phiX174 origin. PriB physically interacts with SSB and binds ssDNA with high affinity.	3.76189e-18
NZ_CP012387.1\|WP_020862841.1\|682384_685108_+\|membrane-protein	gnl\|CDD\|274008	TIGR02168, Chromosome_partition_protein_Smc, chromosome segregation protein SMC, common bacterial type. SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle. [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins].	2.0591e-21
NZ_CP012387.1\|WP_013729691.1\|659885_660908_-\|heat-inducible-transcription-repressor-HrcA	gnl\|CDD\|273017	TIGR00331, Heat-inducible_transcription_repressor_HrcA, heat shock gene repressor HrcA. HrcA represses the class I heat shock operons groE and dnaK; overproduction prevents induction of these operons by heat shock while deletion allows constitutive expression even at low temperatures. In Bacillus subtilis, hrcA is the first gene of the dnaK operon and so is itself a heat shock gene. [Regulatory functions, DNA interactions].	1.46869e-111
NZ_CP012387.1\|WP_020862827.1\|659281_659884_-\|nucleotide-exchange-factor-GrpE	gnl\|CDD\|271355	cd00446, GrpE, nucleotide exchange factor GrpE. GrpE is the adenine nucleotide exchange factor of DnaK (Hsp70)-type ATPases. In bacteria, the DnaK-DnaJ-GrpE (KJE) chaperone system functions at the fulcrum of protein homeostasis. GrpE participates actively in response to heat shock by preventing aggregation of stress-denatured proteins; unfolded proteins initially bind to DnaJ, the J-domain ATPase-activating protein (Hsp40 family), whereupon DnaK hydrolyzes its bound ATP, resulting in a stable complex. The GrpE dimer binds to the ATPase domain of Hsp70 catalyzing the dissociation of ADP, which enables rebinding of ATP, one step in the Hsp70 reaction cycle in protein folding. In eukaryotes, only the mitochondrial Hsp70, not the cytosolic form, is GrpE dependent. Over-expression of Hsp70 molecular chaperones is important in suppressing toxicity of aberrantly folded proteins that occur in Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis, as well as several polyQ-diseases such as Huntington's disease and ataxias.	6.13502e-36

>NZ_CP012387.1|WP_020862833.1|674292_676308_+|type-IV-secretory-system-conjugative-DNA-transfer-family-protein
MNERQIKTINKILGYIFSFIIWPSLGFLLVSTIMILYQVRSFELLTQWILKKRSYKTDLLHFWQFNSYYRNLSILFILLGIPIFLAIFNYRYWWKEFKERFNSKSNPKKKNWEWNQFTKEGNFKVLKKKFKPGKANFALGYLDWKRHNQYLVNNTDSHAIVLGIPGSKKTEKIVLPNLHYNASLSFNEKPNMVITDPKKQILSRTGQMFINKGYNVKVFDFSDARNSLCWNPLEQIWNTVHSKPKDELDEYDYALAYEKIIQIVNSLSWPSDDKSMWTNNAKNVLVCLLKFQLLYSLEDKTFTLDYFTLANLTPNLSEKNIKFGKWVAITEKNSVKNIHWNNLYNEQKAIIDIVPETLSGILTNAIDVIVSFSQNLNISKITSNITFSIKETIRDTSKPFVIFICFPDHKNIFDFLMSILITQIYQEAVDYANSLPKQKLQRMLQFYLEEFNSLSIPEIPDWMAISRSRNILFMLIIQSYEQLQKYSAKGKDYKTIKSQARLNYLLETNSEETLKSFSSSLGEKIVKKETVSKNDKSTSVSTSEQKELIMSISEIKYKDPDMTIISTGGSKPIALKLKPAYEYLNYEPYINSQPKMISNNDMVWDFGSMKLKKFNLFSPTKVSDNDGETDLTKKEVESDSELVTSDNDELLKQALKDIKKTKSLCTDLKSD
>NZ_CP012387.1|WP_020862832.1|673430_674264_+|hypothetical-protein
MKFVDTDIDIIWETPLVIWALFDDGNSSYQKAITKNFNQDEQKQFIVVSIGIKDSKDINFVQNENSIYKQIDLSLTNPNLFEQLKQLPKPDFILASPPCESWSKADCNGIMFKELNLEKTITDEDTSIWKIRNKRYYDEYNKHCKPNKKRWFVQKEISRLLGVSTIGATIAIINFFKPKIWVIENPATSKTWEFQKKHWNFNGFHNLTYYYNYDVNYSKKPTIFKSNIKMNLLKKNLNSNFNKNHCAKGSYDKRSSIPEDLIVHIVEEMKYQYFRVF
>NZ_CP012387.1|WP_020862831.1|672016_673258_+|hypothetical-protein
MIVKLEFTNNSFNKKANKKSGKVHDFNFYSSGVFINYITRNNAVYVQNDDVSKEELIKEWQNSKLEFKDFIKTKTRKKQKIEDKSKTGLYRLFDETPVDIDLKKAKKILKKLNPNQNVWELVINPGQLGIDYQMIDKKEWNDILNKTTKNLFKVNNLNPNNMTGFWTIHTNTEFVHLHLCFFEKQADINNNFRTKGKFKKQSLERYSEIIKTHIISNKDYENLYQVKNEIWDSRKEIKNFFKDGIKSAFVEHSIKVIKEFYKNGNNKNYSLTKDNKRVNEAVWDIFNYIKNTTPELKRKYKEYRESIENMKQQTFSSEQVSKLKNEFLDKEAKEFEQQIGNTIVKDCLNSNWTDIRYHSNSYSSFKPNKKKKSNLDYLVDKWKFEFNQIQFKKKMEALDKFNKNIRQKSLSKH
>NZ_CP012387.1|WP_020862830.1|670959_671748_+|hypothetical-protein
MSAIKNYLLIKDDANELKKECQNSLFYSTYKNKKYDTLTNEAVNKILKSKLVISESYYDEFGTDKVFLEMFMILTVLKDKNIKKTDLFNFGFKRSSVGYAIKKMLNKNIIDENLWKTSRIIKLTTFELKKDDEKFWTLKGTTLVKMFLLYGLSHCLVLLDSNYCFKSTKYDPLPELKRKYVLIQNSYFKSLKLSNSKIYKVFKLFSSFMFIPLKKLILIKKKITKNWINVKNKFSNLVFKKQYQFKTQRYISSEIKSLFVNF
>NZ_CP012387.1|WP_020862829.1|668138_670643_+|MOLPALP-family-lipoprotein
MKKLIAILSSMMMITTASLPIIACHTKQNKFENNNSITNTHSTASLFAKELILADQLQVNLQEIKNRNDQKNLDLLLDEYNLKLDNTDPSIKNISSSNELINQYFEKDSYKNVLDSNIKLDSQKKLSNPLFSEIFKLFGLGTTDLDKFSDDITNILTLLVNLNPMFISSNFDKSNTTLQSFFKNIKPSLKTLFDSITTQKEGITKNVKEFQEKLNVNEKYKNLKVEDLDIAFYTSLINAIGLGIGTKDFTAIEIKIENTNETLQKAGEMLAKITDSPAQPTQNKEWDIVLYTLQALQFLQLKLSLFENVKSHTPISANNLFDDKKTNQEFLTELYKDKTIANITEKRPSSINLKYLLSFIKNAVDELKDEKQLDGYELQKLLAMLFLSTAEVKYGESFNSKDKEQVQKFYKEQKAHPSINILTAVIKDLLSKNLKNFIKDATDEKIKKFIDESIPHIYKWLAYSSNNLLTGQHNAYQTLSSLFAHTIPSIIISLKENTDLLKEIQNDFVPLISSLVFGFISEDILQIAFPIFDKNDKNSFKTLYSGDVFLVDKVDEMFNKFKEEAKKKITEIASLVPNLKLDASKIDFDVAKPYIDIFKGIYDQIFKNVKHLNLKTLLTTPLNKIDSDSWKERNIAKPLQNKSVADILDTLLKSLNIQGSEKLDDLSSSNINLTNLTDITTLIDNYTYKANGVDYQNKTQLSDILKANPDKTLEILGWTFDSKKPIGKGSLIDVFLSKVFNFKTNQNTDKSENAINQLAKIIASANSSLDTSFDSNIEITFEFKDTKKNSSDQLLSETLIASVKNKNNNSESKYFFTYSRDKQSKFKFVKITKN
>NZ_CP012387.1|WP_020862828.1|664639_665242_-|RdgB/HAM1-family-non-canonical-purine-NTP-pyrophosphatase
MDKKIIYLATTNKNKVKEFSEILKDYQIKSLLDIPEYVEIEENKKTFKQNALLKAKHLAKYINGVAIGDDTGICVKALNDFPGIYSKRWAYPLTNHYDICNKLLDKLKHINQLHKRKAYMTTAIALYDAINKKQFVYQARVNGYIDFQINKSDFGFGYDFIFIPKGYHKAYSLMNSELKNQISARKKAIDRLIQYIDNVK
>NZ_CP012387.1|WP_017698376.1|664081_664627_-|tRNA-(cytidine(34)-2'-O)-methyltransferase
MNKRKINIVLYQPEIAQNVGAIMRTCVAINARLHIIEPLGFIFDDRHLSRPSANEYKYVDCIRYDDWNDFITKHPNITLFCLSRYGQKPISDFDFSKINDNVYLVFGKESTGIAKPILKEHYNTTFRIPMISETRSLNIANTVGIASYEVLRQWDYLDLVKYETQKGKDYILSERWKGIEE
>NZ_CP012387.1|WP_017698374.1|660912_663054_-|AAA-family-ATPase
MEFQEKGKVTDALKKYTRDLTKDAKDNKLDPVIGREEEISRVIQILSRKTKNNPVLIGEPGVGKTAIVEGLAQRIVKGDVPTLLKNKRILELDMGSLMAGAMYMGDYESRVKAVVNEIQKSNGEIILFIDELHLIVGAGKTGNNSGMDVSNLLKPALARGELKAIGSTTLNEYRQYIEKDAALERRFQRVLVSEPTIDQTISILRGLKDRFETYHGVRIHDNALVSAAKLSSRYITDRYLPDKAIDLVDEACASIRTELASVPIELDQVNRKVMQLEIETSALEKEKDDKSKERWQEAKKELDSLKIEQASLNEKWEKEKEELSRINSVKSSIESLKQELETAQNDGNYKRAGEIQYSLLPSLEKSLALFEKQTGSKMISEEVTEHEIAKVVSKSTGILVDRLISSEKEKLLNLEDLLKKYVKGQDQAIKAVTSAIMRSRSGIKNPDKPIGSFLFLGPTGVGKTEVARSLADILFNSPKKMIRLDMSEYMEKHSVAKLIGAPPGYVGYEEGGRLTEAVRRNPYSIVLFDEIEKAHTDVFNILLQILDDGRLTDSLGKTIDFKNTIIVMTSNIASQYLLTSDELVQVDDQKIQEELNKVFRPEFLNRIDNIVYFNALSVQTIGEIVDKVLEELSTRLQDEQNYFINFSEEARNKIINEGYDRLFGARPIKRYIEKNIETLIAHYIISGEVVENTRYLIDVKNNQFTLEEFKQFN
>NZ_CP012387.1|WP_013729691.1|659885_660908_-|heat-inducible-transcription-repressor-HrcA
MLTNRQIKILQTIVEEFIKTNQPVGSKRILELLNMKISSATIRNESATLEHEGYLEKQHTSSGRTPSTKGYRYYVDNIMKLDSADYTRLKIYLNQLLDLRKYDIDKTINYASEIISELTKMTAVVIKKQNIKDIKLKKIELILLSEFLASVLFIFSDGDVQNKMFNLKDVALSDLKIAIKLFSDVLVDVKLDEIDQYLNDLKHQLSLSIKQYDYVLNTFINTILESKNEQKETHGMRYMLENPEFNDTNKLKNAVKLVEQLSPFDWFNIAYESNKNMNKIAIKIGNEIDQINDDISMIATELKIGNSSTVLTLVGPKRVDYNQVNQLMNLIIEIINTKEN
>NZ_CP012387.1|WP_020862827.1|659281_659884_-|nucleotide-exchange-factor-GrpE
MTEELKNKKNNKKYYSQNRNKTKAEFQKTHIKKNQYLNLKTKLNTVLLEVQNLKDLNETLKLKLESEKQLNLAEISNLTKKYNQKESETKKYGASNLAKDLIQPLEILKKVVNAPNNNEVVQAYVKGFEMIINQINNVLESHHIKAMNVKVGDMFNPHLHDANEAVESDMYQTNQIVGVLSDGYMIHDKVLVYAIVKVAK
>NZ_CP012387.1|WP_020862835.1|677263_678181_+|DUF285-domain-containing-protein
MGKIIKQAVYNADKTECLEIGYQANFDDGHIQILKFPPTIKKVPKVLPKQITSLKNAFENNINITISGIEHWDTSNVIDMSYMFYCAHNFNQNISMWDVSNVTDMSYMFAFSRFNQDISNWDTSNVTDMSDMFVYAENFNKDISNWDVSKVENMHGMFQNAKKFNQPIGKWDTSNVEDMSKMFEGVKNFNQPIGKWNVSNVTDMSYMFFEATSFNQDISNWDTSKVKHMWGMFYNAESFNQPIGKWNTSKVETMEGMFAWAKSFNQDISNWDTSNVIDMSGMFEGATSFNKEKHWNKSLSKSRTR
>NZ_CP012387.1|WP_020862836.1|678195_678612_+|single-stranded-DNA-binding-protein
MNQVNLIGRLANEKFYEKDYQTENKRDGKLLKFQIATLKTPKTEFLEITVYNKLAELIKKYVHKGDLIQITGKLQNNIFKTKDNKTVSKTEIIGDSILFLTNSNKTTDETNQQVFDEVSDEEMEEFMRDLENDNFEFI
>NZ_CP012387.1|WP_023905959.1|678717_678858_+|hypothetical-protein
MPKGNYFKKCTHNNKIVLASEKTLSCEDCMKHDLTKIINILAKANE
>NZ_CP012387.1|WP_020862837.1|678876_680067_+|ImmA/IrrE-family-metallo-endopeptidase
MLSDNPILNIDFIEDGVIKQDNELETSEQKEATLKTEVKEISQPTKVSSNEKWTAKEVEEQKAKETDYFKQLVEKADKEIEEIFHKPEELKNFFAFATTLQNNYSSRNLMLIHQQFPGATIVKSFTEWKREDLSVKKGEKGIKIIRPLVDEYVFINNNGENQKVFKKNWTRDIWQKIKNNEIEVHEDLLGFKPANVFDIAQTNLPKEEYPEDYFKDFIDEDTAQLKFNELVLSELKLFVKEKNIELKPKASLGQARGLTTINDLGQKVIYLNEHNSTKQNIDTLLHEYAHIKFNHSYKTTERAECEYQAEMTAWALAKTLKVDTTENSYKYIGRWLQTSNVVDKRKWMDETISTLKVIRQELNQHILKSIETRMERKKELEEKEEKKHKQVLSLKQ
>NZ_CP012387.1|WP_020862838.1|680304_681837_+|hypothetical-protein
MRKLLFILLPTILLPTLTVTSCSSWFKLPRKTPTSYTKNPDYKDNLNKDDKKEIIKNFSYNGITYNLNQEDNINPENVYFANEVLENDAKQFKSYIPDYKKYFYNQVSNALKLDTPDLGAPWFDFPTIAKLSQFVRSLEHFNVVNSYNSSFMLKDKTTKQQLTSEEYNNLVNKILEILKNQNNLIKTINDEEVDFSSINNSKNEKVSDQLPSTLEHRKQEMGFNDTSSNKDYWGTYTETKLESGAIKKEYSETPLKDSKATAFLDGSLKQIPVYLWKLKKIFDFNGNFKNEYFLQREFFEKSSEFNREKQDLNNEISDYFYRNKIKIYAMQKDLWNMLIAYLEFQKAMTTLGNVSDENLSLEKNFKNSKILEAISNFENKLLEYMKLSQLFGWLIDPSKEDLNLQLFPGGTHYSFETDYRQAYIWAYREYHEIIQPLSREFTRTNVDSTFNNTFKNPELEKYYDFIWANIKAIDNVDKPYVLGESEAKTKFNKIIDYYARTFNWKYKKGE
>NZ_CP012387.1|WP_052651906.1|681796_682030_+|hypothetical-protein
MLEPLIGNIKKENNMPKRDYWKNCTPAEKQFWEALDEEYKKSKTYIPGTRVVPDTYDGFEDDVQEYIKRLKEEENQK
>NZ_CP012387.1|WP_020862840.1|682126_682357_+|hypothetical-protein
MIKTIAIIVICFAIIIASMGLFLLATSYKDCFSRNKVTKKKARYLYKKEWITTLLITIIAIWLGLSMTGILVNPNM
>NZ_CP012387.1|WP_020862841.1|682384_685108_+|membrane-protein
MKKLLTILGSLAIVGLVAGSGAMIAVYKNKKQVVPTVNTKVNKELEDKISLLTKSKLEVEAQLSKLKLENLNNKAELNNANLALDELVNILEIQELEYEEKLEELQVKSLSNLLNANRVKRALEVANNSDKTNKAELVKLNEQLQVQASEIKQVKAELVKAKDEISSTKQQLVKTQAELKTSKASETEIKQQLQVQVQKVSELLNKQKDLEVKLNEKQTNEKQLEKRIDELVKTNKELTDELSKLKLENLNSKTELNNANLALDELVNILEIQELEYEQKLEELQVKSLSNLLNANRVKRALEVANNSDKTNKAELVKLNEQLQVQASEIKQVKAELVKAKDEISSTKQQLVKTQAELKTSKASETEIKDKLTKEIKKITQDLTSLKSDLGLKNKKIKELSERELVFINQARTYENLNRSLTKIKHQLESKLTETNNQLVATKTALKQSQDDLMKSNQEISNLKVQLESKKQEIQNLEQEHSTLLEKSNKLEVEIRETQNQLNQSSADFKKQLEEITEQKNLLDTKIQKVETELTSKKQELEVQKDKLQKLEIENQRLKTLNQKLEKDLQAAEQRNSINQRNFESKEKDFNKIKSQLERDLVRLSNEIKQLQSSNKSLSTKSEELESTKRRIENELETIKKETVSINKQLEEKVREIGENKQTISNYSQLLETRLKEIEKVNNELSVLQASNSSLEKDKQKLNEEISSLKSESSSNKELIRLKEQELNKYKEDSNKVKRQLEEKQNEYYDLLNKFKEQKQELDQLKQKLASTVNKNEISKLQSKIEELNQELDKKKKELAAFKSSLTTRDLSALKTLVWQINTIYYFILNDLNDYKNLKELKPKTKEDILTKWDELKKWIKMFDIDKNEREANFVKSDIEMLEKIIAGFGSSSSPAPAFPARTPSRN
>NZ_CP012387.1|WP_020862842.1|685214_685400_+|hypothetical-protein
MAYICNHKNKQVTLIRTKKDFTELVFVIEIFCKECKYDGIRQITKTNKEILNWLTQEIKRC
>NZ_CP012387.1|WP_020862843.1|685489_685867_+|hypothetical-protein
MNWLLHLNSIIFAAGIDDSAIEKNLVQIADKVLKYISIVLGSFAGIIVILICIIAAYAWFKGTKSDNEQQRAAHFTKIKLLFGFFLFAIVMWAIAGLVISILKGVWAQPIDLKPATVLIPSLLGV

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Crispr_ID: NZ_CP012387_7

CRISPR_ID

CRISPR_location

CRISPR_type

Repeat_type

Spacer_info

Cas_protein_info

CRISPR-Cas_info

NZ_CP012387_7

1059021-1059126

Orphan

Consensus_repeat	Method
GATTTATCAAATTGAAATACAGAAAATGTAA	CRISPRCasFinder

1 spacers

The CRISPR arrays of NZ_CP012387_7

>merge|NZ_CP012387|7|1059021-1059126|CRISPRCasFinder
GATTTATCAAATTGAAATACAGAAAATGTAACTGATATGAGTTATATGTTTAATGGTGCAACTAAATTCAATGGTGATTTATCAAATTGAAATACAGAAAATGTAA

>NZ_CP012387|7|7|1059021-1059126|CRISPRCasFinder
GATTTATCAAATTGAAATACAGAAAATGTAA	CTGATATGAGTTATATGTTTAATGGTGCAACTAAATTCAATGGT
GATTTATCAAATTGAAATACAGAAAATGTAA

Protein	Signature genes	Signature genes Name	Protein_function
NZ_CP012387.1\|WP_020863068.1\|1062610_1064875_-\|helix-rich-protein	unknown	unknown	gnl\|CDD\|275316
NZ_CP012387.1\|WP_020863069.1\|1064884_1067146_-\|helix-rich-protein	unknown	unknown	gnl\|CDD\|275316
NZ_CP012387.1\|WP_020863063.1\|1055828_1056329_+\|isochorismatase-family-protein	unknown	unknown	gnl\|CDD\|238493
NZ_CP012387.1\|WP_020863075.1\|1077877_1078489_+\|lipoprotein	unknown	unknown	gnl\|CDD\|275340
NZ_CP012387.1\|WP_020863073.1\|1074459_1076700_-\|helix-rich-protein	unknown	unknown	gnl\|CDD\|275316
NZ_CP012387.1\|WP_020863058.1\|1047730_1048375_-\|hypothetical-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020863062.1\|1052670_1054248_-\|dicarboxylate/amino-acid:cation-symporter	unknown	unknown	gnl\|CDD\|366058
NZ_CP012387.1\|WP_020863059.1\|1048431_1049412_-\|aspartate--ammonia-ligase	unknown	unknown	gnl\|CDD\|235456
NZ_CP012387.1\|WP_020863060.1\|1049615_1050374_+\|DUF3800-domain-containing-protein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020863061.1\|1050633_1052523_-\|tRNA-uridine-5-carboxymethylaminomethyl(34)-synthesis-enzyme-MnmG	unknown	unknown	gnl\|CDD\|235362
NZ_CP012387.1\|WP_020863067.1\|1061322_1062528_+\|phosphatase-PAP2-family-protein	unknown	unknown	gnl\|CDD\|366709
NZ_CP012387.1\|WP_020863057.1\|1046098_1047526_-\|MFS-transporter	unknown	unknown	gnl\|CDD\|284977
NZ_CP012387.1\|WP_023905986.1\|1054267_1055611_-\|CoA-disulfide-reductase	unknown	unknown	gnl\|CDD\|181958
NZ_CP012387.1\|WP_023905987.1\|1072183_1074436_-\|helix-rich-protein	unknown	unknown	gnl\|CDD\|275316
NZ_CP012387.1\|WP_020863064.1\|1057208_1057808_-\|type-IV-toxin-antitoxin-system-AbiEi-family-antitoxin-domain-containing-protein	unknown	unknown	gnl\|CDD\|379128
NZ_CP012387.1\|WP_020863074.1\|1077019_1077655_+\|lipoprotein	unknown	unknown	unknown
NZ_CP012387.1\|WP_020863066.1\|1059968_1061192_+\|phosphatase-PAP2-family-protein	unknown	unknown	gnl\|CDD\|366709
NZ_CP012387.1\|WP_020863070.1\|1067463_1069719_-\|helix-rich-protein	unknown	unknown	gnl\|CDD\|275316
NZ_CP012387.1\|WP_080511208.1\|1056374_1057109_-\|nucleotidyl-transferase-AbiEii/AbiGii-toxin-family-protein	unknown	unknown	gnl\|CDD\|378065
NZ_CP012387.1\|WP_020863071.1\|1069728_1071990_-\|helix-rich-protein	unknown	unknown	gnl\|CDD\|275316

Protein	Function_ID	Function_description	E-value
NZ_CP012387.1\|WP_020863068.1\|1062610_1064875_-\|helix-rich-protein	gnl\|CDD\|275316	TIGR04523, conserved_hypothetical_protein, helix-rich Mycoplasma protein. Members of this family occur strictly within a subset of Mycoplasma species. Members average 750 amino acids in length, including signal peptide. Sequences are predicted (Jpred 3) to be almost entirely alpha-helical. These sequences show strong periodicity (consistent with long alpha helical structures) and low complexity rich in D,E,N,Q, and K. Genes encoding these proteins are often found in tandem. The function is unknown.	3.93151e-106
NZ_CP012387.1\|WP_020863069.1\|1064884_1067146_-\|helix-rich-protein	gnl\|CDD\|275316	TIGR04523, conserved_hypothetical_protein, helix-rich Mycoplasma protein. Members of this family occur strictly within a subset of Mycoplasma species. Members average 750 amino acids in length, including signal peptide. Sequences are predicted (Jpred 3) to be almost entirely alpha-helical. These sequences show strong periodicity (consistent with long alpha helical structures) and low complexity rich in D,E,N,Q, and K. Genes encoding these proteins are often found in tandem. The function is unknown.	2.03079e-97
NZ_CP012387.1\|WP_020863063.1\|1055828_1056329_+\|isochorismatase-family-protein	gnl\|CDD\|238493	cd01011, nicotinamidase, Nicotinamidase/pyrazinamidase (PZase). Nicotinamidase, a ubiquitous enzyme in prokaryotes, converts nicotinamide to nicotinic acid (niacin) and ammonia, which in turn can be recycled to make nicotinamide adenine dinucleotide (NAD). The same enzyme is also called pyrazinamidase, because in converts the tuberculosis drug pyrazinamide (PZA) into its active form pyrazinoic acid (POA).	5.68928e-48
NZ_CP012387.1\|WP_020863075.1\|1077877_1078489_+\|lipoprotein	gnl\|CDD\|275340	TIGR04547, putative_liporotein, MOLPALP family lipoprotein. Members of this family are surface lipoproteins, about 900 amino acids long on average, found only in the Mollicutes (Mycoplasma, Entomoplasma, Acholeplasma, Mesoplasma, Spiroplasma). Paralogs occur, such as MCAP_0360, MCAP_0361, and MCAP_0362 in Mycoplasma capricolum. This family shares significant N-terminal sequence similarity with STREFT (Secreted Thousand Residue Frequently Tandem), described by model TIGR04512; several members of the STREFT family have been misannotated as GnsA/GnsB family proteins. For proteins in this family, we suggest the name MOLPALP (Mollicutes Paralogous Lipoprotein) family lipoprotein [Cell envelope, Surface structures].	0.00535295
NZ_CP012387.1\|WP_020863073.1\|1074459_1076700_-\|helix-rich-protein	gnl\|CDD\|275316	TIGR04523, conserved_hypothetical_protein, helix-rich Mycoplasma protein. Members of this family occur strictly within a subset of Mycoplasma species. Members average 750 amino acids in length, including signal peptide. Sequences are predicted (Jpred 3) to be almost entirely alpha-helical. These sequences show strong periodicity (consistent with long alpha helical structures) and low complexity rich in D,E,N,Q, and K. Genes encoding these proteins are often found in tandem. The function is unknown.	6.40692e-82
NZ_CP012387.1\|WP_020863064.1\|1057208_1057808_-\|type-IV-toxin-antitoxin-system-AbiEi-family-antitoxin-domain-containing-protein	gnl\|CDD\|379128	pfam13338, AbiEi_4, Transcriptional regulator, AbiEi antitoxin. AbiEi_4 is the cognate antitoxin of the type IV toxin-antitoxin 'innate immunity' bacterial abortive infection (Abi) system that protects bacteria from the spread of a phage infection. The Abi system is activated upon infection with phage to abort the cell thus preventing the spread of phage through viral replication. There are some 20 or more Abis, and they are predominantly plasmid-encoded lactococcal systems. TA, toxin-antitoxin, systems on plasmids function by killing cells that lose the plasmid upon division. AbiE phage resistance systems function as novel Type IV TAs and are widespread in bacteria and archaea. The cognate antitoxin is pfam13338.	3.53286e-11
NZ_CP012387.1\|WP_020863062.1\|1052670_1054248_-\|dicarboxylate/amino-acid:cation-symporter	gnl\|CDD\|366058	pfam00375, SDF, Sodium:dicarboxylate symporter family.	2.59102e-69
NZ_CP012387.1\|WP_020863059.1\|1048431_1049412_-\|aspartate--ammonia-ligase	gnl\|CDD\|235456	PRK05425, PRK05425, asparagine synthetase AsnA; Provisional.	0
NZ_CP012387.1\|WP_020863070.1\|1067463_1069719_-\|helix-rich-protein	gnl\|CDD\|275316	TIGR04523, conserved_hypothetical_protein, helix-rich Mycoplasma protein. Members of this family occur strictly within a subset of Mycoplasma species. Members average 750 amino acids in length, including signal peptide. Sequences are predicted (Jpred 3) to be almost entirely alpha-helical. These sequences show strong periodicity (consistent with long alpha helical structures) and low complexity rich in D,E,N,Q, and K. Genes encoding these proteins are often found in tandem. The function is unknown.	1.05297e-103
NZ_CP012387.1\|WP_023905987.1\|1072183_1074436_-\|helix-rich-protein	gnl\|CDD\|275316	TIGR04523, conserved_hypothetical_protein, helix-rich Mycoplasma protein. Members of this family occur strictly within a subset of Mycoplasma species. Members average 750 amino acids in length, including signal peptide. Sequences are predicted (Jpred 3) to be almost entirely alpha-helical. These sequences show strong periodicity (consistent with long alpha helical structures) and low complexity rich in D,E,N,Q, and K. Genes encoding these proteins are often found in tandem. The function is unknown.	2.90639e-96
NZ_CP012387.1\|WP_020863067.1\|1061322_1062528_+\|phosphatase-PAP2-family-protein	gnl\|CDD\|366709	pfam01569, PAP2, PAP2 superfamily. This family includes the enzyme type 2 phosphatidic acid phosphatase (PAP2), Glucose-6-phosphatase EC:3.1.3.9, Phosphatidylglycerophosphatase B EC:3.1.3.27 and bacterial acid phosphatase EC:3.1.3.2. The family also includes a variety of haloperoxidases that function by oxidising halides in the presence of hydrogen peroxide to form the corresponding hypohalous acids.	0.000750008
NZ_CP012387.1\|WP_020863057.1\|1046098_1047526_-\|MFS-transporter	gnl\|CDD\|284977	pfam07672, MFS_Mycoplasma, Mycoplasma MFS transporter. These proteins share some similarity with members of the Major Facilitator Superfamily (MFS).	6.48296e-37
NZ_CP012387.1\|WP_023905986.1\|1054267_1055611_-\|CoA-disulfide-reductase	gnl\|CDD\|181958	PRK09564, PRK09564, coenzyme A disulfide reductase; Reviewed.	1.42643e-151
NZ_CP012387.1\|WP_020863066.1\|1059968_1061192_+\|phosphatase-PAP2-family-protein	gnl\|CDD\|366709	pfam01569, PAP2, PAP2 superfamily. This family includes the enzyme type 2 phosphatidic acid phosphatase (PAP2), Glucose-6-phosphatase EC:3.1.3.9, Phosphatidylglycerophosphatase B EC:3.1.3.27 and bacterial acid phosphatase EC:3.1.3.2. The family also includes a variety of haloperoxidases that function by oxidising halides in the presence of hydrogen peroxide to form the corresponding hypohalous acids.	0.00084762
NZ_CP012387.1\|WP_020863061.1\|1050633_1052523_-\|tRNA-uridine-5-carboxymethylaminomethyl(34)-synthesis-enzyme-MnmG	gnl\|CDD\|235362	PRK05192, PRK05192, tRNA uridine-5-carboxymethylaminomethyl(34) synthesis enzyme MnmG.	0
NZ_CP012387.1\|WP_080511208.1\|1056374_1057109_-\|nucleotidyl-transferase-AbiEii/AbiGii-toxin-family-protein	gnl\|CDD\|378065	pfam08843, AbiEii, Nucleotidyl transferase AbiEii toxin, Type IV TA system. This family was recently identified as belonging to the nucleotidyltransferase superfamily. AbiEii is the cognate toxin of the type IV toxin-antitoxin 'innate immunity' bacterial abortive infection (Abi) system that protects bacteria from the spread of a phage infection. The Abi system is activated upon infection with phage to abort the cell thus preventing the spread of phage through viral replication. There are some 20 or more Abis, and they are predominantly plasmid-encoded lactococcal systems. TA, toxin-antitoxin, systems on plasmids function by killing cells that lose the plasmid upon division. AbiE phage resistance systems function as novel Type IV TAs and are widespread in bacteria and archaea. The cognate antitoxin is pfam13338.	6.88965e-26
NZ_CP012387.1\|WP_020863071.1\|1069728_1071990_-\|helix-rich-protein	gnl\|CDD\|275316	TIGR04523, conserved_hypothetical_protein, helix-rich Mycoplasma protein. Members of this family occur strictly within a subset of Mycoplasma species. Members average 750 amino acids in length, including signal peptide. Sequences are predicted (Jpred 3) to be almost entirely alpha-helical. These sequences show strong periodicity (consistent with long alpha helical structures) and low complexity rich in D,E,N,Q, and K. Genes encoding these proteins are often found in tandem. The function is unknown.	1.39444e-91

>NZ_CP012387.1|WP_020863064.1|1057208_1057808_-|type-IV-toxin-antitoxin-system-AbiEi-family-antitoxin-domain-containing-protein
MNYVEKIKEKAIQNNGLITRKEIISLKIPPIYITRMVRKKELEKIDIGIYALTSLDNYPYDPEFNFCSRYQVPVFSYVYALNLFDFTDVIPLNFEVTVYKGYNAHNLKPNTIVHYVNKEIFNLGITEIRNAFGNWVRTYDIERTICDLIKNRKNINVELFVKTMNNYVNYEKKDWNKLYEYAEKMHIEKELVEIFQLII
>NZ_CP012387.1|WP_080511208.1|1056374_1057109_-|nucleotidyl-transferase-AbiEii/AbiGii-toxin-family-protein
MKKISKNKDKINIIFKGGFLLSNIIGIKERTTKDIDYLLNNIVFSPDRIKELFEDILDYKKGDKIHFQIQKINEIKKKEKYTGFRITVECKLDEIVEIIKIDVATGDIITSCQVRYNIENIFHNNSFYVYGYNLETMLAEKIHAIKELSLFNTRTKDFYDIYLIYNLKRDDIDYMTLKNACINTFKQRNSIFDKDDLLELLNKIKNSQSTHNLWTKQKNIYFYNKNIDFKFIIQSIIELIKNIK
>NZ_CP012387.1|WP_020863063.1|1055828_1056329_+|isochorismatase-family-protein
MKSKNKNKALIIVDYQYDFCDPNGSLYVKNAYTLKPKIEKLAKELKSQGWTIIATKDFHPIDHCSFKIWNKHCVQNTKGSELYFDYSDVDLIIEKGVNKDIESYSGFFDDANNSNGLDEYLKSKNIDTLKIVGVATEICVKANYDDAIKLGYDVHVDLEYCKGFTD
>NZ_CP012387.1|WP_023905986.1|1054267_1055611_-|CoA-disulfide-reductase
MKIVIIGGAASGMTVASRLKKADKKAQIIVIQKEKYVSLGACGLPYFVANPSLKPTDLLARTVEQFIEQDILVYSESVVKKIDAENQKVWYEKNNQLLELDYDKLVISTGAKPIVPPIKGIDLPNIFTLTRLEDATELKEKLKDKNIKKVAVIGSGFIGLECCEMLEHFNKEIVLIEKTSRLNQRVFDQEITDLLEQNLIKNNVEIIKENGLKSITQTKDKRLSLTLDQNEELEVDLIILAIGFRPATEFLKDTKLEMLGNGAIVVDKHGRTNLKNIWSCGDCATVYHKITNQITYTPLATVARKFAKVVADDILNVNSEFVGTLQTAILKVFESELVATGVNETLAKELGYDIKTIFIKDSDHPSYYPNPTPLALKLILNKKTNTLIGAQMYGSNLSVLRINFLISLIWNQIEINQELTQVDLPYSPPFSRVVDIIHIALEKLIKN
>NZ_CP012387.1|WP_020863062.1|1052670_1054248_-|dicarboxylate/amino-acid:cation-symporter
MQDKTNVLLDKFLAIGSWQAAIAIIIFIGIQIGLWFTFKKFKIKFIYRVLIGLAIGLVFGIIIQAIYKFPQNGLVNKNLPTELAKDGTTTIKINPDFRLWVYQLDIWISLAKNIFINGILLLTAPVVFIAIFRVTSKKGNKNVGRISLKGVGLLLLNTAFAFVITFWLGYLIKVGAGSGLSLDHSIVKNTPKETQPLPKIVWEYLPNNFIQPWLGSMVIPLMVIAGLIGNSVKILSKKKPVEMDAIRKGMDVAWSIVISILMTFMKIMPLAVMSMIASSVISKPIGALATIGKVLGLGYLGLTISLLFLTFLLFVNKVNVIAWWKLSFKILIQGFATQSSNATLPMSIETLKDEVKIDDSAVSTVVPLSTTMGLMGCAGVQSGVITSLLWTGAVSADFHNMGLFTFFILAFVITLIASLGISGIPGTATVLTSGVLSGLGLGVWFAPVYAIVGSLDGLFDMGRTGVNVTSGAVVTTIVAKSEGLIGEESTILSKHQLEKQKIIREKKSKPEIKEAQQTNKVEVKN
>NZ_CP012387.1|WP_020863061.1|1050633_1052523_-|tRNA-uridine-5-carboxymethylaminomethyl(34)-synthesis-enzyme-MnmG
MKSNYDVIVVGGGHAGVEAALASARLNKKTALINLYEDKIATMPCNPSVGGPAKGIVVREIDALGGEMAKAADATALQTKLLNSSRGPGVWALRVQSDKEEYSKYMRNVIKNQKNLDLITRACTGLVYDDNKTVTGIYLDDQTILNAKAVIITTGTYLKSEILKGVDRYESGPNNEKTTKGISKSLIDLGIKLMRFKTGTPARVYRDSVDLTNAVLEPGTDMKLAFSFSTNTYTPIEKQQPCYLIHSTLETKKIIEDNLEKSAMYSGTVESIGPRYCPSFEDKVVRFKEKDTHQIFIEPETLNGDTWYVQGFSTSMPIEVQELMLKSLPGFENVRVKHWAYAIEYDCIDPMQLSPSLELKDVRNLFTAGQINGTSGYEEAAGQGLIAGINASRKIDGLDPIILRRDEAYIGVMIDDLVNKGVWEPYRLLTSRAEHRLLLRNDNAETRLKQYGREIGLISDQEWNQYLIYVNEIEQAIKELKEIRFTPKSQLAINLKNKNQADLSHGYSGYEIIKIPTVDINELIEFIPSLQKLKTNQLQSIVIEIRFEGYVKKERQLVDKLVKLERKKIPLDINYSKVDNLATEAKDKLEKIRPLNIGQASRITGVNPADIQMLLFYLKKQYPLENIDN
>NZ_CP012387.1|WP_020863060.1|1049615_1050374_+|DUF3800-domain-containing-protein
MKTKNTKYISIYLDESGSGNSPFFIVGGFYLFNFDRKQIYIQEINISKNIEYIESQIKKNNKKTIDLKKIKFINLTFKNKKLLFSNIKNNNQVNISMLYDLVKFKNVNQKPILIDYLYNIMVFLILQNILFDLLKQDFINLKDEISIKVNIDQRRNYKNSSTKSNSFKELKMYLNTRMYEKSKFINMNKIEVLQFNSKLEPNIRYADYYVGLLSSVRRILKNQAKSYDFKSDKLLCLLNNKIKHIEYKNIFS
>NZ_CP012387.1|WP_020863059.1|1048431_1049412_-|aspartate--ammonia-ligase
MYKSKLSIKQTQQAIQDIKFGLTKQLKQNLNLTRVSAPLFVTSESKINDGLNGDIPVVFTPNQWNEDLEIVHSLAKWKRYALDKYNFNFGEGIWADMNAIRKDDVVDYKHSLYVDQWDWELIISKEQRNLEFLKQIATKIYDSIRYVEHKINFKYPDLIDKLPKQLTFIDSLDLYNKYPNLTAEQREDEVAREYKAVFIYKIGYDLPDKKPHSKRAFDYDDWNLNGDLIFYDLVNDKALEISSMGIRVDAKSLSEQTKMLNKTDSDLGLYHDQVLNDKLPLTIGGGIGQSRLSMFLLEKAHIGEVQVSVWEKQYKEELKKQGIILL
>NZ_CP012387.1|WP_020863058.1|1047730_1048375_-|hypothetical-protein
MTLAWIKTNYESHINELIKYLDSNWTTEKIYKKIIHFENNKFKTSPFFNHNQLKTLFNLMLIKNSYQKRITKRVLEIILNKDVLEWIFIDALIRFYVLVLTYDDVWQEYEISDFAMHNNIIDVDKYFQNYLDKSNLKSVRFYQQYIKKNIEDLQIKKNLLDQLKDLDCDYITIDFNTLTITKKVCVSNINLKYKDYVIEQFINMLEKSNQLVEI
>NZ_CP012387.1|WP_020863057.1|1046098_1047526_-|MFS-transporter
MKTVEKWSQNHKMLYGSILWAFIGFGYLLFIANWAFAIGLAGGGIKDGVTSPGFLGYFKIVNDQSFQLTNTAANWAITFGRGIGSVAVAFLLVKFAHKRATLIACVMTLFGLPAIFMPGEKYGYVLFLILRTVMAIGGTMLTILFQPVAANFFTKKAKPVYSQIAIAFFPLGSIVSLVPFVIAGNSEAVQNIQNNWKLVFGIMSLLYLIPLLAVLFLGTNFDVKKDSNEPKVNGFKILKGYLKTKSTYAWLLVFGGWLVVAVFPTSLSLLLFPWISGLESNTLANEIRIWQILFLFAGTVGPVIVGLWSRFNLKRRWYIVALTGMGILLFILSIIVYKFGLATNYSQQSKSLSGNYKGWLALFYILGFLSGFCTWGIEAVILNLPHEYKDADPKTIGWMFSLIWGFGYMFFTFSLIIVSSIPLLGIEKKASVAIIQVVLIVLLALLSFVGILMLKEPRDDAKTFPNFKSKQKEIK
>NZ_CP012387.1|WP_020863066.1|1059968_1061192_+|phosphatase-PAP2-family-protein
MLVETNKKNKQVIFNLKNSKYYSSYFIYICVGILFILGLIALIFSTPYKNDFKLSQFFEKITNYELGKWWARGTELIGDTQVLIYYLALFMIAIECFFAYKKQNKNLFFIKHYYLVKIIYILILFTIISIAIFRIYKVYNFDNGFGKYGDLVFQDTIIYRQVLTTLILVYQVIILSLFFYTIHFKLAKRSDILTNKYFSKSIKILIIGPFLLTVVTLIKGMTSRPFYWNVIFADLLNKMSKTHPEFVTYYLKQEDFQLGFLASSLDFKQYDFLKLVDINQIKNMYFSNANSTDNWAWYVFNGFFSPSKYTCQFTYYQEWAFPSGHACQTMVVGYAWYSIFITDKKLTTKKLMFCFVYLLFLISMSFALVATRGHWVSDVAFSYVFAIPLIVIVEIIYKKLSIKYFKI
>NZ_CP012387.1|WP_020863067.1|1061322_1062528_+|phosphatase-PAP2-family-protein
MTNTLPKKDAISTEFKLKQQKTFSFKPIFISLIIIYVLAIISLIFSTPYKYDFKLSQFFEKGLKFEIVKYWSMWYEIVGDTEIIIVYLSVVMILVESFFKWKTINNQINFWSKNKWILKAIYIIIIISWLIQVIIKNIKTFNQDNGFGSSGDAVLLDSNIYRNSGNILVSVIHTILLISVFYWIHFKFARSKNFLINQYWIDALKVLIVILVSTSTVILKGMTSRPFYYNVIYNDLLERVKLNGNNHWVEHYLNQDVFKHGFLDVKTNKYIANSTTDWPWYVSNGFFNPSKYTNQFNYWHEWAFPSGHVAASLVLGYVLYLFITKNNKITYKTLIILGIYLLHLFSMSFALVVSRGHWVSDIAFSYVFYIPLIVVINMYSKNWILKITDLINKKLYSKKGC
>NZ_CP012387.1|WP_020863068.1|1062610_1064875_-|helix-rich-protein
MKKLTSLLAVISVITATGLGYVGYKNIAVSNNTKEQSMLNQIKSIKKELKTKELELKNIQKILNDSENKKNELTNQINNLDANITSLNDKGKTNKNRLNKLDADLVKINSEIKLDNQNISLKENEIKKLEEQIKENKRLLKTILNEFFKKEKELEDLFAKNEKINKEKSELENVKKSFSDEIHKLESIVQKSNWKYLILNQKLSDIKKYNERINLLNSQINNLKEQSKILKTQFDLEKSKLSDIEAKISFAESQLINVKSEQERIKNQLQQKQNEIDKNNKLISNLEAQLQQLKSELENLNSQKSENWNKDLKNQLKEKQDQLTQIKSEITKNEQAINRLKEQVTSLESELETSRNNNLEKQNELKEKQKKIENINKENNSKKQESLQLESQINILNSKIQEQEKVSQELEKKIKKVEKNKNIIEEEIEKLRKKITEEQKTIKNLKDQDYVLELEYDKTDSYKESLKIQTKVFEIEIRKIEHKQKEIKKELKTKEQEHKTLISETKDLSQRTKDLERQVSLSKQRIEQLNLEKTKKETELKDLESKIDKMEFNLTKEGLEKEIQNKQKEIEQLKEDKESLLATQSEIEKLLQDYESDKKDIKKQIAANMITQGSLEEEIEKTEKENRKLLSEIDGILSKKNILKQEVEHMQDTIDEIRNKEPINIDKEINTSVDLVNEIIVTMGKWNKALAHIKPNITNKIRYGLEPSLEEHFKHIESELKIITELDEALNSFIDNFNDKFDDNYLNVDNENNR
>NZ_CP012387.1|WP_020863069.1|1064884_1067146_-|helix-rich-protein
MKKLIVLLTAISVFSAAGISYVGYKNLSNDTTINNQEHEFKQLEEKLRTLQNEILNSEAKIKDLDTKDAEIIKNSNEKIKILKQLESDITSKLTQENNKINELIKNLNISISESKIKKEQKIKLEQELAKLKREKLKNDANHTFFNGEIRKLQDKLVLSNTKLDELKERIKSYESELIKLETDKNNKQKNIDKVKNELAKKQHLILVLKLKIQEYDQLLKDYSNLEEQFNSLKKSVNEKQKEIQEKTEILQRTHEQLQQLSNSNDNDKKELKNKISKLEQTEEKISNLNNQINQVKSEISDLNKKKESDLMNVKSEISDIDKQLEIANTKLSQSNESISQLKEVIKQLKKDKSHSTLENQKLDRQIEEKNTAIQKLEKEQQQYLTNIEKLNTQKSNLEQKLEKIKKENELKEQQLENQQLEYEKLSREYTRLLAFRIVLNSEISDLTNEIAAKKIILKNHKKFIEKEEQYLESLTKKYNSIKQDLKIKQQQFEQKKSELLMLKAQKTESENKISNLTKEQSEFIEKQKQLSTEIKEINNKISSKKDEFLKDNDDLKRIKEVVDSSNKTIEELKHTNENIERANTEKQEEIDKKADKILDLIKEVEMYETKISQLTRDLNLAEKEHERLSTIKANIESASNKIIEYIQQIRFGFKTTKESLAEIIKKDQELKEDLSSFSELVKKWLVPEELSVRYNEYIKKMTPIQEKINKNHKEIKELNSKLDQYKKEIKDNIKNLEKIIYDAISNNASELTE
>NZ_CP012387.1|WP_020863070.1|1067463_1069719_-|helix-rich-protein
MKKLTSLLAAISVFTATGLGYVGYKNITNFKDTEQNNVINKIKTIKNDLENSQQELKNLEKLLKEKENKKTNLNTEIKILETSINNLNNKTKTNKTKLDKLNADLLNVNNQLDIDKQNISKKEVQISSLEKQIKETKKNIDKVATEILNKHKQIKELSNKNKDTTKLKEQLENYKTTFINELSNIKSALNKIRNKRFILELRLSNIKKYEEKNKTLVSQTNDLKKQNTQLTNEVETLNQQLNKTNSELESITQKINDTKQEQEKIKKQLIDKQKQITQNNKKIDQLTKLVKEYENQLEILKNEKNQVWHKELKDELKSQENKLSEVDSQINKNNQLISELNRDISKLKQELSNLENDNSTKQQELNEKLNKIQTIKNENQSYFKQKYDLEIKTRSLKSKIRHQEQIAKKLDIKIKGIQTNKSLLEKEIDNLKQTTTKNKETLKDLIKEDNQLENKFNKLNILRDELKTKIEIFKLSIKKAKSDLEWTNKQLVEKEKQIKNITNEISQLKQQQKDLVKEISFLTNSINKLESEKNTKETKLKQLETEINNIESGLTKEKLEIELNEKQKEIEQLEQDQKSLLVNQEEADKLLKEYEDQKKEINKGLSKKTYTITTLEKQITEIQKENSDLDTEIRNIKNMKSSLVQEVKFIQTTIDNIINKKPDNADKKIKDSISKIDDVINLMETWKQEKWLHLKPYITEHLKNIDLPTLEEHYKYVEKEIKIQEEFSNILEQLIDIFNKKYDDDILKPNQ
>NZ_CP012387.1|WP_020863071.1|1069728_1071990_-|helix-rich-protein
MKRLILLLTAISVPTASGISYVRYKNLSTNNTINKQDNELRRLEKELEQIKYEIKTREDKIKALDLKDAKDIQNINTKIELLKQQEKQIKDKLTKESNVINKLNEDIRLFKAEVKTKKEQKNKLEVEFNKLKEQKNQTNKKQFLINTRISWLKDQLNSSNVDYDNLKKLIETYKNDLLKLEKDKLDKLKNNSDLNKQLTRSKYLLSVLQAKIQKQTELQTKLVELEEQKNNLQKTAKEKQQEINNKQAILNNNKDQLKQLIESSTNNKNQLDNKTLELNQTSKKIKELEDQLNKLKSEISDLNKQKEEDLLKVKTNIQNNKNQLEVLQNQLDQINKKIDELKQSIEQIKKSIKDKQTENQELDEQLKEKNIELEKLKKEKQKYLNSIEKLTKKSNDLEQTFKDITNSNKQKEQQIKTLEQEYNKLLKQHKLLLALRIDQNSQISSLTEDITVKKLIITNLEKTTSIQQKEVDKLSGEYNIIKKNLQDKSKELKEKTSEFLKLNNEKTNLEKQVKDFTEKQKELLEKQKKLSSEIKQIESKTSEIKNKLLKDDQGLKNIKEVIDGLNQKISELKHTNDNLTKSNDKKYDIADQKAAEIVDLIKEIETKESKISELDKEIRIVRKKHKELSIIESNLELSSEKINQIIKQVKEELKKAKNTWNEMVFKNTDIKKTIDEFIQTTKKWLDPKELSIHYSKYVSEMTRIKWQIADKYKNIQRINAKFLDHKKNLEINISNLEKIVDYALNNNFLELID
>NZ_CP012387.1|WP_023905987.1|1072183_1074436_-|helix-rich-protein
MKKLSVLLATVSVFTSTGFAYVSLKNIAVKRDTREDDITKKLNTLKKQLEQKQKAVKNIENNFNLRITKINSFNSEINDLEKEISSLNNKLMVNNDKLTKLDSDSKKIDEDIKNNNSQMNNNKEQSSKLEKELKEVEKQIYKNLVELTKEDNIATKLNEKFNDLINKKHNVEDKEHEVEHEIAKINNDLLKTKLEELRLEKILTSIKEYTEKNRSLEAKISESKSKVSQIKDDIQKLTSDKNGLVQEINKTQQEILTTTQKQNHIKKQLSDKQKEVVRNNGILEQKNKDLNNIKAELEELNNQKAQNLIKNLKEILDKKEKDKQNIEKQISNNQKTISKLNDEISNLKRELTNSNSNNSSIKTEIAEKENQIKTIKEENESKKQELQNLESNINDLNRNISNQEELNKQLDSKIQVKQQEKQSKEQEIQIIKEENSKANDEIKNLENKNSDFNKEIKSLNDTKTQIEQKISDVSNSIKNEKTNLENVTKELDSKVKELDELKEKNKNSSEEIQVLKSKIESSKLKIQDLEKTKLRKEQEISNLEKELESLDYDKNYNLLEKQKLENDEKINKLHQEQTSLKNKQKELKEKLQQLETNQSDLRKELLEKTKTKENLTGEVTHLNAENKKIEQLIKKIQSKKEKLEKQVELIEKPALTAIEKSNIILDSINASVYKVQNITDLMSDWNKSTRITEKKRITRQITNSDLPKLVEHYESISNNLKDLEKFDKELGQMIQDFNKKFDDKFFEIDN
>NZ_CP012387.1|WP_020863073.1|1074459_1076700_-|helix-rich-protein
MKKLVALLAAISVFSAAGFSYVVYKNIHNQRSFLNTHQNEVKELEKQLKSVSDDINTKENQLKVLLLEDEKNFISSKDKFNELKQKQKELIKKDSDQKQMISKLTRDLTNLKLESKTKNDLKIKSESELINLKKIKEHKDEIKDYFIKEIKNKESELAKKNNEINTTITEIESLKKELDQLNKNKDKKQQEIATIKNQINKDYLLLFKLKTKISRYKKLEKELLELNKQTNTLTDSKIQKQVELNQQKAVLKEKQTQLNNLLDELNKNIDQLNKNNNELENINKQIKETEDQIQTIKTKISELKKEKQADIDKVNSEIRNKEKEIRDLQTQLDQTNSQISSLNQQINDLEKQKQNSTSENNTLTEQLEKKKNELKQLINQKESYLDSIKNLKQQKQELETQLDQAKKQEQQKQEQIKKLEKDLETLDKRIKRLKVEKTDLASQIDELNKTKTSKEKLVNSLKQIIESQQNNLSTLERQYNSIRQTLDQNQQEITRKTNELSSLNSQKQQLENEVKNLTDQSSELNEKQDALNKEINELDSKISTINSDKKTKKERLDWLKGSVDHQNKELDKLKLEIKASDSENFKLQLDVKNKQKEFDNLTSQIELLDAQILTLKKELKLAKAKNEKLVENKKKIDSAYESVQTLIKNIKTILKNIKSDFSELNKEIKTLKELSDKYIQYIEQWLNPKEDDKNFEKYYLFLIGFQNEIEPKQTAIKQITQKLKDNSTSLDNIVKEINQKIQEITS
>NZ_CP012387.1|WP_020863074.1|1077019_1077655_+|lipoprotein
MKKLITILGSVGLVATTSAAVIACGDRAPSTKSAEKVENKEKTKPSEAPKKEESKKEEKKQEEFQPKFSDVENKNLGNFEPSNKNTISQLDIKKELAKKLNVNESDLQELKINYDEKTGKVTLPRFNNKNLKFNFTTFYQLGKIKTNKTGDIWFLSQLDIKKELAKKLNVNESDLQELKTDSSSNGIGFGSVRSKTFVGTLEFKFEIDENK
>NZ_CP012387.1|WP_020863075.1|1077877_1078489_+|lipoprotein
MKKLLTILGSVGLVATTSAAVIACGDKTPQKTPGTNPTEETKKEEDKEKPKKDDEKTEDKEKMDFSKIDKNLGNLEPDNRNILSQDRIKEEIAKRMNVTKPDLQGLQVDYEKGTVKVTLPRFENKTIEFAFTSYLDLRKSFETSKNGKSFLDISKIKEEIAKRMNAKPEELQELSVDSNNNTGTVHSTKFTGTLTFKFNTEKK

You can click texts colored in the table to view more detailed information

Click the colored protein region to show detailed information

Self-targeting detection

CRISPR_ID	Spacer_Info	Spacer_region	Spacer_length	Hit_ID	Protospacer_location	Mismatch	Identity

MGE targeting detection<

CRISPR_ID	Spacer_Info	Spacer_region	Spacer_length	Hit_phage_ID	Hit_phage_def	Protospacer_location	Mismatch	Identity
NZ_CP012387_2	2.1\|229432\|33\|NZ_CP012387\|CRISPRCasFinder	229432-229464	33	NZ_CP013682	Clostridium botulinum strain 1169 plasmid pRSJ8_1, complete sequence	13914-13946	8	0.758
NZ_CP012387_2	2.1\|229432\|33\|NZ_CP012387\|CRISPRCasFinder	229432-229464	33	NZ_CP013295	Clostridium botulinum strain CDC_54064 plasmid pNPD1_1, complete sequence	24630-24662	8	0.758
NZ_CP012387_2	2.1\|229432\|33\|NZ_CP012387\|CRISPRCasFinder	229432-229464	33	MN812211	Flavobacterium phage vB_FspS_laban6-1, complete genome	22169-22201	9	0.727
NZ_CP012387_2	2.1\|229432\|33\|NZ_CP012387\|CRISPRCasFinder	229432-229464	33	CP019152	Acinetobacter lwoffii strain ZS207 plasmid pZS-2, complete sequence	8788-8820	9	0.727
NZ_CP012387_2	2.1\|229432\|33\|NZ_CP012387\|CRISPRCasFinder	229432-229464	33	MN693975	Marine virus AFVG_250M1117, complete genome	8793-8825	9	0.727

1. spacer 2.1|229432|33|NZ_CP012387|CRISPRCasFinder matches to NZ_CP013682 (Clostridium botulinum strain 1169 plasmid pRSJ8_1, complete sequence) position: , mismatch: 8, identity: 0.758

gttcattataattttatcataaaaatacctacg	CRISPR spacer
atctgctataatttcatcataaaaataccaacc	Protospacer
.*....********.************** **

2. spacer 2.1|229432|33|NZ_CP012387|CRISPRCasFinder matches to NZ_CP013295 (Clostridium botulinum strain CDC_54064 plasmid pNPD1_1, complete sequence) position: , mismatch: 8, identity: 0.758

gttcattataattttatcataaaaatacctacg	CRISPR spacer
atctgctataatttcatcataaaaataccaacc	Protospacer
.*....********.************** **

3. spacer 2.1|229432|33|NZ_CP012387|CRISPRCasFinder matches to MN812211 (Flavobacterium phage vB_FspS_laban6-1, complete genome) position: , mismatch: 9, identity: 0.727

gttcattataattttatcataaaaatacctacg	CRISPR spacer
ttttattataattttataataaaaatcaacaat	Protospacer
 **.************* ********   .*

4. spacer 2.1|229432|33|NZ_CP012387|CRISPRCasFinder matches to CP019152 (Acinetobacter lwoffii strain ZS207 plasmid pZS-2, complete sequence) position: , mismatch: 9, identity: 0.727

gttcattataattttatcataaaaatacctacg	CRISPR spacer
gagcattataattttaacataaatatatgaatt	Protospacer
*  ************* ****** ***.  *.

5. spacer 2.1|229432|33|NZ_CP012387|CRISPRCasFinder matches to MN693975 (Marine virus AFVG_250M1117, complete genome) position: , mismatch: 9, identity: 0.727

gttcattataattttatcataaa-----aatacctacg	CRISPR spacer
tttcattataatttgatcatcaaaaagtaatat-----	Protospacer
 ************* ***** **     ****.

Prophage detection

Region

Region Position

Protein_number

Hit_taxonomy

Key_proteins

Att_site

Prophage annotation

DBSCAN-SWA_1

911803 : 925847

Lactococcus_phage(25.0%)

The bacterium proteins that are colored denote the protein is present at specific phage-related keywords (such as 'capsid', 'head', 'integrase', 'plate', 'tail', 'fiber', 'coat', 'transposase', 'portal', 'terminase', 'protease' or 'lysin' and 'tRNA')

Protein_ID	Protein_Def	Hit_ID	Hit_Def	E-value	Identity
WP_020862973.1\|911803_913102_-	adenylosuccinate synthase	L7Y4J5	Megavirus	2.5e-57	34.6
WP_020862974.1\|913322_913475_-	hypothetical protein	NA	NA	NA	NA
WP_023905979.1\|913455_914133_-	hypothetical protein	NA	NA	NA	NA
WP_020862976.1\|914132_914852_-	site-specific DNA-methyltransferase	A0A0C5AFG8	Paenibacillus_phage	8.3e-15	26.6
WP_020862977.1\|914912_915758_-	DUF285 domain-containing protein	NA	NA	NA	NA
WP_020862978.1\|915863_918026_-	class 1b ribonucleoside-diphosphate reductase subunit alpha	V9VI16	Lactococcus_phage	9.4e-163	44.3
WP_020862979.1\|918012_918486_-	class Ib ribonucleoside-diphosphate reductase assembly flavoprotein NrdI	R4JF54	Bacillus_phage	1.0e-13	35.0
WP_013729882.1\|918494_919514_-	class 1b ribonucleoside-diphosphate reductase subunit beta	B5LJM6	Mycobacterium_phage	2.5e-97	53.7
WP_013729883.1\|919812_920097_+	preprotein translocase subunit SecG	NA	NA	NA	NA
WP_020862980.1\|920132_922247_+	ribonuclease R	Q0GXV6	Lactococcus_phage	1.6e-61	32.8
WP_013729885.1\|922256_922703_+	SsrA-binding protein SmpB	W5RAM5	Staphylococcus_phage	1.1e-20	38.5
WP_020862981.1\|922702_923188_+	hypothetical protein	NA	NA	NA	NA
WP_013729887.1\|923307_923559_+	hypothetical protein	NA	NA	NA	NA
WP_020862982.1\|923609_925847_+	PTS transporter subunit EIIC	A0A2I7SAJ6	Vibrio_phage	9.6e-09	45.5

Anti-CRISPR protein detection

Acr ID	Acr position	Acr size	Homology with known anti	Neighbor HTH/AcRanker	Neighbor Aca	In prophage	Protospacer in prophage

Overview of predicted results

Overview of the results

Cas Category Instructions

Results visualization

1. NZ_CP012387

Click the left colored region to show detailed information

CRISPR-Cas detection and classification

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Click the colored protein region to show detailed information

Self-targeting detection

MGE targeting detection<

Prophage detection

Anti-CRISPR protein detection